George A. Poultsides, MD, MS

4.8/5

21 Patient Ratings

396 Patient Reviews

George A. Poultsides, MD, MS

Hepatobiliary surgeon, Pancreatic surgeon, Liver surgeon, Sarcoma specialist, Gastrointestinal specialist, Minimally invasive surgeon

Professor of Surgery (General Surgery)

View Professional Summary

Additional Languages Spoken:

Greek

Insurance Coverage

Online Second Opinion Program

Resources for Referring Physicians

Biography

Dr. Poultsides is Section Chief of Surgical Oncology and Professor of Surgery at Stanford University. He is a high-volume oncologic surgeon specializing in the management of complex cancers of the pancreas, liver, stomach and retroperitoneum. He joined Stanford in 2009 after completing fellowship training in Surgical Oncology at Memorial Sloan Kettering and in Hepato-Pancreato-Biliary (HPB) Surgery at Johns Hopkins. From a scholarly perspective, he has published extensively on the multidisciplinary management of HPB and upper GI malignancies. In addition, he directs an R01-funded molecular imaging program in pancreatic cancer and oversees a first-in-human clinical trial of fluorescence-guided surgery in patients undergoing pancreatic cancer resection. In his role as Co-Lead of the GI Oncology Clinical Research Program at the Stanford Cancer Institute, he provides oversight of the institution’s portfolio of surgical clinical trials in GI cancers. He serves as the Program Director of Stanford’s Complex General Surgical Oncology Fellowship and is a frequent recipient of teaching awards within Stanford Surgery.

View Full Biography

Professional Summary

Education & Certifications

Residency: University of Connecticut School of Medicine Registrar (2007) CT
Fellowship: Johns Hopkins University School of Medicine (2009) MD
Fellowship: Memorial Sloan-Kettering Cancer Center (2008) NY
- MS, Stanford University, Epidemiology (2011)
- Board Certification: American Board of Surgery, General Surgery (2008)
- Medical Education: University of Athens Medical School (2000) Greece

View More Education & Certifications

Honors & Awards

Andrew Canzonetti, MD Award, Outstanding 4th Year Surgery Resident, Department of Surgery, University of Connecticut School of Medicine (2006)
Best PGY-5 Rotation Award, Stanford General Surgery Chief Residents (2012)
Best PGY-5 Rotation Award, Stanford General Surgery Chief Residents (2016)
- Best PGY-5 Rotation Award, Stanford General Surgery Chief Residents (2017)
- Best PGY-5 Rotation Award, Stanford General Surgery Chief Residents (2018)
- Best PGY-5 Rotation Award, Stanford General Surgery Chief Residents (2024)
- Cancer Innovation Fund Award, Stanford Hospital and Clinics (2012)
- Charles Polivy, MD Memorial Award, Department of Surgery, Hartford Hospital, University of Connecticut School of Medicine (2005)
- Faculty Seed Grant, Stanford University Department of Surgery (2019-2020)
- Henry Mannix, Jr, MD Award for Clinical and Academic Excellence, Saint Francis Hospital & Medical Center, University of Connecticut School of Medicine (2007)
- Highly Sensitive Detection of Occult Pancreatic Cancer Using Intraoperative Molecular Imaging, 1 R01 CA273035-01A1 (PI) NCI/NIH (2023-2028)
- James Foster, MD Visiting Professor, University of Connecticut School of Medicine, Department of Surgery (2017)
- John Austin Collins, MD Memorial Award for Outstanding Teaching and Dedication to Resident Training, Department of Surgery, Stanford University (2013)
- Ludwig J. Pyrtek, MD Prize for Clinical and Scientific Capabilities, Department of Surgery, Hartford Hospital, University of Connecticut School of Medicine (2007)
- Pancreatic Cancer Innovation Award, Stanford Cancer Institute (2023-2024)
- Testing Molecule Hypotheses in Human Subjects, Sarafan ChEM-H (Chemistry, Engineering and Medicine for Human Health), Stanford University (2022-2024)
- Translational Research Award, Stanford Cancer Institute (2016)

View More Honors & Awards

Memberships

Editorial Board, Annals of Surgery (2022 - Present)
Editorial Board, Annals of Surgical Oncology (2018 - Present)
Editorial Board, Journal of Gastrointestinal Surgery (2018 - Present)
- Editorial Board, Journal of Surgical Oncology (2017 - Present)
- Associate Editor, BMC Cancer (2015 - 2020)

View More Memberships

Administrative Appointments

Chief, Section of Surgical Oncology, Stanford University (2019 - Present)
Co-Lead, Gastrointestinal Oncology Clinical Research Program, Stanford Cancer Institute (2019 - Present)
Instructor in Surgery, Johns Hopkins University School of Medicine (2008 - 2009)
- Program Director, Stanford University Complex General Surgical Oncology (CGSO) Fellowship (2019 - Present)

View More Administrative Appointments

Publications

Distal trapezius musculocutaneous flap for upper thoracic back wounds associated with spinal instrumentation and radiation
Chun, J. K., Lynch, M. J., & Poultsides, G. A. (2003). Distal trapezius musculocutaneous flap for upper thoracic back wounds associated with spinal instrumentation and radiation. ANNALS OF PLASTIC SURGERY, 51(1), 17–22.
Endovascular stent-graft placement for nonaneurysmal infrarenal aortic rupture: A case report and review of the literature
VASQUEZ, J., Poultsides, G. A., Lorenzo, A. C., Foster, J. E., Drezner, A. D., & Gallagher, J. (2003). Endovascular stent-graft placement for nonaneurysmal infrarenal aortic rupture: A case report and review of the literature. JOURNAL OF VASCULAR SURGERY, 38(4), 836–839.
Double trisomy (48,XXY,+21) in monozygotic twins: case report and review of the literature
Iliopoulos, D., Poultsides, G., Peristeri, V., KOURI, G., Andreou, A., & Voyiatzis, N. (2004). Double trisomy (48,XXY,+21) in monozygotic twins: case report and review of the literature. ANNALES DE GENETIQUE, 47(1), 95–98.
- Common origins of carotid and subclavian arterial systems: Report of a rare aortic arch variant
  Poultsides, G. A., Lolis, E. D., VASQUEZ, J., Drezner, A. D., & Venieratos, D. (2004). Common origins of carotid and subclavian arterial systems: Report of a rare aortic arch variant. ANNALS OF VASCULAR SURGERY, 18(5), 597–600.
- Portal vein thrombosis after laparoscopic colectomy: Thrombolytic therapy via the superior mesenteric vein
  Poultsides, G. A., Lewis, W. C., Feld, R., Walters, D. L., Cherry, D. A., & Ruby, S. T. (2005). Portal vein thrombosis after laparoscopic colectomy: Thrombolytic therapy via the superior mesenteric vein. AMERICAN SURGEON, 71(10), 856–860.
- Range of movement in the wrist as a diagnostic tool in radial-sided wrist pain
  Wollstein, R., Watson, H. K., Poultsides, G., Wear-Maggitti, K., & Carlson, L. (2006). Range of movement in the wrist as a diagnostic tool in radial-sided wrist pain. SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 40(4), 230–233.
- Carcinoid of the ampulla of Vater: Morpholdgic features and clinical implications
  Poultsides, G. A., & Frederick, W. A. I. (2006). Carcinoid of the ampulla of Vater: Morpholdgic features and clinical implications. WORLD JOURNAL OF GASTROENTEROLOGY, 12(43), 7058–7060.
- Hand-assisted laparoscopic management of liver tumors
  Poultsides, G., Brown, M., & Orlando, R. (2007). Hand-assisted laparoscopic management of liver tumors. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 21(8), 1275–1279.
- Angiographic embolization for gastroduodenal hemorrhage
  Poultsides, G. A., Kim, C. J., Orlando, R., Peros, G., Halliscy, M. J., & Vignati, P. V. (2008). Angiographic embolization for gastroduodenal hemorrhage. ARCHIVES OF SURGERY, 143(5), 457–461.
- Epigenetic regulation of hTERT promoter in hepatocellular carcinomas
  Iliopoulos, D., Satra, M., Drakaki, A., Poultsides, G. A., & Tsezou, A. (2009). Epigenetic regulation of hTERT promoter in hepatocellular carcinomas. INTERNATIONAL JOURNAL OF ONCOLOGY, 34(2), 391–399.
- Image of the Month Left Paraduodenal Hernia
  Poultsides, G. A., Zani, S., Bloom, P., & Tishler, D. S. (2009). Image of the Month Left Paraduodenal Hernia. ARCHIVES OF SURGERY, 144(3), 287–288.
- Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment
  Poultsides, G. A., Servais, E. L., Saltz, L. B., Patil, S., Kemeny, N. E., Guillem, J. G., … Paty, P. B. (2009). Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment. JOURNAL OF CLINICAL ONCOLOGY, 27(20), 3379–3384.
- Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas
  Poultsides, G. A., Reddy, S., Cameron, J. L., Hruban, R. H., Pawlik, T. M., Ahuja, N., … Wolfgang, C. L. (2010). Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas. ANNALS OF SURGERY, 251(3), 470–476.
- Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome
  Poultsides, G. A., Schulick, R. D., & Pawlik, T. M. (2010). Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome. HPB, 12(1), 43–49.
- Intrahepatic Cholangiocarcinoma
  Poultsides, G. A., Zhu, A. X., Choti, M. A., & Pawlik, T. M. (2010). Intrahepatic Cholangiocarcinoma. SURGICAL CLINICS OF NORTH AMERICA, 90(4), 817-?
- Colloid Carcinoma of the Pancreas
  Plerhoples, T. A., Ahdoot, M., DiMaio, M. A., Pai, R. K., Park, W. G., & Poultsides, G. A. (2011). Colloid Carcinoma of the Pancreas. DIGESTIVE DISEASES AND SCIENCES, 56(5), 1295–98.
- Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy
  Ghole, S. A., Bakhtary, S., Staudenmayer, K., Sze, D. Y., Pai, R. K., Visser, B. C., … Poultsides, G. A. (2011). Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy. DIGESTIVE DISEASES AND SCIENCES, 56(7), 1949–53.
- Laparoscopic Duodenojejunostomy for Superior Mesenteric Artery Syndrome
  Magee, G., Slater, B. J., Lee, J. T., & Poultsides, G. A. (2011). Laparoscopic Duodenojejunostomy for Superior Mesenteric Artery Syndrome. DIGESTIVE DISEASES AND SCIENCES, 56(9), 2528–31.
- Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection
  Norton, J. A., Harris, E. J., Chen, Y., Visser, B. C., Poultsides, G. A., Kunz, P. C., … Jensen, R. T. (2011). Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection. ARCHIVES OF SURGERY, 146(6), 724–32.
- Hybrid Resection of Duodenal Tumors
  Poultsides, G. A., Pappou, E. P., Bloom, G. P., & Orlando, R. (2011). Hybrid Resection of Duodenal Tumors. JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 21(7), 603–8.
- Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective.
  Poultsides, G. A., & Paty, P. B. (2011). Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective. Therapeutic Advances in Medical Oncology, 3(1), 35–42.
- Surgical Management of Neuroendocrine Tumors of the Gastrointestinal Tract
  Huang, L. C., Poultsides, G. A., & Norton, J. A. (2011). Surgical Management of Neuroendocrine Tumors of the Gastrointestinal Tract. ONCOLOGY-NEW YORK, 25(9), 794–803.
- Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
  Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., Ford, J. M., … Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. CHICAGO,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL: ELSEVIER SCIENCE INC.
- Hybrid Treatment of Celiac Artery Compression (Median Arcuate Ligament) Syndrome
  Palmer, O. P., Tedesco, M., Casey, K., Lee, J. T., & Poultsides, G. A. (2012). Hybrid Treatment of Celiac Artery Compression (Median Arcuate Ligament) Syndrome. DIGESTIVE DISEASES AND SCIENCES, 57(7), 1782–85.
- Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts
  Tun, M. T., Pai, R. K., Kwok, S., Dong, A., Gupta, A., Visser, B. C., … Park, W. G. (2012). Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts. BMC GASTROENTEROLOGY, 12.
- Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
  Poultsides, G. A., Huang, L. C., Chen, Y., Visser, B. C., Pai, R. K., Jeffrey, R. B., … Norton, J. A. (2012). Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis. ANNALS OF SURGICAL ONCOLOGY, 19(7), 2295–2303.
- Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome
  Poultsides, G. A., Bao, F., Servais, E. L., Hernandez-Boussard, T., DeMatteo, R. P., Allen, P. J., … D'Angelica, M. I. (2012). Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome. ANNALS OF SURGICAL ONCOLOGY, 19(9), 2797–2804.
- Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
  Visser, B. C., Ma, Y., Zak, Y., Poultsides, G. A., Norton, J. A., & Rhoads, K. F. (2012). Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB, 14(8), 539–47.
- Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
  Krampitz, G. W., Norton, J. A., Poultsides, G. A., Visser, B. C., Sun, L., & Jensen, R. T. (2012). Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors. ARCHIVES OF SURGERY, 147(9), 820–27.
- Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement?
  Patel, M. I., Rhoads, K. F., Ma, Y., Ford, J. M., Visser, B. C., Kunz, P. L., … Poultsides, G. A. (2013). Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement? ANNALS OF SURGICAL ONCOLOGY, 20(5), 1631–38.
- Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?
  Kastenberg, Z. J., Morton, J. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2013). Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric? HPB, 15(2), 142–48.
- Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
  Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2013). Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. Gastrointestinal Endoscopy, 78(2), 295–302 e2.
- Gastrointestinal stromal tumor: an unusual cause of gastrointestinal bleeding.
  Wong, R. J., Longacre, T. A., Poultsides, G., Park, W., & Rothenberg, M. E. (2013). Gastrointestinal stromal tumor: an unusual cause of gastrointestinal bleeding. Digestive Diseases and Sciences, 58(11), 3112–16.
- Diagnostic Utility of Metabolomic-Derived Biomarkers for Pancreatic Cysts
  Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2012). Diagnostic Utility of Metabolomic-Derived Biomarkers for Pancreatic Cysts. PANCREAS, 41(8), 1394–94.
- Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment
  Poultsides, G. A., Huang, L. C., Cameron, J. L., Tuli, R., Lan, L., Hruban, R. H., … Schulick, R. D. (2012). Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment. ANNALS OF SURGICAL ONCOLOGY, 19(6), 1928–1935.
- Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.
  Kin, C., Kidess, E., Poultsides, G. A., Visser, B. C., & Jeffrey, S. S. (2013). Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis. Expert Review of Molecular Diagnostics, 13(6), 581–99.
- An HNF4 alpha-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis
  Hatziapostolou, M., Polytarchou, C., Aggelidou, E., Drakaki, A., Poultsides, G. A., Jaeger, S. A., … Iliopoulos, D. (2011). An HNF4 alpha-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis. CELL, 147(6), 1233–1247.
- Reassessment of the Current American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Tumors
  Qadan, M., Ma, Y., Visser, B. C., Kunz, P. L., Fisher, G. A., Norton, J. A., & Poultsides, G. A. (2014). Reassessment of the Current American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Tumors. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 218(2), 188–95.
- Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program.
  Cloyd, J. M., Ma, Y., Morton, J. M., Kurella Tamura, M., Poultsides, G. A., & Visser, B. C. (2014). Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program. Journal of Gastrointestinal Surgery , 18(3), 605–12.
- Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.
  Worhunsky, D. J., Krampitz, G. W., Poullos, P. D., Visser, B. C., Kunz, P. L., Fisher, G. A., … Poultsides, G. A. (2014). Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB , 16(4), 304–11.
- Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy.
  Cloyd, J. M., Kastenberg, Z. J., Visser, B. C., Poultsides, G. A., & Norton, J. A. (2014). Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy. Journal of Gastrointestinal Surgery , 18(2), 348–53.
- Iliocaval and aortoiliac reconstruction following en bloc retroperitoneal leiomyosarcoma resection.
  Ohman, J. W., Chandra, V., Poultsides, G., & Harris, E. J. (2013). Iliocaval and aortoiliac reconstruction following en bloc retroperitoneal leiomyosarcoma resection. Journal of Vascular Surgery, 57(3), 850-?
- Molecular assessment of surgical-resection margins of gastric cancer by mass-spectrometric imaging.
  Eberlin, L. S., Tibshirani, R. J., Zhang, J., Longacre, T. A., Berry, G. J., Bingham, D. B., … Poultsides, G. A. (2014). Molecular assessment of surgical-resection margins of gastric cancer by mass-spectrometric imaging. Proceedings of the National Academy of Sciences of the United States of America, 111(7), 2436–41.
- Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
  Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2013). Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. GASTROINTESTINAL ENDOSCOPY, 78(2), 295-?
- Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion.
  Worhunsky, D. J., Zak, Y., Dua, M. M., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion. Journal of Gastrointestinal Surgery , 18(8), 1445–51.
- A Multi-institutional Analysis of Open Versus Minimally-Invasive Surgery for Gastric Adenocarcinoma: Results of the US Gastric Cancer Collaborative
  Spolverato, G., Kim, Y., Ejaz, A., Valero, V., Squires, M. H., Poultsides, G., … Pawlik, T. M. (2014). A Multi-institutional Analysis of Open Versus Minimally-Invasive Surgery for Gastric Adenocarcinoma: Results of the US Gastric Cancer Collaborative. JOURNAL OF GASTROINTESTINAL SURGERY, 18(9), 1563–1574.
- Impact of External-Beam Radiation Therapy on Outcomes Among Patients with Resected Gastric Cancer: A Multi-institutional Analysis
  Ejaz, A., Spolverato, G., Kim, Y., Squires, M. H., Poultsides, G., Fields, R., … Pawlik, T. M. (2014). Impact of External-Beam Radiation Therapy on Outcomes Among Patients with Resected Gastric Cancer: A Multi-institutional Analysis. ANNALS OF SURGICAL ONCOLOGY, 21(11), 3412–21.
- Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis
  Worhunsky, D. J., Qadan, M., Dua, M. M., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 219(4), 735–43.
- Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis
  Spolverato, G., Ejaz, A., Kim, Y., Squires, M. H., Poultsides, G. A., Fields, R. C., … Pawlik, T. M. (2014). Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 219(4), 664–75.
- Extracorporeal Pringle for laparoscopic liver resection
  Dua, M. M., Worhunsky, D. J., Hwa, K., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Extracorporeal Pringle for laparoscopic liver resection. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(6), 1348–55.
- Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity
  Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(4), 918–25.
- Utility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative
  Squires, M. H., Kooby, D. A., Pawlik, T. M., Weber, S. M., Poultsides, G., Schmidt, C., … Maithel, S. K. (2014). Utility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative. ANNALS OF SURGICAL ONCOLOGY, 21(13), 4202–10.
- Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases.
  Cloyd, J. M., Norton, J. A., Visser, B. C., & Poultsides, G. A. (2015). Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases. Annals of Surgical Oncology, 22(2), 573–80.
- False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer.
  Paudel, N., Kunz, P. L., Poultsides, G. A., Koong, A. C., & Chang, D. T. (2014). False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer. Practical Radiation Oncology, 4(6), 368–71.
- Use of Endoscopic Ultrasound in the Preoperative Staging of Gastric Cancer: A Multi-Institutional Study of the US Gastric Cancer Collaborative
  Spolverato, G., Ejaz, A., Kim, Y., Squires, M. H., Poultsides, G. A., Fields, R. C., … Pawlik, T. M. (2015). Use of Endoscopic Ultrasound in the Preoperative Staging of Gastric Cancer: A Multi-Institutional Study of the US Gastric Cancer Collaborative. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 220(1), 48–56.
- Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative.
  Kim, Y., Ejaz, A., Spolverato, G., Squires, M. H., Poultsides, G., Fields, R. C., … Pawlik, T. M. (2015). Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative. Annals of Surgical Oncology, 22(2), 557–564.
- Clinicopathological features and prognosis of gastric cardia adenocarcinoma: A multi-institutional U.S. study.
  Amini, N., Spolverato, G., Kim, Y., Squires, M. H., Poultsides, G. A., Fields, R., … Pawlik, T. M. (2015). Clinicopathological features and prognosis of gastric cardia adenocarcinoma: A multi-institutional U.S. study. Journal of Surgical Oncology, 111(3), 285–292.
- Can the Risk of Non-home Discharge After Resection of Gastric Adenocarcinoma Be Predicted: a Seven-Institution Study of the US Gastric Cancer Collaborative.
  Acher, A. W., Squires, M. H., Fields, R. C., Poultsides, G. A., Schmidt, C., Votanopoulos, K. I., … Weber, S. M. (2015). Can the Risk of Non-home Discharge After Resection of Gastric Adenocarcinoma Be Predicted: a Seven-Institution Study of the US Gastric Cancer Collaborative. Journal of Gastrointestinal Surgery , 19(2), 207–216.
- Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
  Kidess, E., Heirich, K., Wiggin, M., Vysotskaia, V., Visser, B. C., Marziali, A., … Poultsides, G. A. (2015). Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform. ONCOTARGET, 6(4), 2549–61.
- Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes.
  Worhunsky, D. J., Ma, Y., Zak, Y., Poultsides, G. A., Norton, J. A., Rhoads, K. F., & Visser, B. C. (2015). Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes. Journal of the National Comprehensive Cancer Network , 13(3), 319–25.
- Is It Time to Abandon the 5-cm Margin Rule During Resection of Distal Gastric Adenocarcinoma? A Multi-Institution Study of the U.S. Gastric Cancer Collaborative.
  Squires Iii, M. H., Kooby, D. A., Poultsides, G. A., Pawlik, T. M., Weber, S. M., Schmidt, C. R., … Maithel, S. K. (2015). Is It Time to Abandon the 5-cm Margin Rule During Resection of Distal Gastric Adenocarcinoma? A Multi-Institution Study of the U.S. Gastric Cancer Collaborative. Annals of Surgical Oncology, 22(4), 1243–1251.
- Esophageal and Esophagogastric Junction Cancers, Version 1.2015
  Ajani, J. A., D'Amico, T. A., Almhanna, K., Bentrem, D. J., Besh, S., Chao, J., … Sundar, H. (2015). Esophageal and Esophagogastric Junction Cancers, Version 1.2015. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(2), 194–227.
- Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer
  Ejaz, A., Spolverato, G., Kim, Y., Poultsides, G. A., Fields, R. C., Bloomston, M., … Pawlik, T. M. (2015). Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. JOURNAL OF SURGICAL RESEARCH, 195(1), 74–82.
- Cyst Fluid Glucose is Rapidly Feasible and Accurate in Diagnosing Mucinous Pancreatic Cysts.
  Zikos, T., Pham, K., Bowen, R., Chen, A. M., Banerjee, S., Friedland, S., … Park, W. G. (2015). Cyst Fluid Glucose is Rapidly Feasible and Accurate in Diagnosing Mucinous Pancreatic Cysts. American Journal of Gastroenterology, 110(6), 909–14.
- Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin?
  Worhunsky, D. J., Gupta, M., Gholami, S., Tran, T. B., Ganjoo, K. N., van de Rijn, M., … Poultsides, G. A. (2015). Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin? JOURNAL OF SURGICAL ONCOLOGY, 111(7), 808–12.
- Severe acute pancreatitis in the community: confusion reigns
  Dua, M. M., Worhunsky, D. J., Tran, T. B., Rumma, R. T., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2015). Severe acute pancreatitis in the community: confusion reigns. JOURNAL OF SURGICAL RESEARCH, 199(1), 44–50.
- Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma
  Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. SURGERY, 158(2), 486–93.
- Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project.
  Tran, T. B., Dua, M. M., Spain, D. A., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. HPB , 17(9), 763–69.
- Predictive Factors for Surgery Among Patients with Pancreatic Cysts in the Absence of High-Risk Features for Malignancy
  Quan, S. Y., Visser, B. C., Poultsides, G. A., Norton, J. A., Chen, A. M., Banerjee, S., … Park, W. G. (2015). Predictive Factors for Surgery Among Patients with Pancreatic Cysts in the Absence of High-Risk Features for Malignancy. JOURNAL OF GASTROINTESTINAL SURGERY, 19(6), 1101–5.
- Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis
  Spolverato, G., Maqsood, H., Vitale, A., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2015). Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis. JOURNAL OF GASTROINTESTINAL SURGERY, 19(7), 1334–1341.
- A Nomogram to Predict Overall Survival and Disease-Free Survival After Curative Resection of Gastric Adenocarcinoma
  Kim, Y., Spolverato, G., Ejaz, A., Squires, M. H., Poultsides, G., Fields, R. C., … Pawlik, T. M. (2015). A Nomogram to Predict Overall Survival and Disease-Free Survival After Curative Resection of Gastric Adenocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 22(6), 1828–1835.
- Minimally Invasive Resection of Choledochal Cyst: a Feasible and Safe Surgical Option
  Margonis, G. A., Spolverato, G., Kim, Y., Marques, H., Poultsides, G., Maithel, S., … Pawlik, T. M. (2015). Minimally Invasive Resection of Choledochal Cyst: a Feasible and Safe Surgical Option. JOURNAL OF GASTROINTESTINAL SURGERY, 19(5), 858–865.
- Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative
  Gholami, S., Janson, L., Worhunsky, D. J., Tran, T. B., Squires, M. H., Jin, L. X., … Poultsides, G. A. (2015). Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(2), 291–99.
- Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma A Multi-institutional Analysis of 535 Patients
  Spolverato, G., Kim, Y., Ejaz, A., Alexandrescu, S., Marques, H., Aldrighetti, L., … Pawlik, T. M. (2015). Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma A Multi-institutional Analysis of 535 Patients. JAMA SURGERY, 150(6), 538–45.
- Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults A Multi-institutional Analysis
  Soares, K. C., Kim, Y., Spolverato, G., Maithel, S., Bauer, T. W., Marques, H., … Pawlik, T. M. (2015). Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults A Multi-institutional Analysis. JAMA SURGERY, 150(6), 577–84.
- Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration
  Spolverato, G., Kim, Y., Alexandrescu, S., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2015). Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. ANNALS OF SURGICAL ONCOLOGY, 22(7), 2218–2225.
- Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway
  Drakaki, A., Hatziapostolou, M., Polytarchou, C., Vorvis, C., Poultsides, G. A., Souglakos, J., … Iliopoulos, D. (2015). Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC CANCER, 15.
- Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
  Drakaki, A., Hatziapostolou, M., Polytarchou, C., Vorvis, C., Poultsides, G. A., Souglakos, J., … Iliopoulos, D. (2015). Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC Cancer, 15, 542-?
- Pancreatectomy with vein reconstruction: technique matters
  Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB, 17(9), 824–31.
- Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project
  Tran, T. B., Dua, M. M., Spain, D. A., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. HPB, 17(9), 763–69.
- Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative
  Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., Fields, R. C., … Maithel, S. K. (2015). Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(3), 767–77.
- Impact of Complications on Long-Term Survival After Resection of Intrahepatic Cholangiocarcinoma
  Spolverato, G., Yakoob, M. Y., Kim, Y., Alexandrescu, S., Marques, H. P., Lamelas, J., … Pawlik, T. M. (2015). Impact of Complications on Long-Term Survival After Resection of Intrahepatic Cholangiocarcinoma. CANCER, 121(16), 2730–39.
- An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the US gastric cancer collaborative
  Dann, G. C., Squires, M. H., Postlewait, L. M., Kooby, D. A., Poultsides, G. A., Weber, S. M., … Maithel, S. K. (2015). An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the US gastric cancer collaborative. JOURNAL OF SURGICAL ONCOLOGY, 112(2), 195–202.
- The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative
  Postlewait, L. M., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2015). The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative. JOURNAL OF SURGICAL ONCOLOGY, 112(2), 203–7.
- Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma
  Bagante, F., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., … Pawlik, T. M. (2015). Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. JOURNAL OF SURGICAL ONCOLOGY, 112(2), 164–72.
- Laparoscopic transgastric necrosectomy for the management of pancreatic necrosis.
  Worhunsky, D. J., Qadan, M., Dua, M. M., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic transgastric necrosectomy for the management of pancreatic necrosis. Journal of the American College of Surgeons, 219(4), 735–43.
- Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
  Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. International Journal of Radiation Oncology, Biology, Physics, 90(4), 918–25.
- Pancreatectomy with vein reconstruction: technique matters.
  Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB , 17(9), 824–31.
- Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study
  Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. ANNALS OF SURGERY, 262(4), 632–40.
- Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
  Cloyd, J. M., & Poultsides, G. A. (2015). Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management. World Journal of Gastroenterology , 21(32), 9512–25.
- Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
  Ejaz, A., Spolverato, G., Kim, Y., Squires, M. H., Poultsides, G., Fields, R., … Pawlik, T. M. (2014). Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis. Annals of Surgical Oncology, 21(11), 3412–3421.
- Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis.
  Spolverato, G., Ejaz, A., Kim, Y., Squires, M. H., Poultsides, G. A., Fields, R. C., … Pawlik, T. M. (2014). Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. Journal of the American College of Surgeons, 219(4), 664–75.
- Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
  Squires, M. H., Kooby, D. A., Pawlik, T. M., Weber, S. M., Poultsides, G., Schmidt, C., … Maithel, S. K. (2014). Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative. Annals of Surgical Oncology, 21(13), 4202–4210.
- Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative.
  Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., Fields, R. C., … Maithel, S. K. (2015). Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative. Journal of the American College of Surgeons, 221(3), 767–77.
- Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.
  Alagappan, M., Pollom, E. L., von Eyben, R., Kozak, M. M., Aggarwal, S., Poultsides, G. A., … Chang, D. T. (2016). Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT. American Journal of Clinical Oncology, -?
- Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative.
  Tran, T. B., Worhunsky, D. J., Norton, J. A., Squires, M. H., Jin, L. X., Spolverato, G., … Poultsides, G. A. (2015). Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. Annals of Surgical Oncology, 22, 840–47.
- Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
  Kozak, M. M., Anderson, E. M., von Eyben, R., Pai, J. S., Poultsides, G. A., Visser, B. C., … Chang, D. T. (2016). Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer. Pancreas, 45(1), 64–70.
- Outcomes of Gastric Cancer Resection in Octogenarians: A Multi-institutional Study of the US Gastric Cancer Collaborative
  Tran, T. B., Worhunsky, D. J., Squires, M. H., Jin, L. X., Spolverato, G., Votanopoulos, K. I., … Poultsides, G. A. (2015). Outcomes of Gastric Cancer Resection in Octogenarians: A Multi-institutional Study of the US Gastric Cancer Collaborative. ANNALS OF SURGICAL ONCOLOGY, 22(13), 4371–79.
- Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative
  Tran, T. B., Worhunsky, D. J., Norton, J. A., Squires, M. H., Jin, L. X., Spolverato, G., … Poultsides, G. A. (2015). Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. ANNALS OF SURGICAL ONCOLOGY, 22, S840–S847.
- Gastric Remnant Cancer: A Distinct Entity or Simply Another Proximal Gastric Cancer?
  Tran, T. B., Hatzaras, I., Worhunsky, D. J., Vitiello, G. A., Squires, M. H., Jin, L. X., … Poultsides, G. A. (2015). Gastric Remnant Cancer: A Distinct Entity or Simply Another Proximal Gastric Cancer? JOURNAL OF SURGICAL ONCOLOGY, 112(8), 877–82.
- Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy
  Tran, T. B., Bal, C. K., Schaberg, K., Longacre, T. A., Chatrath, B. S., & Poultsides, G. A. (2015). Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy. DIGESTIVE DISEASES AND SCIENCES, 60(11), 3226–29.
- Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma A 7-Institution Study of the US Gastric Cancer Collaborative
  Jin, L. X., Moses, L. E., Squires, M. H., Poultsides, G. A., Votanopoulos, K., Weber, S. M., … Fields, R. C. (2015). Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma A 7-Institution Study of the US Gastric Cancer Collaborative. ANNALS OF SURGERY, 262(6), 999–1005.
- Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection
  Spolverato, G., Kim, Y., Alexandrescu, S., Marques, H. P., Lamelas, J., Aldrighetti, L., … Pawlik, T. M. (2016). Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. ANNALS OF SURGICAL ONCOLOGY, 23(1), 235–43.
- Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence
  Amini, N., Margonis, G. A., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Pawlik, T. M. (2016). Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence. ANNALS OF SURGICAL ONCOLOGY, 23(1), 126–33.
- Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy
  Bagante, F., Gani, F., Spolverato, G., Xu, L., Alexandrescu, S., Marques, H. P., … Pawlik, T. M. (2015). Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(6), 1031-?
- Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?
  Spolverato, G., Vitale, A., Cucchetti, A., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2015). Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? CANCER, 121(22), 3998–4006.
- The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma
  Postlewait, L. M., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2015). The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 22, S832–S839.
- Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma
  Valero-Elizondo, J., Kim, Y., Prescott, J. D., Margonis, G. A., Tran, T. B., Postlewait, L. M., … Pawlik, T. M. (2015). Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma. JOURNAL OF GASTROINTESTINAL SURGERY, 19(12), 2154–61.
- Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes
  Margonis, G. A., Kim, Y., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Pawlik, T. M. (2016). Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. ANNALS OF SURGICAL ONCOLOGY, 23(1), 134–41.
- The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma
  Spolverato, G., Yakoob, M. Y., Kim, Y., Alexandrescu, S., Marques, H. P., Lamelas, J., … Pawlik, T. M. (2015). The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 22(12), 4020–28.
- Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma
  Spolverato, G., Ejaz, A., Kim, Y., Squires, M. H., Poultsides, G., Fields, R. C., … Pawlik, T. M. (2015). Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. ANNALS OF SURGERY, 262(6), 991–98.
- Value of Peritoneal Drain Placement After Total Gastrectomy for Gastric Adenocarcinoma: A Multi-institutional Analysis from the US Gastric Cancer Collaborative
  Dann, G. C., Squires, M. H., Postlewait, L. M., Kooby, D. A., Poultsides, G. A., Weber, S. M., … Cardona, K. (2015). Value of Peritoneal Drain Placement After Total Gastrectomy for Gastric Adenocarcinoma: A Multi-institutional Analysis from the US Gastric Cancer Collaborative. ANNALS OF SURGICAL ONCOLOGY, 22, S888–S897.
- Gastric remnant cancer: A distinct entity or simply another proximal gastric cancer?
  Tran, T. B., Hatzaras, I., Worhunsky, D. J., Vitiello, G. A., Squires, M. H., Jin, L. X., … Poultsides, G. A. (2015). Gastric remnant cancer: A distinct entity or simply another proximal gastric cancer? Journal of Surgical Oncology, 112(8), 877–82.
- Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
  Krampitz, G. W., George, B. M., Willingham, S. B., Volkmer, J.-P., Weiskopf, K., Jahchan, N., … Weissman, I. L. (2016). Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(16), 4464–69.
- Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative.
  Wang, A., Squires, M. H., Melis, M., Poultsides, G. A., Norton, J. A., Jin, L. X., … Hatzaras, I. (2016). Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative. Journal of the American College of Surgeons, 222(4), 633–43.
- Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the US Gastric Cancer Collaborative
  Blackham, A. U., Swords, D. S., Levine, E. A., Fino, N. F., Squires, M. H., Poultsides, G., … Votanopoulos, K. I. (2016). Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the US Gastric Cancer Collaborative. ANNALS OF SURGICAL ONCOLOGY, 23(4), 1203–11.
- Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival
  Margonis, G. A., Amini, N., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Pawlik, T. M. (2016). Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival. WORLD JOURNAL OF SURGERY, 40(3), 706–14.
- Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma
  Postlewait, L. M., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2016). Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 23(4), 1225–33.
- Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
  Postlewait, L. M., Ethun, C. G., Tran, T. B., Prescott, J. D., Pawlik, T. M., Wang, T. S., … Maithel, S. K. (2016). Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group. Journal of the American College of Surgeons, 222(4), 480–90.
- The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma.
  Postlewait, L. M., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2015). The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma. Annals of Surgical Oncology, 22, 832–39.
- Value of Peritoneal Drain Placement After Total Gastrectomy for Gastric Adenocarcinoma: A Multi-institutional Analysis from the US Gastric Cancer Collaborative.
  Dann, G. C., Squires, M. H., Postlewait, L. M., Kooby, D. A., Poultsides, G. A., Weber, S. M., … Cardona, K. (2015). Value of Peritoneal Drain Placement After Total Gastrectomy for Gastric Adenocarcinoma: A Multi-institutional Analysis from the US Gastric Cancer Collaborative. Annals of Surgical Oncology, 22, 888–97.
- Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
  Cloyd, J. M., Kopecky, K. E., Norton, J. A., Kunz, P. L., Fisher, G. A., Visser, B. C., … Poultsides, G. A. (2016). Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis. Surgery, 160(3), 708–13.
- To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer
  Tran, T. B., Worhunsky, D. J., Squires, M. H., Jin, L. X., Spolverato, G., Votanopoulos, K. I., … Poultsides, G. A. (2016). To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer. GASTRIC CANCER, 19(3), 994–1001.
- An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions?
  Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions? AMERICAN JOURNAL OF SURGERY, 211(6), 991-?
- The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample
  Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(5), 1778–83.
- Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis
  Bagante, F., Spolverato, G., Cucchetti, A., Gani, F., Popescu, I., Ruzzenente, A., … Pawlik, T. M. (2016). Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis. SURGERY, 160(1), 106–17.
- Outcomes after resection of cortisol-secreting adrenocortical carcinoma
  Margonis, G. A., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., … Pawlik, T. M. (2016). Outcomes after resection of cortisol-secreting adrenocortical carcinoma. AMERICAN JOURNAL OF SURGERY, 211(6), 1106–13.
- Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma
  Kim, Y., Margonis, G. A., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Pawlik, T. M. (2016). Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma. JAMA SURGERY, 151(4), 365–73.
- A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma
  Vitale, A., Spolverato, G., Bagante, F., Gani, F., Popescu, I., Marques, H. P., … Pawlik, T. M. (2016). A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma. JOURNAL OF SURGICAL ONCOLOGY, 113(4), 420–26.
- Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the US Gastric Cancer Collaborative
  Jin, L. X., Sanford, D. E., Squires, M. H., Moses, L. E., Yan, Y., Poultsides, G. A., … Fields, R. C. (2016). Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the US Gastric Cancer Collaborative. ANNALS OF SURGICAL ONCOLOGY, 23(8), 2398–2408.
- A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma
  Palumbo, T., Poultsides, G. A., Kouraklis, G., Liakakos, T., Drakaki, A., Peros, G., … Iliopoulos, D. (2016). A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma. BMC CANCER, 16.
- Readmission Following Gastric Cancer Resection: Risk Factors and Survival
  Acher, A. W., Squires, M. H., Fields, R. C., Poultsides, G. A., Schmidt, C., Votanopoulos, K. I., … Weber, S. M. (2016). Readmission Following Gastric Cancer Resection: Risk Factors and Survival. JOURNAL OF GASTROINTESTINAL SURGERY, 20(7), 1284–94.
- Optimal Extent of Lymphadenectomy for Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative
  Randle, R. W., Swords, D. S., Levine, E. A., Fino, N. F., Squires, M. H., Poultsides, G., … Votanopoulos, K. I. (2016). Optimal Extent of Lymphadenectomy for Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative. JOURNAL OF SURGICAL ONCOLOGY, 113(7), 750–55.
- Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study
  Buettner, S., Wilson, A., Margonis, G. A., Gani, F., Ethun, C. G., Poultsides, G. A., … Pawlik, T. M. (2016). Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study. JOURNAL OF GASTROINTESTINAL SURGERY, 20(8), 1444–52.
- Conditional probability of long-term survival after resection of hilar cholangiocarcinoma
  Buettner, S., Margonis, G. A., Kim, Y., Gani, F., Ethun, C. G., Poultsides, G., … Pawlik, T. M. (2016). Conditional probability of long-term survival after resection of hilar cholangiocarcinoma. HPB, 18(6), 510–17.
- Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer
  Vorvis, C., Hatziapostolou, M., Mahurkar-Joshi, S., Koutsioumpa, M., Williams, J., Donahue, T. R., … Iliopoulos, D. (2016). Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 310(11), G1124–G1137.
- Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme
  Bagante, F., Thuy Tran, T., Spolverato, G., Ruzzenente, A., Buttner, S., Ethun, C. G., … Pawlik, T. M. (2016). Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 222(5), 750-?
- Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study.
  Amini, N., Kim, Y., Wilson, A., Margonis, G. A., Ethun, C. G., Poultsides, G., … Pawlik, T. M. (2016). Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study. Annals of Surgical Oncology, 23(9), 3016–23.
- Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis.
  Kim, Y., Amini, N., Wilson, A., Margonis, G. A., Ethun, C. G., Poultsides, G., … Pawlik, T. M. (2016). Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis. Annals of Surgical Oncology, 23(9), 2998–3008.
- Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer.
  Gani, F., Buettner, S., Margonis, G. A., Ethun, C. G., Poultsides, G., Tran, T., … Pawlik, T. M. (2016). Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. Journal of Surgical Oncology, 114(2), 176–80.
- Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging.
  Eberlin, L. S., Margulis, K., Planell-Mendez, I., Zare, R. N., Tibshirani, R., Longacre, T. A., … Poultsides, G. A. (2016). Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging. PLoS Medicine, 13(8).
- The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection.
  Tran, T. B., Worhunsky, D. J., Spain, D. A., Dua, M. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2016). The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection. HPB , 18(9), 742–47.
- Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique.
  Worhunsky, D. J., Dua, M. M., Tran, T. B., Siu, B., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique. Surgical Endoscopy, 30(10), 4307–14.
- The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis.
  Margonis, G. A., Buettner, S., Sasaki, K., Kim, Y., Ratti, F., Russolillo, N., … Pawlik, T. M. (2016). The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. HPB , 18(8), 700–705.
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2016). Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. SCIENCE TRANSLATIONAL MEDICINE, 8(364).
- Gastric Cancer, Version 3.2016
  Ajani, J. A., D'Amico, T. A., Almhanna, K., Bentrem, D. J., Chao, J., Das, P., … Sundar, H. (2016). Gastric Cancer, Version 3.2016. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 14(10), 1286–1312.
- A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma
  Buettner, S., van Vugt, J. L. A., Gani, F., Koerkamp, B. G., Margonis, G. A., Ethun, C. G., … Pawlik, T. M. (2016). A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma. JOURNAL OF GASTROINTESTINAL SURGERY, 20(10), 1716–24.
- Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
  Kidess-Sigal, E., Liu, H. E., Triboulet, M. M., Che, J., Ramani, V. C., Visser, B. C., … Jeffrey, S. S. (2016). Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. ONCOTARGET, 7(51), 85349–64.
- Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients.
  Lee, C. W., Md, A. I. S., Schneider, D. F., Leverson, G. E., Tran, T. B., Poultsides, G. A., … Weber, S. M. (2016). Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients. Journal of Gastrointestinal Surgery , -?
- Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.
  Buettner, S., Margonis, G. A., Kim, Y., Gani, F., Ethun, C. G., Poultsides, G. A., … Pawlik, T. M. (2016). Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma. Annals of Surgical Oncology, 23(13), 4401–9.
- A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium.
  Ethun, C. G., Postlewait, L. M., Le, N., Pawlik, T. M., Buettner, S., Poultsides, G., … Maithel, S. K. (2016). A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Annals of Surgical Oncology, -?
- A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma.
  Buettner, S., van Vugt, J. L. A., Gani, F., Groot Koerkamp, B., Margonis, G. A., Ethun, C. G., … Pawlik, T. M. (2016). A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery , 20(10), 1716–24.
- Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium.
  Ethun, C. G., Postlewait, L. M., Le, N., Pawlik, T. M., Buettner, S., Poultsides, G., … Maithel, S. K. (2016). Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium. JAMA Surgery.
- Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
  Margonis, G. A., Gani, F., Buettner, S., Amini, N., Sasaki, K., Andreatos, N., … Pawlik, T. M. (2016). Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB .
- Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.
  Postlewait, L. M., Ethun, C. G., Le, N., Pawlik, T. M., Buettner, S., Poultsides, G., … Maithel, S. K. (2016). Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB , 18(10), 793–99.
- Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
  Tran, T. B., Maithel, S. K., Pawlik, T. M., Wang, T. S., Hatzaras, I., Phay, J. E., … Poultsides, G. A. (2016). Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. Journal of the American College of Surgeons.
- Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
  Beal, E. W., Wei, L., Ethun, C. G., Black, S. M., Dillhoff, M., Salem, A., … Schmidt, C. R. (2016). Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB .
- Oncologic Procedures Amenable to Fluorescence-guided Surgery.
  Tipirneni, K. E., Warram, J. M., Moore, L. S., Prince, A. C., de Boer, E., Jani, A. H., … Rosenthal, E. (2016). Oncologic Procedures Amenable to Fluorescence-guided Surgery. Annals of Surgery.
- Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?
  Gerry, J. M., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Wang, T. S., … Poultsides, G. A. (2016). Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit? ANNALS OF SURGICAL ONCOLOGY, 23, S708–S713.
- Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?
  Gerry, J. M., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Wang, T. S., … Poultsides, G. A. (2016). Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit? Annals of Surgical Oncology, 23, 708–13.
- Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
  Sighinolfi, M., Quan, S. Y., Lee, Y., Ibaseta, A., Pham, K., Dua, M. M., … Park, W. G. (2017). Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria. Digestive Diseases and Sciences, 62(3), 626–32.
- Actual 10-Year Survivors Following Resection of Adrenocortical Carcinoma
  Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Wang, T. S., Glenn, J., … Poultsides, G. A. (2016). Actual 10-Year Survivors Following Resection of Adrenocortical Carcinoma. JOURNAL OF SURGICAL ONCOLOGY, 114(8), 971–76.
- Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population.
  Adeshuko, F. A., Squires, M. H., Poultsides, G., Pawlik, T. M., Weber, S. M., Schmidt, C., … Cardona, K. (2017). Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population. American Surgeon, 83(1), 82–89.
- Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.
  Spolverato, G., Bagante, F., Ethun, C. G., Poultsides, G., Tran, T., Idrees, K., … Pawlik, T. M. (2017). Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer. World Journal of Surgery, 41(1), 224–31.
- Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
  Ethun, C. G., Lopez-Aguiar, A. G., Pawlik, T. M., Poultsides, G., Idrees, K., Fields, R. C., … Maithel, S. K. (2016). Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium. Journal of the American College of Surgeons.
- Neuroendocrine liver metastasis: The chance to be cured after liver surgery.
  Bagante, F., Spolverato, G., Merath, K., Postlewait, L. M. L., Poultsides, G. A., Mullen, M. G., … Pawlik, T. M. (2017). Neuroendocrine liver metastasis: The chance to be cured after liver surgery. Journal of Surgical Oncology.
- Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability
  Kim, Y., Margonis, G. A., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Pawlik, T. M. (2017). Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability. ANNALS OF SURGERY, 265(1), 197–204.
- An Untapped Resource: Left Renal Vein Interposition Graft for Portal Vein Reconstruction During Pancreaticoduodenectomy
  Tran, T. B., Mell, M. W., & Poultsides, G. A. (2017). An Untapped Resource: Left Renal Vein Interposition Graft for Portal Vein Reconstruction During Pancreaticoduodenectomy. DIGESTIVE DISEASES AND SCIENCES, 62(1), 68–71.
- The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis.
  Buettner, S., Koerkamp, B. G., Ejaz, A., Buisman, F. E., Kim, Y., Margonis, G. A., … Pawlik, T. M. (2017). The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis. Journal of Surgical Oncology.
- Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
  Ethun, C. G., Postlewait, L. M., Le, N., Pawlik, T. M., Poultsides, G., Tran, T., … Maithel, S. K. (2017). Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium. Journal of Surgical Oncology.
- Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
  Spolverato, G., Bagante, F., Weiss, M., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2017). Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology.
- Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
  Kim, Y., Squires, M. H., Poultsides, G. A., Fields, R. C., Weber, S. M., Votanopoulos, K. I., … Pawlik, T. M. (2017). Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy. Surgery.
- Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.
  Chan, L. S., Sze, D. Y., Poultsides, G. A., Louie, J. D., Abdelrazek Mohammed, M. A., & Wang, D. S. (2017). Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma. Cardiovascular and Interventional Radiology.
- Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients
  Lee, C. W., Salem, A. I., Schneider, D. F., Leverson, G. E., Tran, T. B., Poultsides, G. A., … Weber, S. M. (2017). Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients. JOURNAL OF GASTROINTESTINAL SURGERY, 21(2), 352–62.
- A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium
  Ethun, C. G., Postlewait, L. M., Le, N., Pawlik, T. M., Buettner, S., Poultsides, G., … Maithel, S. K. (2017). A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. ANNALS OF SURGICAL ONCOLOGY, 24(5), 1343–50.
- A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal versus Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population
  Adeshuko, F. A., Squires, M. H., Poultsides, G., Pawlik, T. M., Weber, S. M., Schmidt, C., … Cardona, K. (2017). A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal versus Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population. AMERICAN SURGEON, 83(1), 82–89.
- Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium
  Ethun, C. G., Postlewait, L. M., Le, N., Pawlik, T. M., Buettner, S., Poultsides, G., … Maithel, S. K. (2017). Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium. JAMA SURGERY, 152(2), 143–48.
- Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable?
  Tran, T. B., Norton, J. A., Ethun, C. G., Pawlik, T. M., Buettner, S., Schmidt, C., … Poultsides, G. A. (2017). Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable? Journal of Gastrointestinal Surgery .
- Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.
  Spolverato, G., Bagante, F., Aldrighetti, L., Poultsides, G. A., Bauer, T. W., Fields, R. C., … Pawlik, T. M. (2017). Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis. Journal of Surgical Oncology.
- Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection.
  Gerry, J. M., & Poultsides, G. A. (2017). Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection. Digestive Diseases and Sciences.
- Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System.
  Bagante, F., Spolverato, G., Weiss, M., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2017). Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System. Journal of Gastrointestinal Surgery .
- Surgical Considerations in the Management of Gastric Adenocarcinoma
  Makris, E. A., & Poultsides, G. A. (2017). Surgical Considerations in the Management of Gastric Adenocarcinoma. SURGICAL CLINICS OF NORTH AMERICA, 97(2), 295-?
- Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis.
  Reames, B. N., Ejaz, A., Koerkamp, B. G., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2017). Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis. Journal of Surgical Oncology.
- Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.
  Buettner, S., van Vugt, J. L. A., Gaspersz, M. P., Coelen, R. J. S., Roos, E., Labeur, T. A., … Groot Koerkamp, B. (2017). Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases. HPB .
- Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.
  Bagante, F., Spolverato, G., Weiss, M., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2017). Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Surrogate End Points for Overall Survival in Metastatic, Locally Advanced, or Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis of 24 Randomized Controlled Trials.
  Makris, E. A., MacBarb, R., Harvey, D. J., & Poultsides, G. A. (2017). Surrogate End Points for Overall Survival in Metastatic, Locally Advanced, or Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis of 24 Randomized Controlled Trials. Annals of Surgical Oncology.
- Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Esfahani, M. S., Craig, A., Stehr, H., … Alizadeh, A. A. (2016). Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma. BLOOD. SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC HEMATOLOGY.
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
  Ajani, J. A., D'Amico, T. A., Almhanna, K., Bentrem, D. J., Chao, J., Das, P., … Sundar, H. (2016). Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network , 14(10), 1286–1312.
- Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis.
  Li, K., Cannon, J. G., Jiang, S. Y., Sambare, T. D., Owens, D. K., Bendavid, E., & Poultsides, G. A. (2017). Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis. Journal of Surgical Oncology.
- Rapid Point-of-Care Measurement of Cyst Fluid Glucose Is Feasible and Accurate in Predicting Mucinous Pancreatic Cysts
  Zikos, T., Pham, K., Chen, A., Banerjee, S., Friedland, S., Dua, M., … Park, W. (2014). Rapid Point-of-Care Measurement of Cyst Fluid Glucose Is Feasible and Accurate in Predicting Mucinous Pancreatic Cysts. AMERICAN JOURNAL OF GASTROENTEROLOGY, 109, S86.
- Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome.
  Norton, J. A., Krampitz, G. W., Poultsides, G. A., Visser, B. C., Fraker, D. L., Alexander, H. R., & Jensen, R. T. (2018). Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome. Annals of Surgery, 267(4), 782–88.
- Clinicopathologic score predicting lymph node metastasis in T1 gastric cancer.
  Tran, T. B., Worhunsky, D. J., Squires, M. H., Jin, L. X., Spolverato, G., Votanopoulos, K. I., … Poultsides, G. A. (2018). Clinicopathologic score predicting lymph node metastasis in T1 gastric cancer. Surgery, 163(4), 889–93.
- Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract
  Norton, J. A., Foster, D. S., Blumgart, L. H., Poultsides, G. A., Visser, B. C., Fraker, D. L., … Jensen, R. T. (2018). Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract. JAMA SURGERY, 153(3), e175083.
- Management of Borderline Resectable Pancreatic Cancer.
  Toesca, D. A., Koong, A. J., Poultsides, G. A., Visser, B. C., Haraldsdottir, S., Koong, A. C., & Chang, D. T. (2018). Management of Borderline Resectable Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics, 100(5), 1155–74.
- Prediction of pancreatic cancer surgical outcomes and prognosis based on an objective resectability scoring system
  Toesca, D. A. S., Jeffrey, B., von Eyben, R., Poullos, P. D., Poultsides, G. A., Fisher, G. A., … Chang, D. T. (2018). Prediction of pancreatic cancer surgical outcomes and prognosis based on an objective resectability scoring system. Journal of Clinical Oncology. San Francisco, CA.
- The Effect of Chronic Kidney Disease on Postoperative Outcomes after Major Hepatectomy: Results from the National Surgical Quality Improvement Program
  Tran, T. B., Dua, M. M., Spain, D. A., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). The Effect of Chronic Kidney Disease on Postoperative Outcomes after Major Hepatectomy: Results from the National Surgical Quality Improvement Program. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), S94–S95.
- Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Liu, C. L., Zhou, L., … Alizadeh, A. A. (2015). Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY.
- Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma (vol 40, pg 1383, 2017)
  Chan, L. S., Sze, D. Y., Poultsides, G. A., Louie, J. D., Abdelrazek Mohammed, M. A., & Wang, D. S. (2017). Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma (vol 40, pg 1383, 2017). CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 40(10), 1657.
- Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.
  Tummers, W. S., Miller, S. E., Teraphongphom, N. T., Gomez, A., Steinberg, I., Huland, D. M., … Rosenthal, E. L. (2018). Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging. Annals of Surgical Oncology, 25(7), 1880–88.
- Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT
  Alagappan, M., Pollom, E. L., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. M., … Chang, D. T. (2015). Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Transgastric pancreatic necrosectomy-expedited return to prepancreatitis health
  Dua, M. M., Worhunsky, D. J., Malhotra, L., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2017). Transgastric pancreatic necrosectomy-expedited return to prepancreatitis health. JOURNAL OF SURGICAL RESEARCH, 219, 11–17.
- Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma
  Titan, A. L., Devereaux, K., Louie, J. D., & Poultsides, G. A. (2018). Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma. DIGESTIVE DISEASES AND SCIENCES, 63(6), 1419–23.
- The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis
  Ejaz, A., Reames, B. N., Maithel, S., Poultsides, G. A., Bauer, T. W., Fields, R. C., … Pawlik, T. M. (2017). The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis. JOURNAL OF SURGICAL ONCOLOGY, 116(7), 841–47.
- Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the US Extrahepatic Biliary Malignancy Consortium
  Beal, E. W., Lyon, E., Kearney, J., Wei, L., Ethun, C. G., Black, S. M., … Schmidt, C. R. (2017). Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the US Extrahepatic Biliary Malignancy Consortium. HPB, 19(12), 1104–11.
- Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery
  Spolverato, G., Bagante, F., Aldrighetti, L., Poultsides, G., Bauer, T. W., Field, R. C., … Pawlik, T. M. (2017). Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery. JOURNAL OF GASTROINTESTINAL SURGERY, 21(12), 2039–47.
- Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study
  Zhang, X.-F., Chakedis, J., Bagante, F., Beal, E. W., Lv, Y., Weiss, M., … Pawlik, T. M. (2018). Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study. WORLD JOURNAL OF SURGERY, 42(3), 849–57.
- The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma
  Bagante, F., Merath, K., Squires, M. H., Weiss, M., Alexandrescu, S., Marques, H. P., … Pawlik, T. M. (2018). The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma. JOURNAL OF GASTROINTESTINAL SURGERY, 22(3), 477–85.
- The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium
  O'Connor, S. C., Mogal, H., Russell, G., Ethun, C., Fields, R. C., Jin, L., … Shen, P. (2017). The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium. JOURNAL OF GASTROINTESTINAL SURGERY, 21(12), 2016–24.
- Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma
  Zhang, X.-F., Bagante, F., Chen, Q., Beal, E. W., Lv, Y., Weiss, M., … Pawlik, T. M. (2018). Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma. SURGERY, 163(5), 1114–20.
- The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma
  Zhang, X.-F., Squires, M. H., Bagante, F., Ethun, C. G., Salem, A., Weber, S. M., … Pawlik, T. M. (2018). The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 25(5), 1140–49.
- Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium
  Schimizzi, G. V., Jin, L. X., Davidson, J. T., Krasnick, B. A., Ethun, C. G., Pawlik, T. M., … Fields, R. C. (2018). Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB, 20(4), 332–39.
- Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis
  Ejaz, A., Reames, B. N., Maithel, S., Poultsides, G. A., Bauer, T. W., Fields, R. C., … Pawlik, T. M. (2018). Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis. HPB, 20(3), 277–84.
- A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group
  Poorman, C. E., Ethun, C. G., Postlewait, L. M., Tran, T. B., Prescott, J. D., Pawlik, T. M., … Maithel, S. K. (2018). A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. ANNALS OF SURGICAL ONCOLOGY, 25(2), 520–27.
- Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies
  Buettner, S., Ethun, C. G., Poultsides, G., Thuy Tran, Idrees, K., Isom, C. A., … Pawlik, T. M. (2017). Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies. JOURNAL OF GASTROINTESTINAL SURGERY, 21(11), 1813–20.
- Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the US extrahepatic biliary malignancy consortium
  Krasnick, B. A., Jin, L. X., Davidson, J. T., Sanford, D. E., Ethun, C. G., Pawlik, T. M., … Fields, R. C. (2018). Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the US extrahepatic biliary malignancy consortium. JOURNAL OF SURGICAL ONCOLOGY, 117(3), 363–71.
- Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma
  Sasaki, K., Margonis, G. A., Andreatos, N., Bagante, F., Weiss, M., Barbon, C., … Pawlik, T. M. (2018). Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma
  Buettner, S., Galjart, B., van Vugt, J. L. A., Bagante, F., Alexandrescu, S., Marques, H. P., … Pawlik, T. M. (2017). Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. JOURNAL OF SURGICAL ONCOLOGY, 116(8), 1085–95.
- The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium
  Bhutiani, N., Scoggins, C. R., McMasters, K. M., Ethun, C. G., Poultsides, G. A., Pawlik, T. M., … Martin, R. C. G. (2018). The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium. SURGERY, 163(4), 726–31.
- Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis
  Zhang, X.-F., Beal, E. W., Weiss, M., Aldrighetti, L., Poultsides, G. A., Bauer, T. W., … Pawlik, T. M. (2018). Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis. JOURNAL OF SURGICAL ONCOLOGY, 117(2), 171–81.
- Transplantation Versus Resection for Hilar Cholangiocarcinoma An Argument for Shifting Treatment Paradigms for Resectable Disease
  Ethun, C. G., Lopez-Aguiar, A. G., Anderson, D. J., Adams, A. B., Fields, R. C., Doyle, M. B., … Maithel, S. K. (2018). Transplantation Versus Resection for Hilar Cholangiocarcinoma An Argument for Shifting Treatment Paradigms for Resectable Disease. ANNALS OF SURGERY, 267(5), 797–805.
- Accuracy of the ACS NSQIP Online Risk Calculator Depends on How You Look at It: Results from the United States Gastric Cancer Collaborative
  Beal, E. W., Saunders, N. D., Kearney, J. F., Lyon, E., Wei, L., Squires, M. H., … Schmidt, C. R. (2018). Accuracy of the ACS NSQIP Online Risk Calculator Depends on How You Look at It: Results from the United States Gastric Cancer Collaborative. AMERICAN SURGEON, 84(3), 358–64.
- Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer
  Karagkounis, G., Squires, M. H., Melis, M., Poultsides, G. A., Worhunsky, D., Jin, L. X., … Hatzaras, I. (2017). Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer. JOURNAL OF GASTROINTESTINAL SURGERY, 21(12), 1984–92.
- Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the US Neuroendocrine Tumor Study Group
  Merath, K., Bagante, F., Beal, E. W., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., … Pawlik, T. M. (2018). Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the US Neuroendocrine Tumor Study Group. JOURNAL OF SURGICAL ONCOLOGY, 117(5), 868–78.
- Hepato-pancreatectomy: perioperative and long term outcomes of synchronous hepatic and pancreatic resection
  Tran, T. B., Dua, M. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: perioperative and long term outcomes of synchronous hepatic and pancreatic resection. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), E95.
- Evaluating the Revised International Consensus Guidelines for Management of Pancreatic Cysts
  Sighinolfi, M., Quan, S., Dua, M., Poultsides, G., Visser, B., & Park, W. (2014). Evaluating the Revised International Consensus Guidelines for Management of Pancreatic Cysts. AMERICAN JOURNAL OF GASTROENTEROLOGY, 109, S86.
- Management of Postoperative Pancreatic Fistula: Drain Position Matters
  Malhotra, L., Dua, M. M., Leal, J. N., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2017). Management of Postoperative Pancreatic Fistula: Drain Position Matters. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 225(4), E123–E124.
- Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the US Adrenocortical Carcinoma Database
  Smith, P. M., Kiernan, C. M., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J., … Solorzano, C. C. (2018). Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the US Adrenocortical Carcinoma Database. ANNALS OF SURGICAL ONCOLOGY, 25(8), 2308–15.
- Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes
  Bagante, F., Spolverato, G., Weiss, M., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2018). Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes. WORLD JOURNAL OF SURGERY, 42(8), 2551–60.
- Monitoring Gastric Myoelectric Activity After Pancreaticoduodenectomy for Diet "Readiness".
  Dua, M. M., Navalgund, A., Axelrod, S., Axelrod, L., Worth, P. J., Norton, J. A., … Visser, B. C. (2018). Monitoring Gastric Myoelectric Activity After Pancreaticoduodenectomy for Diet "Readiness". American Journal of Physiology. Gastrointestinal and Liver Physiology.
- Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
  Margonis, G. A., Buettner, S., Andreatos, N., Kim, Y., Wagner, D., Sasaki, K., … Weiss, M. J. (2018). Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer. JAMA SURGERY, 153(7), e180996.
- Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival
  Zhang, X.-F., Beal, E. W., Merath, K., Ethun, C. G., Salem, A., Weber, S. M., … Pawlik, T. M. (2018). Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival. JOURNAL OF SURGICAL ONCOLOGY, 117(6), 1267–77.
- Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium
  Zhang, X.-F., Beal, E. W., Chakedis, J., Chen, Q., Lv, Y., Ethun, C. G., … Pawlik, T. M. (2018). Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium. WORLD JOURNAL OF SURGERY, 42(9), 2919–29.
- Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth?
  Johnson, A. C., Ethun, C. G., Liu, Y., Lopez-Aguiar, A. G., Tran, T. B., Poultsides, G., … Maithel, S. K. (2018). Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 227(3), 357-+.
- Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
  Kurtz, D. M., Scherer, F., Newman, A. M., Craig, A., Jin, M., Stehr, H., … Alizadeh, A. A. (2016). Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY.
- The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma
  Buettner, S., Spolverato, G., Kimbrough, C. W., Alexandrescu, S., Marques, H. P., Lamelas, J., … Pawlik, T. M. (2018). The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. SURGERY, 164(3), 411–18.
- Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium
  Lopez-Aguiar, A. G., Ethun, C. G., McInnis, M. R., Pawlik, T. M., Poultsides, G., Thuy Tran, … Maithel, S. K. (2018). Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF SURGICAL ONCOLOGY, 117(8), 1638–47.
- Isolated pancreatic tail remnants after transgastric necrosectomy can be observed.
  Dua, M. M., Jensen, C. W., Friedland, S., Worth, P. J., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2018). Isolated pancreatic tail remnants after transgastric necrosectomy can be observed. The Journal of Surgical Research, 231, 109–15.
- Circulating tumor DNA (ctDNA) in B-cell lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating tumor DNA (ctDNA) in B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. WILEY.
- Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection
  Akguel, O., Bagante, F., Olsen, G., Cloyd, J. M., Weiss, M., Merath, K., … Pawlik, T. M. (2018). Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection. JOURNAL OF SURGICAL ONCOLOGY, 118(3), 422–30.
- Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma
  Yu, P. Y., Beal, E. W., Hughes, T. M., Suarez-Kelly, L. P., Shelby, R. D., Ethun, C. G., … Howard, J. H. (2018). Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. JOURNAL OF SURGICAL RESEARCH, 231, 248–56.
- Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma
  Sasaki, K., Margonis, G. A., Andreatos, N., Chen, Q., Barbon, C., Bagante, F., … Pawlik, T. M. (2018). Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma. HPB, 20(10), 956–65.
- ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.
  Tummers, W. S., Rosenthal, E. L., Vahrmeijer, A. L., & Poultsides, G. P. (2018). ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. Annals of Surgical Oncology.
- Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
  Chakedis, J., Beal, E. W., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F. G., … Dillhoff, M. (2018). Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- The prognostic significance of adrenocortical carcinomas identified incidentally.
  Rossfeld, K. K., Maithel, S. K., Prescott, J., Wang, T. S., Fields, R. C., Weber, S. M., … Shirley, L. A. (2018). The prognostic significance of adrenocortical carcinomas identified incidentally. Journal of Surgical Oncology.
- Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
  Zhang, X.-F., Wu, Z., Cloyd, J., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., … Pawlik, T. M. (2018). Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group. Surgery.
- A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database.
  Johnson, A. C., Ethun, C. G., Liu, Y., Poultsides, G., Howard, J. H., Bedi, M., … Cardona, K. (2018). A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database. Journal of Surgical Oncology.
- The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
  Margonis, G. A., Buettner, S., Andreatos, N., Wagner, D., Sasaki, K., Galjart, B., … Weiss, M. J. (2018). The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis. Journal of Surgical Oncology.
- Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
  Xiang, J.-X., Zhang, X.-F., Weiss, M., Aldrighetti, L., Poultsides, G. A., Bauer, T. W., … Pawlik, T. M. (2018). Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome. Journal of Surgical Oncology.
- Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
  Koutsioumpa, M., Hatziapostolou, M., Polytarchou, C., Tolosa, E. J., Almada, L. L., Mahurkar-Joshi, S., … Iliopoulos, D. (2018). Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming. Gut.
- Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.
  Kimbrough, C. W., Beal, E. W., Dillhoff, M. E., Schmidt, C. R., Pawlik, T. M., Lopez-Aguiar, A. G., … Cloyd, J. M. (2018). Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection. Surgery.
- Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small Bowel Neuroendocrine Tumors.
  Zaidi, M. Y., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E., Poultsides, G., Makris, E., … Maithel, S. K. (2018). Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small Bowel Neuroendocrine Tumors. JAMA Surgery.
- Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.
  Tummers, W. S., Rosenthal, E. L., Vahrmeijer, A. L., & Poultsides, G. A. (2018). Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. Annals of Surgical Oncology.
- Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
  Xiang, J.-X., Zhang, X.-F., Beal, E. W., Weiss, M., Aldrighetti, L., Poultsides, G. A., … Pawlik, T. M. (2018). Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter? ANNALS OF SURGICAL ONCOLOGY, 25(13), 3928–35.
- The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group.
  Zaidi, M. Y., Lopez-Aguiar, A. G., Poultsides, G. A., Dillhoff, M., Rocha, F. G., Idrees, K., … Maithel, S. K. (2018). The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group. Journal of Surgical Oncology.
- Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
  Hu, L.-S., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., Maithel, S. K., … Pawlik, T. M. (2018). Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology.
- Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series
  Deshwar, A., Margonis, G. A., Andreatos, N., Barbon, C., Wang, J., Buettner, S., … Weis, M. J. (2018). Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series. ANTICANCER RESEARCH, 38(5), 2891–95.
- Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.
  Wilkinson, K. H., Ethun, C. G., Hembrook, M., Bedi, M., Charlson, J., Mogal, H., … Clarke, C. N. (2019). Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. The Journal of Surgical Research, 233, 154–62.
- Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma.
  Tran, T. B., Ethun, C. G., Pawlik, T. M., Schmidt, C., Beal, E. W., Fields, R. C., … Poultsides, G. A. (2018). Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma. Annals of Surgical Oncology.
- Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma
  Bagante, F., Weiss, M., Alexandrescu, S., Marques, H. P., Aldrighetti, L., Maithel, S. K., … Pawlik, T. M. (2018). Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma. HPB, 20(12), 1189–97.
- Perioperative Management in Hepatic Resections: Comparative Effectiveness of Neuraxial Anesthesia and Disparity of Care Patterns
  Zerillo, J., Agarwal, P., Poeran, J., Zubizarreta, N., Poultsides, G., Schwartz, M., … DeMaria, S. (2018). Perioperative Management in Hepatic Resections: Comparative Effectiveness of Neuraxial Anesthesia and Disparity of Care Patterns. ANESTHESIA AND ANALGESIA, 127(4), 855–63.
- Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions.
  Davidson, J. T., Jin, L. X., Krasnick, B., Ethun, C. G., Pawlik, T. M., Poultsides, G. A., … Fields, R. C. (2018). Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions. Journal of Surgical Oncology.
- Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors.
  Fisher, A. V., Lopez-Aguiar, A. G., Rendell, V. R., Pokrzywa, C., Rocha, F. G., Kanji, Z. S., … Weber, S. M. (2019). Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Gastric carcinoids: Does type of surgery or tumor affect survival?
  Crown, A., Kennecke, H., Kozarek, R., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E. W., … Rocha, F. G. (2018). Gastric carcinoids: Does type of surgery or tumor affect survival? American Journal of Surgery.
- Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer.
  Tummers, W. S., Miller, S. E., Teraphongphom, N. T., van den Berg, N. S., Hasan, A., Longacre, T. A., … Poultsides, G. A. (2019). Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Complications after liver surgery: a benchmark analysis.
  Bagante, F., Ruzzenente, A., Beal, E. W., Campagnaro, T., Merath, K., Conci, S., … Pawlik, T. M. (2019). Complications after liver surgery: a benchmark analysis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases.
  Ruzzenente, A., Bagante, F., Ratti, F., Beal, E. W., Alexandrescu, S., Merath, K., … Pawlik, T. M. (2019). Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma.
  Buettner, S., Ten Cate, D. W., Bagante, F., Alexandrescu, S., Marques, H. P., Lamelas, J., … Koerkamp, B. G. (2019). Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
  Lopez-Aguiar, A. G., Ethun, C. G., Pawlik, T. M., Tran, T., Poultsides, G. A., Isom, C. A., … Maithel, S. K. (2019). Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. Annals of Surgical Oncology.
- Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
  Merath, K., Mehta, R., Hyer, J. M., Bagante, F., Sahara, K., Alexandrescu, S., … Pawlik, T. M. (2019). Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
- Identification and molecular characterization of pancreatic tumor-initiating cells
  Vorvis, C., Poultsides, G. A., Norton, J. A., & Iliopoulos, D. (2012). Identification and molecular characterization of pancreatic tumor-initiating cells. CANCER RESEARCH, 72.
- Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Cancers
  Krampitz, G. W., Willingham, S. B., Volkmer, J. P., Weiskopf, K. A., George, B. M., Sage, J., … Weissman, I. L. (2015). Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Cancers. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), S59–S60.
- Performance of a novel TNM staging system for pancreatic neuroendocrine tumors versus the current AJCC staging system
  Qadan, M., Ma, Y., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2013). Performance of a novel TNM staging system for pancreatic neuroendocrine tumors versus the current AJCC staging system. JOURNAL OF CLINICAL ONCOLOGY, 31(4).
- Vascular Reconstruction During Major Oncologic Pancreatic Resections
  Pineda, C., Chandra, V., Krampitz, G., Poultsides, G. A., Norton, J. A., & Harris, E. J. (2013). Vascular Reconstruction During Major Oncologic Pancreatic Resections. JOURNAL OF VASCULAR SURGERY, 58(2), 559.
- Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group.
  Dave, A., Beal, E. W., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F. G., … Dillhoff, M. E. (2019). Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
  Sahara, K., Paredes, A. Z., Merath, K., Tsilimigras, D. I., Bagante, F., Ratti, F., … Pawlik, T. M. (2019). Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study
  Sham, J. G., Ejaz, A., Gage, M. M., Bagante, F., Reames, B. N., Maithel, S., … He, J. (2019). The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study. JOURNAL OF GASTROINTESTINAL SURGERY, 23(3), 484–91.
- KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases.
  Margonis, G. A., Amini, N., Andreatos, N., Sasaki, K., McVey, J., Mirza, M. B., … Weiss, M. J. (2019). KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study.
  Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. Annals of Surgery, 262(4), 632–40.
- Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.
  Gholami, S., Janson, L., Worhunsky, D. J., Tran, T. B., Squires, M. H., Jin, L. X., … Poultsides, G. A. (2015). Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. Journal of the American College of Surgeons, 221(2), 291–9.
- Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
  Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. Surgery, 158(2), 486–93.
- Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience.
  Melstrom, L. G., Eng, O. S., Raoof, M., Singh, G., Fong, Y., Latorre, K., … Abbott, D. E. (2019). Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
  Lopez-Aguiar, A. G., Zaidi, M. Y., Beal, E. W., Dillhoff, M., Cannon, J. G., Poultsides, G. A., … Maithel, S. K. (2019). Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. Annals of Surgical Oncology.
- Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group.
  Zhang, X.-F., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F., Kanji, Z., … Pawlik, T. M. (2019). Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group. Journal of Surgical Oncology.
- Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma?
  Zhang, X.-F., Lv, Y., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2019). Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma? Annals of Surgical Oncology.
- A Multi-Institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma.
  Merath, K., Chen, Q., Bagante, F., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2019). A Multi-Institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma. JAMA Surgery, e190571.
- Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
  Margonis, G. A., Buettner, S., Andreatos, N., Wagner, D., Sasaki, K., Barbon, C., … Weiss, M. J. (2018). Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients. Annals of Surgery.
- Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.
  Bagante, F., Spolverato, G., Weiss, M., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2017). Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 21(11), 1888–97.
- Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.
  Zhang, X.-F. F., Bagante, F., Chakedis, J., Moris, D., Beal, E. W., Weiss, M., … Pawlik, T. M. (2017). Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 21(11), 1841–50.
- Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
  Zhang, X.-F. F., Beal, E. W., Chakedis, J., Lv, Y., Bagante, F., Aldrighetti, L., … Pawlik, T. M. (2017). Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 21(11), 1821–30.
- Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis.
  Reames, B. N., Bagante, F., Ejaz, A., Spolverato, G., Ruzzenente, A., Weiss, M., … Pawlik, T. M. (2017). Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association, 19(10), 901–9.
- The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis.
  Ejaz, A., Reames, B. N., Maithel, S., Poultsides, G. A., Bauer, T. W., Fields, R. C., … Pawlik, T. M. (2017). The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis. Journal of Surgical Oncology, 116(7), 841–847.
- Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
  Margonis, G. A., Kim, Y., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Pawlik, T. M. (2016). Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. Annals of Surgical Oncology, 23(1), 134–41.
- Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.
  Amini, N., Margonis, G. A., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Pawlik, T. M. (2016). Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence. Annals of Surgical Oncology, 23(1), 126–33.
- The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative.
  Postlewait, L. M., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2015). The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative. Journal of Surgical Oncology, 112(2), 203–7.
- An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative.
  Dann, G. C., Squires, M. H., Postlewait, L. M., Kooby, D. A., Poultsides, G. A., Weber, S. M., … Maithel, S. K. (2015). An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative. Journal of Surgical Oncology, 112(2), 195–202.
- Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma.
  Bagante, F., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., … Pawlik, T. M. (2015). Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. Journal of Surgical Oncology, 112(2), 164–72.
- Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.
  Spolverato, G., Kim, Y., Alexandrescu, S., Marques, H. P., Lamelas, J., Aldrighetti, L., … Pawlik, T. M. (2016). Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Annals of Surgical Oncology, 23(1), 235–43.
- Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
  Jin, L. X., Moses, L. E., Squires, M. H., Poultsides, G. A., Votanopoulos, K., Weber, S. M., … Fields, R. C. (2015). Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative. Annals of Surgery, 262(6), 999–1005.
- Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
  Spolverato, G., Ejaz, A., Kim, Y., Squires, M. H., Poultsides, G., Fields, R. C., … Pawlik, T. M. (2015). Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. Annals of Surgery, 262(6), 991–8.
- Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
  Hu, L.-S., Zhang, X.-F., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2019). Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer?
  Mazer, L. M., & Poultsides, G. A. (2019). What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer? The Surgical Clinics of North America, 99(3), 457–69.
- Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome
  Norton, J. A., Krampitz, G. W., Poultsides, G. A., Visser, B. C., Fraker, D. L., Alexander, H. R., & Jensen, R. T. (2018). Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome. ANNALS OF SURGERY, 267(4), 782–88.
- Gastric carcinoids: Does type of surgery or tumor affect survival?
  Crown, A., Kennecke, H., Kozarek, R., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E. W., … Rocha, F. G. (2019). Gastric carcinoids: Does type of surgery or tumor affect survival? AMERICAN JOURNAL OF SURGERY, 217(5), 937–42.
- Isolated pancreatic tail remnants after transgastric necrosectomy can be observed
  Dua, M. M., Jensen, C. W., Friedland, S., Worth, P. J., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2018). Isolated pancreatic tail remnants after transgastric necrosectomy can be observed. JOURNAL OF SURGICAL RESEARCH, 231, 109–15.
- Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet "readiness"
  Dua, M. M., Navalgund, A., Axelrod, S., Axelrod, L., Worth, P. J., Norton, J. A., … Visser, B. C. (2018). Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet "readiness". AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 315(5), G743–G751.
- The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
  Lopez-Aguiar, A. G., Ethun, C. G., Zaidi, M. Y., Rocha, F. G., Poultsides, G. A., Dillhoff, M., … Maithel, S. K. (2019). The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management. Surgery.
- Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.
  Toesca, D. A., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. Pancreas, 48(5), 622–28.
- Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
  Margonis, G. A., Buettner, S., Andreatos, N., Wagner, D., Sasaki, K., Barbon, C., … Weiss, M. J. (2019). Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients. Annals of Surgery, 269(6), 1129–37.
- Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis
  Li, K., Cannon, J. G. D., Jiang, S. Y., Sambare, T. D., Owens, D. K., Bendavid, E., & Poultsides, G. A. (2018). Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis. JOURNAL OF SURGICAL ONCOLOGY, 117(6), 1288–96.
- Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium
  Lopez-Aguiar, A. G., Ethun, C. G., Pawlik, T. M., Tran, T., Poultsides, G. A., Isom, C. A., … Maithel, S. K. (2019). Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. ANNALS OF SURGICAL ONCOLOGY, 26(6), 1814–23.
- Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging
  Tummers, W. S., Miller, S. E., Teraphongphom, N. T., Gomez, A., Steinberg, I., Huland, D. M., … Rosenthal, E. L. (2018). Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging. ANNALS OF SURGICAL ONCOLOGY, 25(7), 1880–88.
- Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?
  Sahara, K., Tsilimigras, D. I., Merath, K., Bagante, F., Guglielmi, A., Aldrighetti, L., … Pawlik, T. M. (2019). Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation? Annals of Surgical Oncology.
- The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative.
  Zaidi, M. Y., Ethun, C. G., Liu, Y., Poultsides, G., Howard, J. H., Mogal, H., … Cardona, K. (2019). The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative. Journal of Surgical Oncology.
- The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative.
  Gannon, N. P., King, D. M., Ethun, C. G., Charlson, J., Tran, T. B., Poultsides, G., … Bedi, M. (2019). The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. Journal of Surgical Oncology.
- Characterization of colorectal liver metastasis at single-cell resolution reveals dynamic interplay in the tumor microenvironment
  Sathe, A., Chen, J., Wood-Bouwens, C., Almeda, A., Lau, B., Grimes, S. M., … Ji, H. (2018). Characterization of colorectal liver metastasis at single-cell resolution reveals dynamic interplay in the tumor microenvironment. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Integrated single-cell DNA and RNA analysis of intratumoral heterogeneity and immune lineages in colorectal and gastric tumor biopsies
  Lau, B., Andor, N., Sathe, A., Wood-Bouwens, C., Poultsides, G., & Ji, H. (2018). Integrated single-cell DNA and RNA analysis of intratumoral heterogeneity and immune lineages in colorectal and gastric tumor biopsies. CANCER RESEARCH, 78(13).
- What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer?
  Mazer, L. M., & Poultsides, G. A. (2019). What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer? SURGICAL CLINICS OF NORTH AMERICA, 99(3), 457-+.
- Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma?
  Zhang, X.-F., Lv, Y., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2019). Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma? ANNALS OF SURGICAL ONCOLOGY, 26(7), 2242–50.
- Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.
  Chouliaras, K., Senehi, R., Ethun, C. G., Poultsides, G., Tran, T., Grignol, V., … Votanopoulos, K. (2019). Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of Surgical Oncology.
- Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
  Tsilimigras, D. I., Sahara, K., Moris, D., Hyer, J. M., Paredes, A. Z., Bagante, F., … Pawlik, T. M. (2019). Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence.
  Dong, D.-H., Zhang, X.-F., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F., … Pawlik, T. M. (2019). Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis
  Merath, K., Mehta, R., Hyer, J. M., Bagante, F., Sahara, K., Alexandrescu, S., … Pawlik, T. M. (2019). Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis. EJSO, 45(6), 1084–91.
- Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming
  Koutsioumpa, M., Hatziapostolou, M., Polytarchou, C., Tolosa, E. J., Almada, L. L., Mahurkar-Joshi, S., … Iliopoulos, D. (2019). Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming. GUT, 68(7), 1271–86.
- Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
  Tsilimigras, D. I., Bagante, F., Sahara, K., Moris, D., Hyer, J. M., Wu, L., … Pawlik, T. M. (2019). Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification. Annals of Surgical Oncology.
- Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database.
  Prendergast, K. M., Smith, P. M., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., … Kiernan, C. M. (2019). Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database. Surgery.
- A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma
  Merath, K., Chen, Q., Bagante, F., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2019). A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma. JAMA SURGERY, 154(6).
- A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.
  Zaidi, M. Y., Lopez-Aguiar, A. G., Switchenko, J. M., Lipscomb, J., Andreasi, V., Partelli, S., … Maithel, S. K. (2019). A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. Annals of Surgery.
- Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC).
  Schwartz, P. B., Vande Walle, K., Winslow, E. R., Ethun, C. G., Tran, T. B., Poultsides, G., … Abbott, D. E. (2019). Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC). Sarcoma, 2019, 5395131.
- The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management
  Lopez-Aguiar, A. G., Ethun, C. G., Zaidi, M. Y., Rocha, F. G., Poultsides, G. A., Dillhoff, M., … Maithel, S. K. (2019). The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management. SURGERY, 166(1), 15–21.
- Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
  Bagante, F., Spolverato, G., Merath, K., Weiss, M., Alexandrescu, S., Marques, H. P., … Pawlik, T. M. (2019). Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection. Surgery.
- Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).
  Panni, R. Z., Lopez-Aguiar, A. G., Liu, J., Poultsides, G. A., Rocha, F. G., Hawkins, W. G., … Fields, R. C. (2019). Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG). Journal of Surgical Oncology.
- Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group
  Lopez-Aguiar, A. G., Zaidi, M. Y., Beal, E. W., Dillhoff, M., Cannon, J. G. D., Poultsides, G. A., … Maithel, S. K. (2019). Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. ANNALS OF SURGICAL ONCOLOGY, 26(8), 2517–24.
- Management of Ileal Neuroendocrine Tumors with Liver Metastases.
  Fisher, A. T., Titan, A. L., Foster, D. S., Worth, P. J., Poultsides, G. A., Visser, B. C., … Norton, J. A. (2019). Management of Ileal Neuroendocrine Tumors with Liver Metastases. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer
  Tummers, W. S., Miller, S. E., Teraphongphom, N. T., van den Berg, N. S., Hasan, A., Longacre, T. A., … Poultsides, G. A. (2019). Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer. HPB, 21(7), 883–90.
- Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
  Zaidi, M. Y., Ethun, C. G., Tran, T. B., Poultsides, G., Grignol, V. P., Howard, J. H., … Cardona, K. (2019). Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. Annals of Surgical Oncology.
- Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma
  Hu, L.-S., Zhang, X.-F., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2019). Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 26(8), 2549–57.
- New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
  Zhang, X.-F., Xue, F., Dong, D.-H., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., … Pawlik, T. M. (2019). New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis. Annals of Surgery.
- Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients
  Tsilimigras, D. I., Hyer, J. M., Moris, D., Sahara, K., Bagante, F., Guglielmi, A., … Soubrane, O. (2019). Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients. JOURNAL OF SURGICAL ONCOLOGY, 120(2), 206–13.
- Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the US neuroendocrine tumor study group
  Zhang, X.-F., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F., Kanji, Z., … Pawlik, T. M. (2019). Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the US neuroendocrine tumor study group. JOURNAL OF SURGICAL ONCOLOGY, 120(2), 231–40.
- Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?
  Gamboa, A. C., Ethun, C. G., Switchenko, J. M., Lipscomb, J., Poultsides, G. A., Grignol, V., … Cardona, K. (2019). Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan? Journal of the American College of Surgeons.
- The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
  Margonis, G. A., Amini, N., Buettner, S., Kim, Y., Wang, J., Andreatos, N., … Weiss, M. J. (2019). The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis. Annals of Surgery.
- Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
  DePalo, D. K., Lee, R. M., Lopez-Aguiar, A. G., Gamboa, A. C., Rocha, F., Poultsides, G., … Russell, M. C. (2019). Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity? Journal of Surgical Oncology.
- Esophageal and Esophagogastric Junction Cancers, Version 2.2019
  Ajani, J. A., D'Amico, T. A., Bentrem, D. J., Chao, J., Corvera, C., Das, P., … Pluchino, L. A. (2019). Esophageal and Esophagogastric Junction Cancers, Version 2.2019. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 17(7), 855–83.
- A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database
  Johnson, A. C., Ethun, C. G., Liu, Y., Poultsides, G., Howard, J. H., Bedi, M., … Cardona, K. (2018). A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database. JOURNAL OF SURGICAL ONCOLOGY, 118(7), 1135–41.
- Seventh edition (2010) of gastric adenocarcinoma AJCC staging system: Is there room for improvement?
  Patel, M. I., Rhoads, K. F., Ma, Y., Ford, J. M., Norton, J. A., & Poultsides, G. A. (2012). Seventh edition (2010) of gastric adenocarcinoma AJCC staging system: Is there room for improvement? JOURNAL OF CLINICAL ONCOLOGY, 30(4).
- Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System
  Toesca, D. A. S., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. (2019). Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS.
- Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective
  Moro, A., Paredes, A. Z., Farooq, A., Sahara, K., Tsilimigras, D., Mehta, R., … Soubrane, O. (2019). Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective. JOURNAL OF SURGICAL ONCOLOGY.
- Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases A Multi-institutional, International Analysis of 1099 Patients
  Margonis, G. A., Buettner, S., Andreatos, N., Wagner, D., Sasaki, K., Barbon, C., … Weiss, M. J. (2019). Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases A Multi-institutional, International Analysis of 1099 Patients. ANNALS OF SURGERY, 269(6), 1129–37.
- Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.
  Wu, L., Sahara, K., Tsilimigras, D. I., Maithel, S. K., Poultsides, G. A., Rocha, F. G., … Pawlik, T. M. (2019). Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis. Journal of Surgical Oncology.
- Clinicopathologic score predicting lymph node metastasis in T1 gastric cancer
  Tran, T. B., Worhunsky, D. J., Squires, M. H., Jin, L. X., Spolverato, G., Votanopoulos, K. I., … Poultsides, G. A. (2018). Clinicopathologic score predicting lymph node metastasis in T1 gastric cancer. SURGERY, 163(4), 889–93.
- Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.
  Chouliaras, K., Senehi, R., Ethun, C. G., Poultsides, G., Grignol, V., Clarke, C. N., … Votanopoulos, K. I. (2019). Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of Surgical Oncology.
- Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
  Squires, M. H., Ethun, C. G., Suarez-Kelly, L. P., Yu, P. Y., Hughes, T. M., Shelby, R. D., … Howard, J. H. (2019). Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. The Journal of Surgical Research, 245, 577–86.
- Correction to: Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
  Spolverato, G., Bagante, F., Aldrighetti, L., Poultsides, G., Bauer, T. W., Fields, R. C., … Pawlik, T. M. (2019). Correction to: Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.
  Sahara, K., Merath, K., Tsilimigras, D. I., Hyer, J. M., Guglielmi, A., Aldrighetti, L., … Other Members Of The U S Neuroendocrine Tumor Study Group. (2019). Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis. Journal of Surgical Oncology.
- Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors =2cm after curative resection: A multi-institutional study of 392 cases.
  Dong, D.-H., Zhang, X.-F., Poultsides, G., Rocha, F., Weber, S., Fields, R., … Pawlik, T. M. (2019). Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors =2cm after curative resection: A multi-institutional study of 392 cases. Journal of Surgical Oncology.
- Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases
  Ruzzenente, A., Bagante, F., Ratti, F., Beal, E. W., Alexandrescu, S., Merath, K., … Pawlik, T. M. (2019). Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases. HPB, 21(9), 1230–39.
- Complications after liver surgery: a benchmark analysis
  Bagante, F., Ruzzenente, A., Beal, E. W., Campagnaro, T., Merath, K., Conci, S., … Pawlik, T. M. (2019). Complications after liver surgery: a benchmark analysis. HPB, 21(9), 1139–49.
- Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis.
  Kimura, R. H., Wang, L., Shen, B., Huo, L., Tummers, W., Filipp, F. V., … Gambhir, S. S. (2019). Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nature Communications, 10(1), 4673.
- Comprehensive characterization of gastric cancer at single-cell resolution
  Chen, J., Sathe, A., Grimes, S., Greer, S., Lau, B., Renschler, A., … Ji, H. (2019). Comprehensive characterization of gastric cancer at single-cell resolution. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
  Tsilimigras, D. I., Bagante, F., Moris, D., Merath, K., Paredes, A. Z., Sahara, K., … Pawlik, T. M. (2019). Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients. Surgery.
- Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
  Lee, R. M., DePalo, D. K., Lopez-Aguiar, A. G., Zaidi, M. Y., Rocha, F. G., Kanji, Z. S., … Russell, M. C. (2019). Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity? JOURNAL OF CLINICAL ONCOLOGY, 37(4).
- Resection margin distance in extrahepatic cholangiocarcinoma: How much is enough?
  Rahnemai-Azar, A. A., Ronnekleiv-Kelly, S., Abbott, D., Ethun, C. G., Poultsides, G. A., Thuy Tran, … Weber, S. M. (2019). Resection margin distance in extrahepatic cholangiocarcinoma: How much is enough? JOURNAL OF CLINICAL ONCOLOGY, 37(4).
- Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.
  Zhang, X.-F., Wu, X.-N., Tsilimigras, D. I., Poultsides, G., Rocha, F., Abbott, D. E., … Pawlik, T. M. (2019). Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined. Journal of Surgical Oncology.
- Postoperative Outcomes of Laparoscopic vs Robotic Distal Pancreatectomy: A Propensity-Matched Analysis
  Jensen, C. W., Baiocchi, M., Dua, M. M., Poultsides, G. A., Norton, J. A., Worth, P. J., & Visser, B. C. (2019). Postoperative Outcomes of Laparoscopic vs Robotic Distal Pancreatectomy: A Propensity-Matched Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S181–S182.
- Role of Adjuvant Radiation Therapy for Retroperitoneal Sarcomas: An 8-Institution Study from the US Sarcoma Collaborative
  Chouliaras, K., Cardona, K., Poultsides, G. A., Grignol, V. P., Clarke, C. N., Roggin, K., … Votanopoulos, K. (2019). Role of Adjuvant Radiation Therapy for Retroperitoneal Sarcomas: An 8-Institution Study from the US Sarcoma Collaborative. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Prognostic Impact of KRAS Mutational Status in Patients with Colorectal Cancer Liver Metastases Differs According to the Location of the Primary Tumor
  Amini, N., Margonis, G. A., Kreis, M. E., Poultsides, G. A., Sasaki, K., Wagner, D., … Safar, B. (2019). Prognostic Impact of KRAS Mutational Status in Patients with Colorectal Cancer Liver Metastases Differs According to the Location of the Primary Tumor. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
  Tsilimigras, D. I., Mehta, R., Moris, D., Sahara, K., Bagante, F., Paredes, A. Z., … Pawlik, T. M. (2019). Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines. Annals of Surgical Oncology.
- A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.
  Tsilimigras, D. I., Mehta, R., Moris, D., Sahara, K., Bagante, F., Paredes, A. Z., … Pawlik, T. M. (2019). A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients. Annals of Surgical Oncology.
- Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group
  Dave, A., Beal, E. W., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F. G., … Dillhoff, M. E. (2019). Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group. JOURNAL OF GASTROINTESTINAL SURGERY, 23(11), 2225–31.
- Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?
  Crown, A., Simianu, V. V., Kennecke, H., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E. W., … Rocha, F. G. (2019). Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes? Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma
  Buettner, S., ten Cate, D. W. G., Bagante, F., Alexandrescu, S., Marques, H. P., Lamelas, J., … Koerkamp, B. G. (2019). Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. JOURNAL OF GASTROINTESTINAL SURGERY, 23(11), 2239–46.
- Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience
  Melstrom, L. G., Eng, O. S., Raoof, M., Singh, G., Fong, Y., Latorre, K., … Abbott, D. E. (2019). Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience. HPB, 21(11), 1520–26.
- KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases
  Margonis, G. A., Amini, N., Andreatos, N., Sasaki, K., Mcvey, J., Mirza, M. B., … Weiss, M. J. (2019). KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases. HPB. ELSEVIER SCI LTD.
- Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group.
  Marincola Smith, P., Baechle, J., Solórzano, C. C., Tan, M., Lopez-Aguiar, A. G., Dillhoff, M., … Idrees, K. (2019). Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Redefining Conditional Overall and Disease-Free Survival After Curative Resection for Intrahepatic Cholangiocarcinoma: a Multi-institutional, International Study of 1221 patients.
  Hu, L.-S., Zhang, X.-F., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2019). Redefining Conditional Overall and Disease-Free Survival After Curative Resection for Intrahepatic Cholangiocarcinoma: a Multi-institutional, International Study of 1221 patients. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection.
  Dong, D.-H., Zhang, X.-F., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F., … Pawlik, T. M. (2019). Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
  Sahara, K., Tsilimigras, D. I., Mehta, R., Moro, A., Paredes, A. Z., Lopez-Aguiar, A. G., … Pawlik, T. M. (2019). Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Annals of Surgical Oncology.
- Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis.
  Tsilimigras, D. I., Mehta, R., Merath, K., Bagante, F., Paredes, A. Z., Farooq, A., … Pawlik, T. M. (2019). Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group.
  Armstrong, E. A., Beal, E. W., Lopez-Aguiar, A. G., Poultsides, G., Cannon, J. G., Rocha, F., … Dillhoff, M. (2019). Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group. The American Surgeon, 85(12), 1334–40.
- Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium.
  Sahara, K., Tsilimigras, D. I., Maithel, S. K., Abbott, D. E., Poultsides, G. A., Hatzaras, I., … Pawlik, T. M. (2020). Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium. Journal of Surgical Oncology.
- Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group
  Armstrong, E. A., Beal, E. W., Lopez-Aguiar, A. G., Poultsides, G., Cannon, J. G., Rocha, F., … Dillhoff, M. (2019). Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group. AMERICAN SURGEON, 85(12), 1334–40.
- Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
  Zhang, X.-F. F., Xue, F., Dong, D.-H. H., Weiss, M., Popescu, I., Marques, H. P., … Pawlik, T. M. (2020). Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis. Annals of Surgery.
- Long-term outcomes after curative resection of HCV-positive versus non-hepatitis related hepatocellular carcinoma: an international multi-institutional analysis.
  Wei, T., Zhang, X.-F. F., Bagante, F., Ratti, F., Marques, H. P., Soubrane, O., … Pawlik, T. M. (2020). Long-term outcomes after curative resection of HCV-positive versus non-hepatitis related hepatocellular carcinoma: an international multi-institutional analysis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.
  Tsilimigras, D. I., Mehta, R., Aldrighetti, L., Poultsides, G. A., Maithel, S. K., Martel, G., … Pawlik, T. M. (2020). Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma. Journal of the American College of Surgeons.
- Single cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment.
  Sathe, A., Grimes, S. M., Lau, B. T., Chen, J., Suarez, C., Huang, R. J., … Ji, H. P. (2020). Single cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis.
  Wei, T., Zhang, X.-F. F., Bagante, F., Ratti, F., Marques, H. P., Silva, S., … Pawlik, T. M. (2020). Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors.
  Squires, M. H., Worth, P. J., Konda, B., Shah, M. H., Dillhoff, M. E., Abdel-Misih, S., … Cloyd, J. M. (2020). Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors. Pancreas.
- Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit.
  Barrett, J. R., Rendell, V., Pokrzywa, C., Lopez-Aguiar, A. G., Cannon, J., Poultsides, G. A., … Erik Abbott, D. (2020). Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. Journal of Surgical Oncology.
- Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?
  Bedi, M., Ethun, C. G., Charlson, J., Tran, T. B., Poultsides, G., Grignol, V., … King, D. M. (2020). Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity? Clinical Orthopaedics and Related Research, 478(3), 550–59.
- Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative.
  Thalji, S. Z., Tsai, S., Gamblin, T. C., Clarke, C., Christians, K., Charlson, J., … Mogal, H. (2020). Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. Journal of Surgical Oncology.
- PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC.
  Schwartz, P. B., Poultsides, G., Roggin, K., Howard, J. H., Fields, R. C., Clarke, C. N., … Winslow, E. R. (2020). PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC. The Journal of Surgical Research, 251, 228–38.
- Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group.
  Heidsma, C. M., Hyer, M., Tsilimigras, D. I., Rocha, F., Abbott, D. E., Fields, R., … Pawlik, T. M. (2020). Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group. Journal of Surgical Oncology.
- The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma.
  Moro, A., Mehta, R., Sahara, K., Tsilimigras, D. I., Paredes, A. Z., Farooq, A., … Pawlik, T. M. (2020). The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors.
  Marincola Smith, P., Baechle, J., Tan, M. C., Solórzano, C. C., Lopez-Aguiar, A. G., Dillhoff, M., … Idrees, K. (2020). Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors. Annals of Surgical Oncology.
- Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival.
  Shelby, R. D., Suarez-Kelly, L. P., Yu, P. Y., Hughes, T. M., Ethun, C. G., Tran, T. B., … Grignol, V. (2020). Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. Journal of Surgical Oncology.
- The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis.
  Tsilimigras, D. I., Moris, D., Mehta, R., Paredes, A. Z., Sahara, K., Guglielmi, A., … Pawlik, T. M. (2020). The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Minimally Invasive Versus Open Liver Resection for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension: Results of an International Multi-institutional Analysis.
  Ruzzenente, A., Bagante, F., Ratti, F., Alaimo, L., Marques, H. P., Silva, S., … Pawlik, T. M. (2020). Minimally Invasive Versus Open Liver Resection for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension: Results of an International Multi-institutional Analysis. Annals of Surgical Oncology.
- Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
  Tsilimigras, D. I., Bagante, F., Moris, D., Hyer, J. M., Sahara, K., Paredes, A. Z., … Pawlik, T. M. (2020). Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria. Annals of Surgical Oncology.
- Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group.
  Baechle, J. J., Marincola Smith, P., Tan, M., Solórzano, C. C., Lopez-Aguiar, A. G., Dillhoff, M., … Idrees, K. (2020). Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group. Annals of Surgical Oncology.
- Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
  Sahara, K., Tsilimigras, D. I., Mehta, R., Moro, A., Paredes, A. Z., Lopez-Aguiar, A. G., … Pawlik, T. M. (2020). Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Annals of Surgical Oncology.
- Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
  Squires, M., Worth, P., Konda, B., Dillhoff, M. S. M., Abdel-Misih, S., Pawlik, T., … Cloyd, J. (2020). Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors. PANCREAS, 49(3), 488.
- Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
  Sahara, K., Paredes, A. Z., Merath, K., Tsilimigras, D., Bagante, F., Ratti, F., … Pawlik, T. M. (2020). Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. JOURNAL OF GASTROINTESTINAL SURGERY, 24(3), 551–59.
- Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers.
  Tsilimigras, D. I., Sahara, K., Moris, D., Mehta, R., Paredes, A. Z., Ratti, F., … Pawlik, T. M. (2020). Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers. Annals of Surgical Oncology.
- Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
  Lu, G., van den Berg, N. S., Martin, B. A., Nishio, N., Hart, Z. P., van Keulen, S., … Poultsides, G. A. (2020). Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study. The Lancet. Gastroenterology & Hepatology.
- Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis.
  Xiang, J.-X., Zhang, X.-F., Weiss, M., Aldrighetti, L., Poultsides, G. A., Bauer, T. W., … Pawlik, T. M. (2020). Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis. Annals of Surgical Oncology.
- Laparoscopic hepatic lobectomy for symptomatic polycystic liver disease.
  Li, A. Y., Bergquist, J. R., August, A. T., Dua, M. M., Poultsides, G. A., & Visser, B. C. (2020). Laparoscopic hepatic lobectomy for symptomatic polycystic liver disease. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
  Dong, D.-H. H., Zhang, X.-F. F., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., Weber, S., … Pawlik, T. M. (2020). Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy. Journal of Surgical Oncology.
- A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis.
  Tsilimigras, D. I., Hyer, J. M., Paredes, A. Z., Diaz, A., Moris, D., Guglielmi, A., … Pawlik, T. M. (2020). A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis. Annals of Surgical Oncology.
- Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors.
  Zhang, X.-F. F., Xue, F., Wu, Z., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., … Pawlik, T. M. (2020). Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors. Annals of Surgery.
- Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP risk calculator.
  Schwartz, P. B., Stahl, C. C., Ethun, C., Marka, N., Poultsides, G. A., Roggin, K. K., … Abbott, D. E. (2020). Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP risk calculator. Journal of Surgical Oncology.
- Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model.
  Tsilimigras, D. I., Mehta, R., Guglielmi, A., Ratti, F., Marques, H. P., Soubrane, O., … Pawlik, T. M. (2020). Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model. Journal of Surgical Oncology.
- Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
  Tsilimigras, D. I., Sahara, K., Wu, L., Moris, D., Bagante, F., Guglielmi, A., … Pawlik, T. M. (2020). Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. JAMA Surgery.
- Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
  Moro, A., Mehta, R., Tsilimigras, D. I., Sahara, K., Paredes, A. Z., Bagante, F., … Pawlik, T. M. (2020). Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis. Surgery.
- Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative.
  Wiseman, J. T., Ethun, C. G., Cloyd, J. M., Shelby, R., Suarez-Kelly, L., Tran, T., … Grignol, V. (2020). Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative. Journal of Surgical Oncology.
- Islet Tumors: Resect or Follow?
  Sinclair, T. J., & Poultsides, G. A. (2020). Islet Tumors: Resect or Follow? Advances in Surgery, 54, 69–88.
- High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma.
  Strong, E. A., Park, S. H., Ethun, C. G., Chow, B., King, D., Bedi, M., … Clarke, C. N. (2020). High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery.
- Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group
  Zhang, X.-F., Wu, Z., Cloyd, J., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., … Pawlik, T. M. (2019). Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group. SURGERY, 165(3), 548–56.
- Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma.
  Tsilimigras, D. I., Sahara, K., Paredes, A. Z., Moro, A., Mehta, R., Moris, D., … Pawlik, T. M. (2020). Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Pancreatic Cancer Prognostication: From Trousseau to Thrombelastography.
  Poultsides, G. A. (2020). Pancreatic Cancer Prognostication: From Trousseau to Thrombelastography. Annals of Surgery.
- A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases.
  Paredes, A. Z., Hyer, J. M., Tsilimigras, D. I., Moro, A., Bagante, F., Guglielmi, A., … Pawlik, T. M. (2020). A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases. Annals of Surgical Oncology.
- Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors.
  Heidsma, C. M., Tsilimigras, D. I., van Dieren, S., Rocha, F., Abbott, D. E., Fields, R., … Pawlik, T. M. (2020). Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2?cm.
  Heidsma, C. M., Tsilimigras, D. I., Rocha, F., Abbott, D. E., Fields, R., Smith, P. M., … Pawlik, T. M. (2020). Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2?cm. Journal of Surgical Oncology.
- Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging.
  Pei, J., Juniper, G., van den Berg, N. S., Nisho, N., Broadt, T., Welch, A. R., … Rosenthal, E. L. (2020). Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging. Molecular Imaging and Biology.
- A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative.
  Lee, R. M., Ethun, C. G., Zaidi, M. Y., Tran, T. B., Poultsides, G. A., Grignol, V. P., … Cardona, K. (2020). A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative. Surgical Oncology, 34, 292–97.
- Defining and Predicting Early Recurrence after Resection for Gallbladder Cancer.
  Sahara, K., Tsilimigras, D. I., Kikuchi, Y., Ethun, C. G., Maithel, S. K., Abbott, D. E., … Pawlik, T. M. (2020). Defining and Predicting Early Recurrence after Resection for Gallbladder Cancer. Annals of Surgical Oncology.
- Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
  Tsilimigras, D. I., Mehta, R., Paredes, A. Z., Moris, D., Sahara, K., Bagante, F., … Pawlik, T. M. (2020). Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria. Annals of Surgery, 272(4), 574–81.
- The Landmark Series: Pancreatic Neuroendocrine Tumors.
  Cloyd, J. M., & Poultsides, G. A. (2020). The Landmark Series: Pancreatic Neuroendocrine Tumors. Annals of Surgical Oncology.
- ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors.
  Cloyd, J. M., & Poultsides, G. A. (2020). ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors. Annals of Surgical Oncology.
- Prediction of tumor recurrence by alpha-fetoprotein model after curative resection for hepatocellular carcinoma.
  Ding, H.-F., Zhang, X.-F., Bagante, F., Ratti, F., Marques, H. P., Soubrane, O., … Pawlik, T. M. (2020). Prediction of tumor recurrence by alpha-fetoprotein model after curative resection for hepatocellular carcinoma. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
- Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
  Titan, A. L., Norton, J. A., Fisher, A. T., Foster, D. S., Harris, E. J., Worhunsky, D. J., … Jensen, R. T. (2020). Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors. JAMA Network Open, 3(11), e2024318.
- Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database.
  Stahl, C. C., Schwartz, P. B., Ethun, C. G., Marka, N., Krasnick, B. A., Tran, T. B., … Abbott, D. E. (2020). Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database. Annals of Surgical Oncology.
- Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis.
  Chouliaras, K., Patel, N., Senehi, R., Ethun, C. G., Poultsides, G., Grignol, V., … Votanopoulos, K. (2020). Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis. Journal of Surgical Oncology.
- Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma.
  Tsilimigras, D. I., Hyer, J. M., Diaz, A., Moris, D., Bagante, F., Ratti, F., … Pawlik, T. M. (2020). Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma. Journal of Surgical Oncology.
- Tumor Burden Dictates Prognosis among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma: An International, Multi-Institutional Analysis
  Tsilimigras, D. I., Moris, D., Paredes, A., Weiss, M. J., Bauer, T. W., Poultsides, G. A., … Pawlik, T. M. (2020). Tumor Burden Dictates Prognosis among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma: An International, Multi-Institutional Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 231(4), S173.
- Tumor Necrosis Impacts Prognosis of Patients Undergoing Curative-Intent Hepatocellular Carcinoma.
  Wei, T., Zhang, X.-F., Bagante, F., Ratti, F., Marques, H. P., Silva, S., … Pawlik, T. M. (2020). Tumor Necrosis Impacts Prognosis of Patients Undergoing Curative-Intent Hepatocellular Carcinoma. Annals of Surgical Oncology.
- Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?
  Tsilimigras, D. I., Hyer, J. M., Paredes, A. Z., Moris, D., Sahara, K., Guglielmi, A., … Pawlik, T. M. (2020). Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? Annals of Surgical Oncology.
- Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
  Sahara, K., Tsilimigras, D. I., Moro, A., Mehta, R., Dillhoff, M., Heidsma, C. M., … Pawlik, T. M. (2021). Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group. Neuroendocrinology, 111(1-2), 129–38.
- Advances in the surgical management of gastric and gastroesophageal junction cancer
  Narayan, R. R., & Poultsides, G. A. (2021). Advances in the surgical management of gastric and gastroesophageal junction cancer. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 6.
- Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
  Tsilimigras, D. I., Hyer, J. M., Bagante, F., Guglielmi, A., Ruzzenente, A., Alexandrescu, S., … Pawlik, T. M. (2020). Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status. Journal of the American College of Surgeons.
- The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
  Kamphues, C., Andreatos, N., Kruppa, J., Buettner, S., Wang, J., Sasaki, K., … Margonis, G. A. (2021). The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study. Journal of Surgical Oncology.
- Advances in the surgical management of gastric and gastroesophageal junction cancer.
  Narayan, R. R., & Poultsides, G. A. (2021). Advances in the surgical management of gastric and gastroesophageal junction cancer. Translational Gastroenterology and Hepatology, 6, 16.
- Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma.
  Xiang, J.-X., Zhang, X.-F., Weber, S. M., Poultsides, G., Fields, R. C., Hatzaras, I., … Pawlik, T. M. (2021). Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma. Journal of Surgical Oncology.
- Correction to: Laparoscopic Duodenojejunostomy for Superior Mesenteric Artery Syndrome.
  Magee, G. A., Slater, B. J., Lee, J. T., & Poultsides, G. A. (2021). Correction to: Laparoscopic Duodenojejunostomy for Superior Mesenteric Artery Syndrome. Digestive Diseases and Sciences.
- Regional lymph node sampling in hepatoma resection: insight into prognosis.
  Bergquist, J. R., Li, A. Y., Javadi, C. S., Lee, B., Norton, J. A., Poultsides, G. A., … Visser, B. C. (2021). Regional lymph node sampling in hepatoma resection: insight into prognosis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database.
  Baechle, J. J., Marincola Smith, P., Solorzano, C. C., Tran, T. B., Postlewait, L. M., Maithel, S. K., … Kiernan, C. M. (2021). Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database. Annals of Surgical Oncology.
- Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases.
  Tsilimigras, D. I., Sahara, K., Hyer, J. M., Diaz, A., Moris, D., Bagante, F., … Pawlik, T. M. (2021). Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases. Surgery.
- Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma.
  Tsilimigras, D. I., Hyer, J. M., Diaz, A., Bagante, F., Ratti, F., Marques, H. P., … Pawlik, T. M. (2021). Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma. Cancers, 13(4).
- Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma.
  Sahara, K., Tsilimigras, D. I., Toyoda, J., Miyake, K., Ethun, C. G., Maithel, S. K., … Pawlik, T. M. (2021). Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma. Annals of Surgical Oncology.
- Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model.
  Dong, D.-H., Zhang, X.-F., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., Weber, S., … Pawlik, T. M. (2021). Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model. World Journal of Surgery.
- Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: an external validation of the MD Anderson and JHH-MSK scores.
  Sasaki, K., Gagniere, J., Dupre, A., Ardiles, V., O Connor, J., Wang, J., … Margonis, G. (2021). Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: an external validation of the MD Anderson and JHH-MSK scores. Journal of Hepato-Biliary-Pancreatic Sciences.
- Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma.
  Zhang, X.-F., Xue, F., He, J., Alexandrescu, S., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2021). Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Serum alpha-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma.
  Tsilimigras, D. I., Moris, D., Hyer, J. M., Bagante, F., Ratti, F., Marques, H. P., … Pawlik, T. M. (2021). Serum alpha-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology.
- Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma
  Tran, T. B., Ethun, C. G., Pawlik, T. M., Schmidt, C., Beal, E. W., Fields, R. C., … Poultsides, G. A. (2019). Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 26(2), 611–618.
- Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors
  Fisher, A. V., Lopez-Aguiar, A. G., Rendell, V. R., Pokrzywa, C., Rocha, F. G., Kanji, Z. S., … Weber, S. M. (2019). Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. JOURNAL OF GASTROINTESTINAL SURGERY, 23(4), 651–658.
- Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions
  Davidson, J. T., Jin, L. X., Krasnick, B., Ethun, C. G., Pawlik, T. M., Poultsides, G. A., … Shenoy, R. (2019). Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions. JOURNAL OF SURGICAL ONCOLOGY, 119(3), 288–294.
- Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative
  Wilkinson, K. H., Ethun, C. G., Hembrook, M., Bedi, M., Charlson, J., Mogal, H., … Clarke, C. N. (2019). Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. JOURNAL OF SURGICAL RESEARCH, 233, 154–162.
- The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group
  Zaidi, M. Y., Lopez-Aguiar, A. G., Poultsides, G. A., Dillhoff, M., Rocha, F. G., Idrees, K., … Maithel, S. K. (2019). The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group. JOURNAL OF SURGICAL ONCOLOGY, 119(1), 5–11.
- Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma
  Hu, L.-S., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., Maithel, S. K., … Pawlik, T. M. (2019). Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma. JOURNAL OF SURGICAL ONCOLOGY, 119(1), 21–29.
- ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery (vol 25, pg 820, 2018)
  Tummers, W. S., Rosenthal, E. L., Vahrmeijer, A. L., & Poultsides, G. A. (2018). ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery (vol 25, pg 820, 2018). ANNALS OF SURGICAL ONCOLOGY, 25, 999.
- Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors
  Zaidi, M. Y., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E., Poultsides, G., Makris, E., … Maithel, S. K. (2019). Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors. JAMA SURGERY, 154(2), 134–140.
- Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection
  Kimbrough, C. W., Beal, E. W., Dillhoff, M. E., Schmidt, C. R., Pawlik, T. M., Lopez-Aguiar, A. G., … Cloyd, J. M. (2019). Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection. SURGERY, 165(3), 657–663.
- Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms
  Chakedis, J., Beal, E. W., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F. G., … Dillhoff, M. (2019). Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. JOURNAL OF GASTROINTESTINAL SURGERY, 23(1), 122–134.
- The prognostic significance of adrenocortical carcinomas identified incidentally
  Rossfeld, K. K., Maithel, S. K., Prescott, J., Wang, T. S., Fields, R. C., Weber, S. M., … Shirley, L. A. (2018). The prognostic significance of adrenocortical carcinomas identified incidentally. JOURNAL OF SURGICAL ONCOLOGY, 118(7), 1155–1162.
- ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery
  Tummers, W. S., Rosenthal, E. L., Vahrmeijer, A. L., & Poultsides, G. A. (2018). ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. ANNALS OF SURGICAL ONCOLOGY, 25, 820–821.
- The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis
  Margonis, G. A., Buettner, S., Andreatos, N., Wagner, D., Sasaki, K., Galjart, B., … Weiss, M. J. (2018). The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis. JOURNAL OF SURGICAL ONCOLOGY, 118(7), 1074–1080.
- Effect of perioperative transfusion on recurrence and survival after resection of distal cholangiocarcinoma: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium.
  Lopez-Aguiar, A. G., Ethun, C., Pawlik, T. M., Poultsides, G. A., Thuy Tran, Idrees, K., … Maithel, S. K. (2017). Effect of perioperative transfusion on recurrence and survival after resection of distal cholangiocarcinoma: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF CLINICAL ONCOLOGY, 35(4).
- The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis: A multi-institutional analysis.
  Ejaz, A., Pawlik, T. M., Reames, B., Maithel, S. K., Poultsides, G. A., Bauer, T. W., … Aldrighetti, L. (2017). The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis: A multi-institutional analysis. JOURNAL OF CLINICAL ONCOLOGY, 35(4).
- A novel t-stage classification system for adrenocortical carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.
  Poorman, C. E., Ethun, C. G., Postlewait, L. M. L., Thuy Tran, Pawlik, T. M., Wang, T. S., … Maithel, S. K. (2017). A novel t-stage classification system for adrenocortical carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. JOURNAL OF CLINICAL ONCOLOGY, 35(4).
- Actual 5-year survivors following resection of hilar cholangiocarcinoma.
  Thuy Tran, Ethun, C. G., Pawlik, T. M., Buettner, S., Idrees, K., Isom, C. A., … Poultsides, G. A. (2017). Actual 5-year survivors following resection of hilar cholangiocarcinoma. JOURNAL OF CLINICAL ONCOLOGY, 35(4).
- Impact of major vascular resection on short- and long-term outcomes in patients with intrahepatic cholangiocarcinoma.
  Reames, B., Pawlik, T. M., Ejaz, A., Marques, H., Aldrighetti, L., Maithel, S. K., … Clark, T. (2017). Impact of major vascular resection on short- and long-term outcomes in patients with intrahepatic cholangiocarcinoma. JOURNAL OF CLINICAL ONCOLOGY, 35(4).
- Impact of insurance status on survival in neuroendocrine tumors: A multi-institutional Study from the US Neuroendocrine Study Group.
  Smith, P. M., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E. W., Poultsides, G. A., Makris, E., … Idrees, K. (2018). Impact of insurance status on survival in neuroendocrine tumors: A multi-institutional Study from the US Neuroendocrine Study Group. JOURNAL OF CLINICAL ONCOLOGY, 36(4).
- Defining the role of lymphadenectomy for pancreatic neuroendocrine tumors: An eight institution study of 695 patients from the US Neuroendocrine Tumor Study Group.
  Lopez-Aguiar, A. G., Zaidi, M., Dillhoff, M., Beal, E. W., Poultsides, G. A., Makris, E., … Maithel, S. (2018). Defining the role of lymphadenectomy for pancreatic neuroendocrine tumors: An eight institution study of 695 patients from the US Neuroendocrine Tumor Study Group. JOURNAL OF CLINICAL ONCOLOGY, 36(4).
- Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in intestinal neuroendocrine tumors: An analysis of the US Neuroendocrine Tumor Study Group.
  Krasnick, B. A., Davidson, J. T., Panni, R. Z., McGilvray, M., Rodriguez, J. Z., Lopez-Aguiar, A. G., … Fields, R. (2018). Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in intestinal neuroendocrine tumors: An analysis of the US Neuroendocrine Tumor Study Group. JOURNAL OF CLINICAL ONCOLOGY, 36(4).
- Microsatellite instability in resectable colorectal liver metastasis: An international multi-institutional analysis.
  Margonis, G. A., Buettner, S., Wagner, D., McVey, J., Andreatos, N., Beer, A., … Weiss, M. J. (2018). Microsatellite instability in resectable colorectal liver metastasis: An international multi-institutional analysis. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Defining the number of lymph nodes needed to accurately stage small bowel neuroendocrine tumors: An 8-institution study from the US neuroendocrine tumor study group.
  Zaidi, M., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E. W., Poultsides, G. A., Makris, E., … Maithel, S. (2018). Defining the number of lymph nodes needed to accurately stage small bowel neuroendocrine tumors: An 8-institution study from the US neuroendocrine tumor study group. JOURNAL OF CLINICAL ONCOLOGY, 36(4).
- Association of preoperative monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with overall survival after resection of pancreatic neuroendocrine tumors.
  Panni, R. Z., Davidson, J. T., Krasnick, B. A., McGilvray, M., Rodriguez, J. Z., Lopez-Aguiar, A. G., … Fields, R. (2018). Association of preoperative monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with overall survival after resection of pancreatic neuroendocrine tumors. JOURNAL OF CLINICAL ONCOLOGY, 36(4).
- Gastric carcinoids: Does type of surgery or tumor affect survival?
  Crown, A., Kanji, Z. S., Lopez-Aguiar, A. G., Dillhoff, M., Poultsides, G. A., Makris, E., … Rocha, F. G. (2018). Gastric carcinoids: Does type of surgery or tumor affect survival? JOURNAL OF CLINICAL ONCOLOGY, 36(4).
- Histologic classification and grading enhances gallbladder cancer staging: A population-based prognostic score validated by the US Extrahepatic Biliary Malignancy Consortium.
  Thuy Tran, Ethun, C. G., Pawlik, T. M., Buettner, S., Idrees, K., Isom, C. A., … Poultsides, G. A. (2017). Histologic classification and grading enhances gallbladder cancer staging: A population-based prognostic score validated by the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF CLINICAL ONCOLOGY, 35(4).
- Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group
  Poorman, C. E., Postlewait, L. M., Ethun, C. G., Tran, T. B., Prescott, J. D., Pawlik, T. M., … Maithel, S. K. (2017). Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group. AMERICAN SURGEON, 83(7), 761–768.
- Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium
  Ethun, C. G., Le, N., Lopez-Aguiar, A. G., Pawlik, T. M., Poultsides, G., Thuy Tran, … Maithel, S. K. (2017). Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium. AMERICAN SURGEON, 83(7), 679–686.
- A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma
  Buettner, S., van Vugti, J., Gani, F., Koerkamp, B. G., Margonis, G. A., Ethun, C. G., … Pawlik, T. M. (2016). A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma. HEPATOLOGY, 64, 699A.
- Rates, Predictors, and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer
  Karagkounis, G., Squires, M. H., Poultsides, G. A., Fields, R. C., Pawlik, T. M., Votanopoulos, K. I., … Maithel, S. (2016). Rates, Predictors, and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 223(4), E186–E187.
- Incidence and Predictors of Readmission after Curative-Intent Resection for Extrahepatic Cholangiocarcinoma: A Multi-Institutional 15-Year Experience from the US Extrahepatic Biliary Malignancy Collaborative
  Hatzaras, I., Maithel, S., Shen, P., Pawlik, T. M., Idrees, K., Fields, R. C., … Poultsides, G. A. (2016). Incidence and Predictors of Readmission after Curative-Intent Resection for Extrahepatic Cholangiocarcinoma: A Multi-Institutional 15-Year Experience from the US Extrahepatic Biliary Malignancy Collaborative. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 223(4), E25.
- Palliative treatment in extrahepatic biliary malignancies: A multi-institutional cohort.
  Wilson, A., Ethun, C. G., Poultsides, G. A., Thuy Tran, Idrees, K., Isom, C. A., … Pawlik, T. M. (2016). Palliative treatment in extrahepatic biliary malignancies: A multi-institutional cohort. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- The effect of postoperative morbidity on long-term survival after curative resection for extra-hepatic biliary tumors: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
  Jin, L., Krasnick, B., Davidson, J., Ethun, C. G., Pawlik, T. M., Poultsides, G. A., … Fields, R. C. (2016). The effect of postoperative morbidity on long-term survival after curative resection for extra-hepatic biliary tumors: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Optimal prognostic lymph node staging system for gallbladder adenocarcinoma: A multi-institutional study.
  Amini, N., Kim, Y., Wilson, A., Ethun, C. G., Maithel, S. K., Poultsides, G. A., … Pawlik, T. M. (2016). Optimal prognostic lymph node staging system for gallbladder adenocarcinoma: A multi-institutional study. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Impact of chemotherapy and external beam radiation therapy on outcomes among patients with resected gallbladder cancer: A multi-institutional analysis.
  Kim, Y., Amini, N., Wilson, A., Ethun, C. G., Poultsides, G. A., Tran, T., … Pawlik, T. M. (2016). Impact of chemotherapy and external beam radiation therapy on outcomes among patients with resected gallbladder cancer: A multi-institutional analysis. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Curative resection for hilar cholangiocarcinoma: Does adjuvant therapy impact overall survival? A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
  Krasnick, B., Jin, L., Davidson, J., Ethun, C. G., Pawlik, T. M., Poultsides, G. A., … Tumors, E. B. (2016). Curative resection for hilar cholangiocarcinoma: Does adjuvant therapy impact overall survival? A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Gallbladder cancer presenting with jaundice: Uniformly fatal or still potentially curable?
  Thuy Tran, Ethun, C. G., Pawlik, T. M., Buettner, S., Idrees, K., Isom, C. A., … Poultsides, G. A. (2016). Gallbladder cancer presenting with jaundice: Uniformly fatal or still potentially curable? JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Rates and patterns of recurrence following complete resection of Hilar cholangiocarcinoma: Results from the US Extrahepatic Biliary Consortium
  Mogal, H., O'Connor, S., Fino, N., Ethun, C. G., Pawlik, T. M., Poultsides, G. A., … Shen, P. (2016). Rates and patterns of recurrence following complete resection of Hilar cholangiocarcinoma: Results from the US Extrahepatic Biliary Consortium. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis
  Mogal, H., Dodson, R., Fino, N., Ethun, C. G., Pawlik, T. M., Poultsides, G. A., … Shen, P. (2016). Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- A reappraisal of staging laparoscopy in three subtypes of cholangiocarcinoma: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
  Davidson, J., Jin, L., Krasnick, B., Ethun, C. G., Pawlik, T. M., Poultsides, G. A., … Fields, R. C. (2016). A reappraisal of staging laparoscopy in three subtypes of cholangiocarcinoma: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- A multi-institutional analysis of duodenal neuroendocrine tumors: Tumor biology rather than extent of resection to dictate prognosis.
  Margonis, G. A., Samaha, M., Kim, Y., Postlewait, L. M. L., Maithel, S. K., Poultsides, G. A., … Pawlik, T. M. (2016). A multi-institutional analysis of duodenal neuroendocrine tumors: Tumor biology rather than extent of resection to dictate prognosis. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- The optimal time-interval to re-resection for incidentally discovered gallbladder cancer: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
  Ethun, C. G., Postlewait, L. M. L., Pawlik, T. M., Buettner, S., Poultsides, G. A., Tran, T., … Maithel, S. K. (2016). The optimal time-interval to re-resection for incidentally discovered gallbladder cancer: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- A novel pathology-based preoperative risk score to predict distant and locoregional residual disease and survival for incidentally discovered gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium.
  Ethun, C. G., Postlewait, L. M. L., Pawlik, T. M., Buettner, S., Poultsides, G. A., Tran, T., … Maithel, S. K. (2016). A novel pathology-based preoperative risk score to predict distant and locoregional residual disease and survival for incidentally discovered gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Conditional survival probability of long-term survival after resection of peri-hilar cholangiocarcinoma.
  Buettner, S., Ethun, C. G., Maithel, S. K., Poultsides, G. A., Thuy Tran, Idrees, K., … Pawlik, T. M. (2016). Conditional survival probability of long-term survival after resection of peri-hilar cholangiocarcinoma. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Difference in outcomes among patients undergoing open versus laparoscopy-assisted approach for gastric cancer: A multi-institutional analysis.
  Spolverato, G., Valero, V., Kim, Y., Ejaz, A., Squires, M. H., Poultsides, G. A., … Pawlik, T. M. (2014). Difference in outcomes among patients undergoing open versus laparoscopy-assisted approach for gastric cancer: A multi-institutional analysis. JOURNAL OF CLINICAL ONCOLOGY, 32(15).
- Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: A multi-institutional analysis.
  Ejaz, A., Spolverato, G., Kim, Y., Squires, M. H., Weber, S. M., Poultsides, G. A., … Pawlik, T. M. (2014). Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: A multi-institutional analysis. JOURNAL OF CLINICAL ONCOLOGY, 32(15).
- Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative intent surgical resection.
  Spolverato, G., Kim, Y., Alexandresou, S., Marques, H., Aldrighetti, L., Gamblin, T. C., … Pawlik, T. M. (2015). Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative intent surgical resection. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- The prognostic value of preoperative helicobacter pylori infection in resected gastric cancer
  Postlewait, L. M. L., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2015). The prognostic value of preoperative helicobacter pylori infection in resected gastric cancer. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- The prognostic value of signet ring cell histology in resected gastric cancer
  Postlewait, L. M. L., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2015). The prognostic value of signet ring cell histology in resected gastric cancer. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- Value of peritoneal drain placement after total gastrectomy for gastric adenocarcinoma: A multi-institutional analysis from the US Gastric Cancer Collaborative
  Dann, G. C., Squires, M. H., Postlewait, L. M. L., Kooby, D. A., Poultsides, G. A., Weber, S. M., … Cardona, K. (2015). Value of peritoneal drain placement after total gastrectomy for gastric adenocarcinoma: A multi-institutional analysis from the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the US Gastric Cancer Collaborative.
  Dann, G. C., Squires, M. H., Postlewait, L. M. L., Kooby, D. A., Poultsides, G. A., Weber, S. M., … Maithel, S. K. (2015). An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- Is linitis plastica a contraindication for surgical resection? A 7-institution study of the US Gastric Cancer Collaborative.
  Blackham, A. U., Swords, D. S., Levine, E. A., Fitzgerald, N., Squires, M. H., Poultsides, G. A., … Votanopoulos, K. I. (2015). Is linitis plastica a contraindication for surgical resection? A 7-institution study of the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- Optimal extent of lymphadenectomy in gastric adenocarcinoma: A seven-institution study of the US Gastric Cancer Collaborative.
  Randle, R. W., Swords, D. S., Levine, E. A., Fitzgerald, N., Squires, M. H., Poultsides, G. A., … Votanopoulos, K. I. (2015). Optimal extent of lymphadenectomy in gastric adenocarcinoma: A seven-institution study of the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- The optimal length of the proximal resection margin in patients with proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative.
  Postlewait, L. M. L., Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., … Maithel, S. K. (2015). The optimal length of the proximal resection margin in patients with proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
- Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: A 7-institution study of the US gastric cancer collaborative.
  Squires, M. H., Kooby, D. A., Pawlik, T. M., Weber, S. M., Poultsides, G. A., Schmidt, C. R., … Maithel, S. K. (2014). Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: A 7-institution study of the US gastric cancer collaborative. JOURNAL OF CLINICAL ONCOLOGY, 32(3).
- The effect of perioperative transfusion on recurrence and survival following gastric cancer resection: A seven-institution analysis of 765 patients from the US Gastric Cancer Collaborative.
  Squires, M. H., Kooby, D. A., Poultsides, G. A., Weber, S. M., Bloomston, M., Fields, R. C., … Maithel, S. K. (2014). The effect of perioperative transfusion on recurrence and survival following gastric cancer resection: A seven-institution analysis of 765 patients from the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 32(3).
- Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: A multi-institutional analysis
  Ejaz, A., Spolverato, G., Kim, Y., Squires, M. H., Weber, S. M., Poultsides, G. A., … Pawlik, T. M. (2014). Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: A multi-institutional analysis. JOURNAL OF CLINICAL ONCOLOGY, 32(3).
- Factors associated with recurrence in lymph node-negative gastric adenocarcinoma: Results from the US Gastric Cancer Collaborative
  Jin, L. X., Squires, M. H., Poultsides, G. A., Votanopoulos, K. I., Weber, S. M., Bloomston, M., … Fields, R. C. (2014). Factors associated with recurrence in lymph node-negative gastric adenocarcinoma: Results from the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 32(3).
- The effect of postoperative morbidity on survival after resection for gastric adenocarcinoma: Results from the US Gastric Cancer Collaborative
  Jin, L. X., Moses, L. E., Yan, Y., Squires, M. H., Weber, S. M., Bloomston, M., … Fields, R. C. (2014). The effect of postoperative morbidity on survival after resection for gastric adenocarcinoma: Results from the US Gastric Cancer Collaborative. JOURNAL OF CLINICAL ONCOLOGY, 32(3).
- Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study
  Heidsma, C. M., Tsilimigras, D. I., Rocha, F., Abbott, D. E., Fields, R., Poultsides, G. A., … Pawlik, T. M. (2021). Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study. CANCERS, 13(9).
- Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma.
  Wei, T., Zhang, X.-F., Xue, F., Bagante, F., Ratti, F., Marques, H. P., … Pawlik, T. M. (2021). Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma. Annals of Surgical Oncology.
- Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
  Jiang, Y., Liang, X., Han, Z., Wang, W., Xi, S., Li, T., … Li, R. (2021). Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study. The Lancet. Digital Health, 3(6), e371–e382.
- Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
  Heidsma, C. M., Tsilimigras, D. I., Rocha, F., Abbott, D. E., Fields, R., Poultsides, G. A., … Pawlik, T. M. (2021). Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study. Cancers, 13(9).
- Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study
  Jiang, Y., Liang, X., Han, Z., Wang, W., Xi, S., Li, T., … Li, R. (2021). Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study. LANCET DIGITAL HEALTH, 3(6), E371–E382.
- Surgical Strategies for Bismuth Type I and II Hilar Cholangiocarcinoma: Impact on Long-Term Outcomes.
  Zhang, X.-F., Zhang, N., Tsilimigras, D. I., Weber, S. M., Poultsides, G., Hatzaras, I., … Pawlik, T. M. (2021). Surgical Strategies for Bismuth Type I and II Hilar Cholangiocarcinoma: Impact on Long-Term Outcomes. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- ASO Visual Abstract: Prediction of Extrahepatic Recurrence (EHR) After Curative-Intent Resection of Hepatocellular Carcinoma.
  Wei, T., Zhang, X.-F., Xue, F., Bagante, F., Ratti, F., Marques, H. P., … Pawlik, T. M. (2021). ASO Visual Abstract: Prediction of Extrahepatic Recurrence (EHR) After Curative-Intent Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology.
- A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma
  Squires, M. H., Ethun, C. G., Donahue, E. E., Benbow, J. H., Anderson, C. J., Jagosky, M. H., … Howard, J. H. (2021). A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma. JOURNAL OF SURGICAL ONCOLOGY.
- Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis.
  Elfadaly, A. N., Tsilimigras, D. I., Hyer, J. M., Paro, A., Bagante, F., Ratti, F., … Pawlik, T. M. (2021). Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis. World Journal of Surgery.
- Postoperative Infectious Complications Worsen Long-Term Survival After Curative-Intent Resection for Hepatocellular Carcinoma.
  Wei, T., Zhang, X.-F., Bagante, F., Ratti, F., Marques, H. P., Silva, S., … Pawlik, T. M. (2021). Postoperative Infectious Complications Worsen Long-Term Survival After Curative-Intent Resection for Hepatocellular Carcinoma. Annals of Surgical Oncology.
- A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative.
  Lee, R. M., Ethun, C. G., Gamboa, A. C., Turgeon, M. K., Tran, T., Poultsides, G., … Cardona, K. (2021). A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative. Journal of Surgical Oncology.
- Subtle endoscopic manifestations of diffuse signet cell gastric adenocarcinoma in patients with CDH1 mutations.
  Ladabaum, U., Ford, J. M., Poultsides, G., & Norton, J. (2021). Subtle endoscopic manifestations of diffuse signet cell gastric adenocarcinoma in patients with CDH1 mutations. Gastrointestinal Endoscopy.
- Patient-derived ex vivo TME-models and single-cell sequencing reveal transcriptional responses to immunotherapy.
  Sathe, A., Chen, J., Grimes, S. M., Ayala, C. I., Poultsides, G., & Ji, H. P. (2021). Patient-derived ex vivo TME-models and single-cell sequencing reveal transcriptional responses to immunotherapy. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- ASO Visual Abstract: Postoperative Infectious Complications Worsen Long-term Survival After Curative-Intent Resection for Hepatocellular Carcinoma.
  Wei, T., Zhang, X.-F., Bagante, F., Ratti, F., Marques, H. P., Silva, S., … Pawlik, T. M. (2021). ASO Visual Abstract: Postoperative Infectious Complications Worsen Long-term Survival After Curative-Intent Resection for Hepatocellular Carcinoma. Annals of Surgical Oncology.
- Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer.
  Spolverato, G., Capelli, G., Lorenzoni, G., Gregori, D., Squires, M. H., Poultsides, G. A., … Pawlik, T. M. (2021). Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer. Annals of Surgical Oncology.
- ASO Visual Abstract: Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer.
  Spolverato, G., Capelli, G., Lorenzoni, G., Gregori, D., Squires, M. H., Poultsides, G. A., … Pawlik, T. M. (2021). ASO Visual Abstract: Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer. Annals of Surgical Oncology.
- Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: does the primary disease site matter?
  Amini, N., Andreatos, N., Margonis, G. A., Buettner, S., Wang, J., Galjart, B., … Burkhart, R. A. (2021). Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: does the primary disease site matter? Journal of Hepato-Biliary-Pancreatic Sciences.
- More Than an ERAS Pathway is Needed to Meet Target Length of Stay After Pancreaticoduodenectomy.
  Ayala, C. I., Li, A. Y., Lu, A., Wilson, A., Bergquist, J. R., Poultsides, G. A., … Dua, M. M. (2021). More Than an ERAS Pathway is Needed to Meet Target Length of Stay After Pancreaticoduodenectomy. The Journal of Surgical Research, 270, 195–202.
- Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review.
  Zhou, M., Javadi, C., Charville, G. W., Bui, N. Q., Harris, E. J., Poultsides, G. A., … Ganjoo, K. N. (2021). Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review. Surgical Oncology, 39, 101670.
- Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice.
  Zhang, X.-F., Xue, F., Bagante, F., Ratti, F., Marques, H. P., Silva, S., … Pawlik, T. M. (2021). Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity
  Olson, C. R., Suarez-Kelly, L. P., Ethun, C. G., Shelby, R. D., Yu, P. Y., Hughes, T. M., … Howard, J. H. (2021). Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity. AMERICAN SURGEON, 31348211054536.
- Predictors of Desmoid Recurrence after Surgical Management from the US Sarcoma Collaborative
  Chouliaras, K., Ethun, C. G., Poultsides, G. A., Howard, J. H., Clarke, C. N., Roggin, K. K., … Votanopoulos, K. I. (2021). Predictors of Desmoid Recurrence after Surgical Management from the US Sarcoma Collaborative. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Dynamic Prediction of Survival after Curative Resection of Gastric Adenocarcinoma: A landmarking-based analysis.
  Spolverato, G., Azzolina, D., Paro, A., Lorenzoni, G., Gregori, D., Poultsides, G., … Pawlik, T. M. (1800). Dynamic Prediction of Survival after Curative Resection of Gastric Adenocarcinoma: A landmarking-based analysis. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
- Surgical treatment of gastric adenocarcinoma: Are we achieving textbook oncologic outcomes for our patients?
  Spolverato, G., Paro, A., Capelli, G., Dalmacy, D., Poultsides, G. A., Fields, R. C., … Pawlik, T. M. (1800). Surgical treatment of gastric adenocarcinoma: Are we achieving textbook oncologic outcomes for our patients? Journal of Surgical Oncology.
- Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma.
  Przybyl, J., Spans, L., Ganjoo, K., Bui, N., Mohler, D., Norton, J., … van de Rijn, M. (2022). Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma. PloS One, 17(1), e0262272.
- Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.
  Squires, M. H., Ethun, C. G., Donahue, E. E., Benbow, J. H., Anderson, C. J., Jagosky, M. H., … Howard, J. H. (1800). Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms. Annals of Surgical Oncology.
- ASO Visual Abstract: Extremity Soft Tissue Sarcoma-A Multi-institutional Validation of Prognostic Nomograms.
  Squires, M. H., Ethun, C. G., Donahue, E. E., Benbow, J. H., Anderson, C. J., Jagosky, M. H., … Howard, J. H. (1800). ASO Visual Abstract: Extremity Soft Tissue Sarcoma-A Multi-institutional Validation of Prognostic Nomograms. Annals of Surgical Oncology.
- Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
  Ajani, J. A., D'Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., … Pluchino, L. A. (2022). Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 20(2), 167–192.
- Surgical Treatment of Neuroendocrine Tumors of the Terminal Ileum or Cecum: Ileocecectomy Versus Right Hemicolectomy.
  Li, M.-X. X., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., Weber, S., Fields, R., … Pawlik, T. M. (2022). Surgical Treatment of Neuroendocrine Tumors of the Terminal Ileum or Cecum: Ileocecectomy Versus Right Hemicolectomy. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- ASO Visual Abstract: Tumor Necrosis Impacts the Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma.
  Tsilimigras, D. I., Ejaz, A., Cloyd, J., Guglielmi, A., Aldrighetti, L., Weiss, M., … Pawlik, T. M. (2022). ASO Visual Abstract: Tumor Necrosis Impacts the Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Machine Learning Approach to Stratifying Prognosis Relative to Tumor Burden after Resection of Colorectal Liver Metastases: An International Cohort Analysis.
  Paro, A., Hyer, M. J., Tsilimigras, D. I., Guglielmi, A., Ruzzenente, A., Alexandrescu, S., … Pawlik, T. M. (2022). Machine Learning Approach to Stratifying Prognosis Relative to Tumor Burden after Resection of Colorectal Liver Metastases: An International Cohort Analysis. Journal of the American College of Surgeons, 234(4), 504–513.
- Tumor Necrosis Impacts Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma.
  Tsilimigras, D. I., Ejaz, A., Cloyd, J., Guglielmi, A., Aldrighetti, L., Weiss, M., … Pawlik, T. M. (2022). Tumor Necrosis Impacts Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer.
  Ahmad, M. U., Javadi, C., & Poultsides, G. A. (2022). Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer. Cancers, 14(7).
- Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
  Jiang, Y., Zhang, Z., Yuan, Q., Wang, W., Wang, H., Li, T., … Li, R. (2022). Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study. The Lancet. Digital Health, 4(5), e340–e350.
- Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study.
  Wei, T., Zhang, X.-F., He, J., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2022). Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study. The British Journal of Surgery.
- Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
  Franssen, S., Soares, K. C., Jolissaint, J. S., Tsilimigras, D. I., Buettner, S., Alexandrescu, S., … Koerkamp, B. G. (2022). Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma. JAMA Surgery.
- Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?
  Javadi, C., Chang, J., Forgo, E., Ahmad, M. U., Fisher, G. A., Chang, D. T., … Poultsides, G. A. (2022). Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Mucinous Epithelial Cell Secretion Drives Mucinous Ascites Formation in Pseudomyxoma Peritonei Patients
  Ayala, C., Sathe, A., Grimes, S., Zhao, L., Bai, X., Poultsides, G., … Ji, H. (2022). Mucinous Epithelial Cell Secretion Drives Mucinous Ascites Formation in Pseudomyxoma Peritonei Patients. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
  Olthof, P. B., Buettner, S., Andreatos, N., Wang, J., Løes, I. M., Wagner, D., … Margonis, G. A. (2022). KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations. The British Journal of Surgery.
- Surgical outcomes of gastro-entero-pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma.
  Li, M.-X., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., Weber, S., Fields, R., … Pawlik, T. M. (2022). Surgical outcomes of gastro-entero-pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma. Journal of Surgical Oncology.
- Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases.
  Bertsimas, D., Margonis, G. A., Sujichantararat, S., Boerner, T., Ma, Y., Wang, J., … D'Angelica, M. (2022). Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases. JAMA Surgery, e221819.
- Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
  Toyoda, J., Sahara, K., Maithel, S. K., Abbott, D. E., Poultsides, G. A., Wolfgang, C., … Pawlik, T. M. (2022). Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium. Annals of Surgical Oncology.
- Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases
  Paro, A., Hyer, J. M., Avery, B. S., Tsilimigras, D. I., Bagante, F., Guglielmi, A., … Pawlik, T. M. (2022). Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases. HEPATOBILIARY SURGERY AND NUTRITION.
- Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: amulti-institutional analysis.
  Cotter, G., Beal, E. W., Poultsides, G. A., Idrees, K., Fields, R. C., Weber, S. M., … Pawlik, T. M. (2022). Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: amulti-institutional analysis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Novel cause of postoperative anion gap acidosis in a patient with diabetes following gastrectomy
  Muhammad, H. A., Narayan, R. R., Basina, M., & Poultsides, G. A. (2022). Novel cause of postoperative anion gap acidosis in a patient with diabetes following gastrectomy. TRAUMA SURGERY & ACUTE CARE OPEN, 7(1).
- Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis.
  Spolverato, G., Capelli, G., Lorenzoni, G., Gregori, D., He, J., Popescu, I., … Pawlik, T. M. (2022). Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis. Annals of Surgical Oncology.
- ASO Visual Abstract: Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma-Results from the US Extrahepatic Biliary Malignancy Consortium.
  Toyoda, J., Sahara, K., Maithel, S. K., Abbott, D. E., Poultsides, G. A., Wolfgang, C., … Pawlik, T. M. (2022). ASO Visual Abstract: Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma-Results from the US Extrahepatic Biliary Malignancy Consortium. Annals of Surgical Oncology.
- ASO Visual Abstract: Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis.
  Spolverato, G., Capelli, G., Lorenzoni, G., Gregori, D., He, J., Popescu, I., … Pawlik, T. M. (2022). ASO Visual Abstract: Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis. Annals of Surgical Oncology.
- Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study
  Jiang, Y., Zhang, Z., Yuan, Q., Wang, W., Wang, H., Li, T., … Li, R. (2022). Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study. LANCET DIGITAL HEALTH, 4(5), E340–E350.
- Novel cause of postoperative anion gap acidosis in a patient with diabetes following gastrectomy.
  Muhammad, H. A., Narayan, R. R., Basina, M., & Poultsides, G. A. (2022). Novel cause of postoperative anion gap acidosis in a patient with diabetes following gastrectomy. Trauma Surgery & Acute Care Open, 7(1), e000977.
- Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database.
  Gusho, C. A., King, D., Ethun, C. G., Cardona, K., Harrison Howard, J., Tran, T. B., … Bedi, M. (2022). Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database. Journal of Surgical Oncology.
- Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
  Alaimo, L., Moazzam, Z., Brown, Z. J., Endo, Y., Ruzzenente, A., Guglielmi, A., … Pawlik, T. M. (2022). Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence. Annals of Surgical Oncology.
- Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.
  Spolverato, G., Capelli, G., Mari, V., Lorenzoni, G., Gregori, D., Poultsides, G., … Pawlik, T. M. (2022). Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma. Annals of Surgical Oncology.
- Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma.
  Moazzam, Z., Lima, H. A., Alaimo, L., Endo, Y., Shaikh, C. F., Ratti, F., … Pawlik, T. M. (2022). Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma. Surgery.
- A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score.
  Alaimo, L., Endo, Y., Lima, H. A., Moazzam, Z., Shaikh, C. F., Ruzzenente, A., … Pawlik, T. M. (2022). A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- ASO Visual Abstract: A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for HCC Patients Undergoing Curative-Intent Surgery.
  Endo, Y., Alaimo, L., Lima, H. A., Moazzam, Z., Ratti, F., Marques, H. P., … Pawlik, T. M. (2022). ASO Visual Abstract: A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for HCC Patients Undergoing Curative-Intent Surgery. Annals of Surgical Oncology.
- A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery.
  Endo, Y., Alaimo, L., Lima, H. A., Moazzam, Z., Ratti, F., Marques, H. P., … Pawlik, T. M. (2022). A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery. Annals of Surgical Oncology.
- ASO Visual Abstract: Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
  Alaimo, L., Moazzam, Z., Brown, Z. J., Endo, Y., Ruzzenente, A., Guglielmi, A., … Pawlik, T. M. (2022). ASO Visual Abstract: Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence. Annals of Surgical Oncology.
- ASO Visual Abstract: Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.
  Spolverato, G., Capelli, G., Mari, V., Lorenzoni, G., Gregori, D., Poultsides, G., … Pawlik, T. M. (2022). ASO Visual Abstract: Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma. Annals of Surgical Oncology.
- Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.
  Lima, H. A., Endo, Y., Alaimo, L., Moazzam, Z., Munir, M. M., Shaikh, C., … Pawlik, T. M. (2022). Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
  Lima, H. A., Endo, Y., Moazzam, Z., Alaimo, L., Shaikh, C., Munir, M. M., … Pawlik, T. M. (2022). TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma. Journal of Surgical Oncology.
- Colorectal cancer metastases in the liver establish immunosuppressive spatial networking between tumor associated SPP1+ macrophages and fibroblasts.
  Sathe, A., Mason, K., Grimes, S. M., Zhou, Z., Lau, B. T., Bai, X., … Ji, H. P. (2022). Colorectal cancer metastases in the liver establish immunosuppressive spatial networking between tumor associated SPP1+ macrophages and fibroblasts. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Comparison of Spleen-Preservation vs Splenectomy in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis
  Timmerhuis, H. C., Ngongoni, R. F., Jensen, C., Baiocchi, M., DeLong, J. C., Dua, M. M., … Visser, B. C. (2022). Comparison of Spleen-Preservation vs Splenectomy in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Impact of Preoperative Jaundice and Biliary Drainage on Short- and Long-term Outcomes among Patients with Gallbladder Cancer.
  Xiang, J.-X., Maithel, S. K., Weber, S. M., Poultsides, G., Wolfgang, C., Jin, L., … Pawlik, T. M. (2022). Impact of Preoperative Jaundice and Biliary Drainage on Short- and Long-term Outcomes among Patients with Gallbladder Cancer. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Lymph Node Examination and Patterns of Nodal Metastasis Among Patients with Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma After Major Curative-Intent Resection.
  Zhang, X.-F., Xue, F., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2022). Lymph Node Examination and Patterns of Nodal Metastasis Among Patients with Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma After Major Curative-Intent Resection. Annals of Surgical Oncology.
- Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
  Endo, Y., Sasaki, K., Moazzam, Z., Lima, H. A., Alaimo, L., Guglielmi, A., … Pawlik, T. M. (2022). Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy.
  Endo, Y., Moazzam, Z., Alaimo, L., Lima, H. A., Munir, M. M., Shaikh, C. F., … Pawlik, T. M. (2022). Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Impact of adjuvant therapy on outcomes after curative-intentresection for distal cholangiocarcinoma.
  Hou, J.-J., Maithel, S. K., Weber, S. M., Poultsides, G., Wolfgang, C. L., Fields, R. C., … Pawlik, T. M. (2022). Impact of adjuvant therapy on outcomes after curative-intentresection for distal cholangiocarcinoma. Journal of Surgical Oncology.
- Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Moazzam, Z., Endo, Y., Lima, H. A., Ruzzenente, A., Guglielmi, A., … Pawlik, T. M. (2022). Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Variations in Textbook Oncologic Outcomes After Curative-Intent Resection: Early Versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification.
  Moazzam, Z., Alaimo, L., Endo, Y., Lima, H. A., Shaikh, C. F., Ratti, F., … Pawlik, T. M. (2022). Variations in Textbook Oncologic Outcomes After Curative-Intent Resection: Early Versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification. Annals of Surgical Oncology.
- Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors.
  Makris, E. A., Cannon, J. G., Norton, J. A., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E., … Poultsides, G. A. (2022). Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors. Annals of Surgical Oncology.
- ACR Appropriateness Criteria Management of Liver Cancer: 2022 Update.
  Knavel Koepsel, E. M., Smolock, A. R., Pinchot, J. W., Kim, C. Y., Ahmed, O., Chamarthy, M. R., … Hohenwalter, E. J. (2022). ACR Appropriateness Criteria Management of Liver Cancer: 2022 Update. Journal of the American College of Radiology : JACR, 19(11S), S390–S408.
- Simultaneous versus staged resection for synchronous colorectal liver metastases: The win ratio approach.
  Endo, Y., Alaimo, L., Araujo Lima, H., Tsilimigras, D. I., Hyer, J. M., Guglielmi, A., … Pawlik, T. M. (2022). Simultaneous versus staged resection for synchronous colorectal liver metastases: The win ratio approach. American Journal of Surgery.
- Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
  Margonis, G. A., Boerner, T., Bachet, J.-B. B., Buettner, S., Moretto, R., Andreatos, N., … D'Angelica, M. (2022). Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions. Annals of Surgery.
- ASO Visual Abstract: Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Moazzam, Z., Endo, Y., Lima, H. A., Ruzzenente, A., Guglielmi, A., … Pawlik, T. M. (2022). ASO Visual Abstract: Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma.
  Lima, H. A., Alaimo, L., Brown, Z. J., Endo, Y., Moazzam, Z., Tsilimigras, D. I., … Pawlik, T. M. (2022). Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- ASO Visual Abstract: Variations in Textbook Oncologic Outcomes following Curative-Intent Resection: Early versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification.
  Moazzam, Z., Alaimo, L., Endo, Y., Lima, H. A., Shaikh, C. F., Ratti, F., … Pawlik, T. M. (2022). ASO Visual Abstract: Variations in Textbook Oncologic Outcomes following Curative-Intent Resection: Early versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification. Annals of Surgical Oncology.
- Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative.
  Thalji, S. Z., Ethun, C. G., Tsai, S., Gamblin, T. C., Clarke, C. N., Bedi, M., … Mogal, H. (2022). Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative. Journal of Surgical Oncology.
- ASO Visual Abstract: Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors.
  Makris, E. A., Cannon, J. G., Norton, J. A., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E., … Poultsides, G. A. (2022). ASO Visual Abstract: Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors. Annals of Surgical Oncology.
- Biology-guided deep learning predicts prognosis and cancer immunotherapy response
  Jiang, Y., Zhang, Z., Wang, W., Huang, W., Chen, C., Xi, S., … Li, R. (2022). Biology-guided deep learning predicts prognosis and cancer immunotherapy response. Journal for ImmunoTherapy of Cancer. Boston.
- Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis.
  Munir, M. M., Endo, Y., Lima, H. A., Alaimo, L., Moazzam, Z., Shaikh, C., … Pawlik, T. M. (2023). Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma.
  Endo, Y., Lima, H. A., Alaimo, L., Moazzam, Z., Brown, Z., Shaikh, C. F., … Pawlik, T. M. (2023). Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
  Moazzam, Z., Alaimo, L., Endo, Y., Lima, H. A., Ruzzenente, A., Guglielmi, A., … Pawlik, T. M. (2023). Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma. Journal of the American College of Surgeons.
- Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes.
  Toesca, D. A., Susko, M., von Eyben, R., Baclay, J. R., Pollom, E. L., Jeffrey, R. B., … Chang, D. T. (2023). Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes. Annals of Surgical Oncology.
- TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
  Lima, H. A., Moazzam, Z., Endo, Y., Alaimo, L., Shaikh, C., Munir, M. M., … Pawlik, T. M. (2023). TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma. Annals of Surgical Oncology.
- The impact of tumor location on the value of lymphadenectomy for intrahepatic cholangiocarcinoma.
  Endo, Y., Moazzam, Z., Lima, H. A., Alaimo, L., Munir, M. M., Shaikh, C. F., … Pawlik, T. M. (2023). The impact of tumor location on the value of lymphadenectomy for intrahepatic cholangiocarcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Moazzam, Z., Endo, Y., Lima, H. A., Butey, S. P., Ruzzenente, A., … Pawlik, T. M. (2023). The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- ASO Visual Abstract: TBS-Based Preoperative Score to?Predict Non-transplantable?Recurrence and?Identify Candidates for?Upfront Resection Versus Transplantation for?Hepatocellular Carcinoma.
  Lima, H. A., Moazzam, Z., Endo, Y., Alaimo, L., Shaikh, C., Munir, M. M., … Pawlik, T. M. (2023). ASO Visual Abstract: TBS-Based Preoperative Score to?Predict Non-transplantable?Recurrence and?Identify Candidates for?Upfront Resection Versus Transplantation for?Hepatocellular Carcinoma. Annals of Surgical Oncology.
- Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma.
  Endo, Y., Moazzam, Z., Woldesenbet, S., Araujo Lima, H., Alaimo, L., Munir, M. M., … Pawlik, T. M. (2023). Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma. World Journal of Surgery.
- ASO Visual Abstract: The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Moazzam, Z., Endo, Y., Lima, H. A., Butey, S. P., Ruzzenente, A., … Pawlik, T. M. (2023). ASO Visual Abstract: The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  Ajani, J. A., D'Amico, T. A., Bentrem, D. J., Cooke, D., Corvera, C., Das, P., … Pluchino, L. A. (2023). Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 21(4), 393–422.
- Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates.
  King, D. A., Smith, A. R., Pineda, G., Nakano, M., Michelini, F., Goedegebuure, S. P., … Kuo, C. J. (2023). Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates. JCO Precision Oncology, 7, e2100489.
- Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study.
  Vega, E. A., Newhook, T. E., Mellado, S., Ruzzenente, A., Okuno, M., De Bellis, M., … Vauthey, J.-N. (2023). Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Annals of Surgical Oncology.
- The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases.
  Endo, Y., Rueda, B. O., Woldesenbet, S., Munir, M. M., Lima, H. A., Katayama, E. S., … Pawlik, T. M. (2023). The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases. Journal of Surgical Oncology.
- Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Lima, H. A., Moazzam, Z., Endo, Y., Yang, J., Ruzzenente, A., … Pawlik, T. M. (2023). Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Effect of Perioperative Palliative Care on Health-Related Quality of Life Among Patients Undergoing Surgery for Cancer: A Randomized Clinical Trial.
  Aslakson, R. A., Rickerson, E., Fahy, B., Waterman, B., Siden, R., Colborn, K., … Johnston, F. (2023). Effect of Perioperative Palliative Care on Health-Related Quality of Life Among Patients Undergoing Surgery for Cancer: A Randomized Clinical Trial. JAMA Network Open, 6(5), e2314660.
- ASO Visual Abstract: Development and Validation of a Machine Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Lima, H. A., Moazzam, Z., Endo, Y., Yang, J., Ruzzenente, A., … Pawlik, T. M. (2023). ASO Visual Abstract: Development and Validation of a Machine Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies on the Basis of Preoperative Alpha-Feto Protein and Tumor Burden Score.
  Endo, Y., Munir, M. M., Woldesenbet, S., Katayama, E., Ratti, F., Marques, H. P., … Pawlik, T. M. (2023). Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies on the Basis of Preoperative Alpha-Feto Protein and Tumor Burden Score. Annals of Surgical Oncology.
- A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma.
  Moazzam, Z., Alaimo, L., Endo, Y., Lima, H. A., Woldesenbet, S., Rueda, B. O., … Pawlik, T. M. (2023). A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma. Annals of Surgery.
- ASO Visual Abstract: Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies Based on Preoperative Alpha-Feto Protein and Tumor Burden Score.
  Endo, Y., Munir, M. M., Woldesenbet, S., Katayama, E., Ratti, F., Marques, H. P., … Pawlik, T. M. (2023). ASO Visual Abstract: Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies Based on Preoperative Alpha-Feto Protein and Tumor Burden Score. Annals of Surgical Oncology.
- Modified integrated tumor burden, liver function, systemic inflammation, and tumor biology score to predict long-term outcomes after resection for hepatocellular carcinoma.
  Endo, Y., Moazzam, Z., Alaimo, L., Woldesenbet, S., Lima, H. A., Munir, M. M., … Pawlik, T. M. (2023). Modified integrated tumor burden, liver function, systemic inflammation, and tumor biology score to predict long-term outcomes after resection for hepatocellular carcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Biology-guided deep learning predicts prognosis and cancer immunotherapy response.
  Jiang, Y., Zhang, Z., Wang, W., Huang, W., Chen, C., Xi, S., … Li, R. (2023). Biology-guided deep learning predicts prognosis and cancer immunotherapy response. Nature Communications, 14(1), 5135.
- Comparison of Spleen-Preservation Versus Splenectomy in Minimally Invasive Distal Pancreatectomy.
  Timmerhuis, H. C., Ngongoni, R. F., Jensen, C. W., Baiocchi, M., DeLong, J. C., Dua, M. M., … Visser, B. C. (2023). Comparison of Spleen-Preservation Versus Splenectomy in Minimally Invasive Distal Pancreatectomy. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Single Cell Transcriptomic Analysis of Human Extra- and Intra-Hepatic Cholangiocarcinoma
  Ayala, C. I., Sathe, A., Grimes, S., Bae, X., Dua, M., Poultsides, G., … Ji, H. (2023). Single Cell Transcriptomic Analysis of Human Extra- and Intra-Hepatic Cholangiocarcinoma. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
  Sun, B. J., Li, A., Alobuia, W., Hur, D., Daniel, S. K., Kirane, A. R., … Lee, B. (2023). Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
  Saadat, L. V., Chou, J., Gonen, M., Lee, R. M., Maithel, S. K., Li, A. Y., … D'Angelica, M. I. (2023). Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Peribiliary cysts masquerading as choledocholithiasis.
  Narayan, R. R., Juakiem, W. Y., Poultsides, G. A., & El-Dika, S. (2023). Peribiliary cysts masquerading as choledocholithiasis. VideoGIE : an Official Video Journal of the American Society for Gastrointestinal Endoscopy, 8(9), 351–353.
- An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors.
  Alaimo, L., Moazzam, Z., Lima, H. A., Endo, Y., Ruzzenente, A., Guglielmi, A., … Pawlik, T. M. (2023). An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors. Surgery.
- Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation.
  Hui, C., Ewongwo, A., Lau, B., Fisher, G., Delitto, D., Poultsides, G., … Vitzthum, L. K. (2023). Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation. Annals of Surgical Oncology.
- Assessment of open-field fluorescence guided surgery systems: implementing a standardized method for characterization and comparison.
  Ochoa, M. I., Ruiz, A., LaRochelle, E., Reed, M., Berber, E., Poultsides, G., & Pogue, B. W. (2023). Assessment of open-field fluorescence guided surgery systems: implementing a standardized method for characterization and comparison. Journal of Biomedical Optics, 28(9), 096007.
- Low Prognostic Nutritional Index is Common and Associated with Poor Outcomes Following Curative-intent Resection for Gastro-entero-pancreatic Neuroendocrine Tumors
  Xiang, J.-X., Qian, Y.-R., He, J., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., … Pawlik, T. M. (2023). Low Prognostic Nutritional Index is Common and Associated with Poor Outcomes Following Curative-intent Resection for Gastro-entero-pancreatic Neuroendocrine Tumors. NEUROENDOCRINOLOGY.
- Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma.
  Resende, V., Tsilimigras, D. I., Endo, Y., Guglielmi, A., Ratti, F., Aldrighetti, L., … Pawlik, T. M. (2023). Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma. World Journal of Surgery.
- Optimal policy tree to assist in adjuvant therapy decision-making after resection of colorectal liver metastases.
  Endo, Y., Alaimo, L., Moazzam, Z., Woldesenbet, S., Lima, H. A., Yang, J., … Pawlik, T. M. (2023). Optimal policy tree to assist in adjuvant therapy decision-making after resection of colorectal liver metastases. Surgery.
- GITR and TIGIT immunotherapy provokes divergent multi-cellular responses in the tumor microenvironment of gastrointestinal cancers.
  Sathe, A., Ayala, C., Bai, X., Grimes, S. M., Lee, B., Kin, C., … Ji, H. P. (2023). GITR and TIGIT immunotherapy provokes divergent multi-cellular responses in the tumor microenvironment of gastrointestinal cancers. BioRxiv : the Preprint Server for Biology.
- ASO Visual Abstract: Patterns of Recurrence after Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation.
  Hui, C., Ewongwo, A., Lau, B., Fisher, G., Delitto, D., Poultsides, G., … Vitzthum, L. K. (2023). ASO Visual Abstract: Patterns of Recurrence after Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation. Annals of Surgical Oncology.
- Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma
  Resende, V., Tsilimigras, D. I., Endo, Y., Guglielmi, A., Ratti, F., Aldrighetti, L., … Pawlik, T. M. (2023). Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma. WORLD JOURNAL OF SURGERY.
- Great Debate: Chemoradiation Should be Added to Chemotherapy as a Neoadjuvant Treatment Strategy for Resectable Gastric Adenocarcinoma.
  Daniel, S. K., Badgwell, B. D., McKinley, S. K., Strong, V. E., & Poultsides, G. A. (2023). Great Debate: Chemoradiation Should be Added to Chemotherapy as a Neoadjuvant Treatment Strategy for Resectable Gastric Adenocarcinoma. Annals of Surgical Oncology.
- Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases.
  Paro, A., Hyer, J. M., Avery, B. S., Tsilimigras, D. I., Bagante, F., Guglielmi, A., … Pawlik, T. M. (2023). Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases. Hepatobiliary Surgery and Nutrition, 12(5), 692–703.
- Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype.
  Wei, T., Lu, J., Xiao, X.-L., Weiss, M., Popescu, I., Marques, H. P., … Pawlik, T. M. (2023). Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype. Annals of Surgical Oncology.
- ASO Visual Abstract: Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype.
  Wei, T., Lu, J., Xiao, X.-L., Weiss, M., Popescu, I., Marques, H. P., … Pawlik, T. M. (2023). ASO Visual Abstract: Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype. Annals of Surgical Oncology.
- Postoperative morbidity after simultaneous versus staged resection of synchronous colorectal liver metastases: Impact of hepatic tumor burden.
  Endo, Y., Alaimo, L., Moazzam, Z., Woldesenbet, S., Lima, H. A., Munir, M. M., … Pawlik, T. M. (2023). Postoperative morbidity after simultaneous versus staged resection of synchronous colorectal liver metastases: Impact of hepatic tumor burden. Surgery.
- GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers.
  Sathe, A., Ayala, C., Bai, X., Grimes, S. M., Lee, B., Kin, C., … Ji, H. P. (2023). GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. Genome Medicine, 15(1), 100.
- Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
  Zhang, N., He, J., Maithel, S. K., Poultsides, G., Rocha, F., Weber, S., … Pawlik, T. M. (2023). Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study. Annals of Surgical Oncology.
- Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma.
  Tsilimigras, D. I., Endo, Y., Ratti, F., Marques, H. P., Cauchy, F., Lam, V., … Pawlik, T. M. (2024). Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma. Annals of Surgical Oncology.
- Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Endo, Y., Catalano, G., Ruzzenente, A., Aldrighetti, L., Weiss, M., … Pawlik, T. M. (2024). Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis.
  Tsilimigras, D. I., Endo, Y., Ratti, F., Marques, H. P., Cauchy, F., Lam, V., … Pawlik, T. M. (2024). The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- ASO Visual Abstract: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors-A Multi-Institutional Study.
  Zhang, N., He, J., Maithel, S. K., Poultsides, G., Rocha, F., Weber, S., … Pawlik, T. M. (2024). ASO Visual Abstract: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors-A Multi-Institutional Study. Annals of Surgical Oncology.
- Perioperative Changes in Serum Transaminase Levels: Impact on Postoperative Morbidity Following Liver Resection of Hepatocellular Carcinoma.
  Wang, F., Lu, J., Yang, T., Ren, Y., Ratti, F., Marques, H. P., … Pawlik, T. M. (2024). Perioperative Changes in Serum Transaminase Levels: Impact on Postoperative Morbidity Following Liver Resection of Hepatocellular Carcinoma. Annals of Surgery.
- Early Onset Intrahepatic Cholangiocarcinoma: Clinical Characteristics, Oncological Outcomes, and Genomic/Transcriptomic Features.
  Tsilimigras, D. I., Han, X., Guglielmi, A., Aldrighetti, L., Weiss, M., Bauer, T. W., … Pawlik, T. M. (2024). Early Onset Intrahepatic Cholangiocarcinoma: Clinical Characteristics, Oncological Outcomes, and Genomic/Transcriptomic Features. Annals of Surgical Oncology.
- Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma.
  Kawashima, J., Sahara, K., Shen, F., Guglielmi, A., Aldrighetti, L., Weiss, M., … Pawlik, T. M. (2024). Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 28(1), 18–25.
- ASO Visual Abstract: Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma.
  Alaimo, L., Endo, Y., Catalano, G., Ruzzenente, A., Aldrighetti, L., Weiss, M., … Pawlik, T. M. (2024). ASO Visual Abstract: Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology.
- Postoperative outcomes and costs of laparoscopic versus robotic distal pancreatectomy: a propensity-matched analysis.
  Timmerhuis, H. C., Jensen, C. W., Ngongoni, R. F., Baiocchi, M., DeLong, J. C., Ohkuma, R., … Visser, B. C. (2024). Postoperative outcomes and costs of laparoscopic versus robotic distal pancreatectomy: a propensity-matched analysis. Surgical Endoscopy.
- The complication-overall survival (CompOS) risk tool predicts risk of a severe postoperative complications relative to long-term survival among patients with primary liver cancer.
  Endo, Y., Tsilimigras, D. I., Woldesenbet, S., Marques, H. P., Cauchy, F., Weiss, M., … Pawlik, T. M. (2024). The complication-overall survival (CompOS) risk tool predicts risk of a severe postoperative complications relative to long-term survival among patients with primary liver cancer. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 28(2), 132–140.
- Survival disparities in rural versus urban patients with pancreatic neuroendocrine tumor: A multi-institutional study from the US neuroendocrine tumor study group.
  Mirza, M. B., Baechle, J. J., Marincola Smith, P., Dillhoff, M., Poultsides, G., Rocha, F. G., … Idrees, K. (2024). Survival disparities in rural versus urban patients with pancreatic neuroendocrine tumor: A multi-institutional study from the US neuroendocrine tumor study group. American Journal of Surgery.
- Festschrift for Dr. Jeffrey A. Norton, 12-13 October 2023, Stanford, CA, USA.
  Poultsides, G. A., Kebebew, E., & Hawn, M. T. (2024). Festschrift for Dr. Jeffrey A. Norton, 12-13 October 2023, Stanford, CA, USA. Annals of Surgical Oncology.
- Distal Pancreatectomy With and Without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy
  Daniel, S. K., Hironaka, C., Ahmad, M. U., Delitto, D., Dua, M., Lee, B., … Poultsides, G. (2024). Distal Pancreatectomy With and Without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Single cell pharmacogenic pipeline identifies novel opportunities in uterine leiomyosarcoma
  Daniel, S. K., Foster, D., Nosrati, F., Korah, M., Fallah, M., Sun, B. J., … Delitto, D. (2024). Single cell pharmacogenic pipeline identifies novel opportunities in uterine leiomyosarcoma. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Recurrent Intrahepatic Cholangiocarcinoma: A Novel Prognostic Model to Predict Post-Recurrence Survival and Guide Treatment of Recurrence
  Tsilimigras, D., Guglielmi, A., Aldrighetti, L., Weiss, M., Bauer, T., Alexandrescu, S., … Pawlik, T. M. (2024). Recurrent Intrahepatic Cholangiocarcinoma: A Novel Prognostic Model to Predict Post-Recurrence Survival and Guide Treatment of Recurrence. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- A Novel Classification of Small Bowl Adenocarcinoma Based on the Hidden Genome Classifier: A Multi-Institutional Study
  Ethun, C. G., Court, C. M., Chou, J., Schleimer, L. E., McIntyre, S. M., Walch, H., … Jarnagin, W. R. (2024). A Novel Classification of Small Bowl Adenocarcinoma Based on the Hidden Genome Classifier: A Multi-Institutional Study. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence.
  Tsilimigras, D. I., Endo, Y., Guglielmi, A., Aldrighetti, L., Weiss, M., Bauer, T. W., … Pawlik, T. M. (2024). Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence. Annals of Surgical Oncology.
- Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors.
  Xiang, J.-X. X., Nan, Y.-L. L., He, J., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., … Pawlik, T. M. (2024). Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative
  Makris, E. A., Tran, T. B., Delitto, D. J., Lee, B., Ethun, C. G., Grignol, V., … Kirane, A. (2024). Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative. JOURNAL OF SURGICAL ONCOLOGY.
- Textbook outcome in liver surgery: open vs minimally invasive hepatectomy among patients with hepatocellular carcinoma.
  Endo, Y., Tsilimigras, D. I., Munir, M. M., Woldesenbet, S., Yang, J., Katayama, E., … Pawlik, T. M. (2024). Textbook outcome in liver surgery: open vs minimally invasive hepatectomy among patients with hepatocellular carcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 28(4), 417–424.
- Prognostic significance of postoperative complications for patients with hepatocellular carcinoma relative to alpha-feto protein and tumor burden score.
  Endo, Y., Tsilimigras, D. I., Munir, M. M., Woldesenbet, S., Yang, J., Guglielmi, A., … Pawlik, T. M. (2024). Prognostic significance of postoperative complications for patients with hepatocellular carcinoma relative to alpha-feto protein and tumor burden score. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- "Duct tape:" Management strategies for the pancreatic anastomosis during pancreatoduodenectomy.
  Harrison, J., Dua, M. M., Kastrinakis, W. V., Fagenholz, P. J., Fernandez-Del Castillo, C., Lillemoe, K. D., … Qadan, M. (2024). "Duct tape:" Management strategies for the pancreatic anastomosis during pancreatoduodenectomy. Surgery.
- Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma.
  Altaf, A., Endo, Y., Munir, M. M., Khan, M. M., Rashid, Z., Khalil, M., … Pawlik, T. M. (2024). Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Long-term survivors after curative-intent resection for intrahepatic cholangiocarcinoma.
  Ma, Z.-J. J., Xiang, J.-X. X., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., … Pawlik, T. M. (2024). Long-term survivors after curative-intent resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology.
- Preoperative and postoperative predictive models of early recurrence for colorectal liver metastases following chemotherapy and curative-intent one-stage hepatectomy.
  Kawashima, J., Chatzipanagiotou, O. P., Tsilimigras, D. I., Khan, M. M., Catalano, G., Rashid, Z., … Pawlik, T. M. (2024). Preoperative and postoperative predictive models of early recurrence for colorectal liver metastases following chemotherapy and curative-intent one-stage hepatectomy. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 50(9), 108532.
- Local Therapy for Metastatic Colorectal Cancer: A Case-Based Review.
  Dykstra, M. P., Apisarnthanarax, S., Poultsides, G., Atkins, K. M., Binder, D., Olsen, J., … Chang, D. T. (2024). Local Therapy for Metastatic Colorectal Cancer: A Case-Based Review. Cancer Journal (Sudbury, Mass.), 30(4), 280–289.
- Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection.
  Harrison, J. M., Li, A. Y., Bergquist, J. R., Ngongoni, F., Norton, J. A., Dua, M. M., … Visser, B. C. (2024). Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
  Margonis, G. A., Wang, J. J., Boerner, T., Moretto, R., Buettner, S., Andreatos, N., … D'Angelica, M. (2024). Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study. The British Journal of Surgery, 111(7).
- Circulating Tumor DNA in the Monitoring of Soft Tissue Sarcoma Treatment and Recurrence.
  Sun, B. J., Li, A. Y., Hur, D. G., Zhou, M., Poultsides, G. A., Delitto, D. J., & Lee, B. (2024). Circulating Tumor DNA in the Monitoring of Soft Tissue Sarcoma Treatment and Recurrence. Annals of Surgical Oncology.
- Machine learning models including preoperative and postoperative albumin-bilirubin score: short-term outcomes among patients with hepatocellular carcinoma.
  Endo, Y., Tsilimigras, D. I., Munir, M. M., Woldesenbet, S., Guglielmi, A., Ratti, F., … Pawlik, T. M. (2024). Machine learning models including preoperative and postoperative albumin-bilirubin score: short-term outcomes among patients with hepatocellular carcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle.
  Shrager, J. B., Randle, R., Lee, M., Ahmed, S. S., Trope, W., Lui, N., … Tang, H. (2024). JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle. Life Science Alliance, 7(11).
- Preoperative platelet count as an independent predictor of long-term outcomes among patients undergoing resection for intrahepatic cholangiocarcinoma.
  Chatzipanagiotou, O. P., Tsilimigras, D. I., Catalano, G., Ruzzenente, A., Aldrighetti, L., Weiss, M., … Pawlik, T. M. (2024). Preoperative platelet count as an independent predictor of long-term outcomes among patients undergoing resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology.
- Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness.
  Hatziapostolou, M., Koutsioumpa, M., Zaitoun, A. M., Polytarchou, C., Edderkaoui, M., Mahurkar-Joshi, S., … Iliopoulos, D. (2024). Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. Gastro Hep Advances, 3(5), 687–702.
- Development of an Artificial Intelligence Based Model to Predict Early Recurrence of Neuroendocrine Liver Metastasis Following Resection.
  Altaf, A., Munir, M. M., Endo, Y., Khan, M. M., Rashid, Z., Khalil, M., … Pawlik, T. M. (2024). Development of an Artificial Intelligence Based Model to Predict Early Recurrence of Neuroendocrine Liver Metastasis Following Resection. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure
  Somasegar, S., Tostrud, L., Poultsides, G., & Renz, M. (2024). Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure. HELIYON, 10(16).
- Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure.
  Somasegar, S., Tostrud, L., Poultsides, G., & Renz, M. (2024). Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure. Heliyon, 10(16), e36581.
- A novel classification of small bowel adenocarcinoma based on a hidden genome classifier: A multi-institutional study.
  Schleimer, L. E., Ethun, C. G., Court, C., Chou, J. F., Mcintyre, S. M. H., Walch, H. S., … Jarnagin, W. R. (2024). A novel classification of small bowel adenocarcinoma based on a hidden genome classifier: A multi-institutional study. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Development and Validation of a Predictive Risk Score for Blood Transfusion in Patients Undergoing Curative-Intent Surgery for Intrahepatic Cholangiocarcinoma.
  Catalano, G., Alaimo, L., Endo, Y., Chatzipanagiotou, O. P., Ruzzenente, A., Aldrighetti, L., … Pawlik, T. M. (2024). Development and Validation of a Predictive Risk Score for Blood Transfusion in Patients Undergoing Curative-Intent Surgery for Intrahepatic Cholangiocarcinoma. Journal of Surgical Oncology.
- Upfront surgery for intrahepatic cholangiocarcinoma: Prediction of futility using artificial intelligence.
  Altaf, A., Endo, Y., Guglielmi, A., Aldrighetti, L., Bauer, T. W., Marques, H. P., … Pawlik, T. M. (2024). Upfront surgery for intrahepatic cholangiocarcinoma: Prediction of futility using artificial intelligence. Surgery.
- Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group.
  Sahara, K., Tsilimigras, D. I., Homma, Y., Kawashima, J., Maithel, S. K., Rocha, F., … Pawlik, T. M. (2024). Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group. Journal of Surgical Oncology.
- Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors.
  Li, M.-X. X., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., Weber, S., Fields, R., … Pawlik, T. M. (2024). Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors. Journal of Surgical Oncology.
- Preoperative identification of early extrahepatic recurrence after hepatectomy for colorectal liver metastases: A machine learning approach.
  Kawashima, J., Endo, Y., Woldesenbet, S., Chatzipanagiotou, O. P., Tsilimigras, D. I., Catalano, G., … Pawlik, T. M. (2024). Preoperative identification of early extrahepatic recurrence after hepatectomy for colorectal liver metastases: A machine learning approach. World Journal of Surgery.
- Prognostic value of the advanced lung cancer inflammation index in intrahepatic cholangiocarcinoma.
  Catalano, G., Alaimo, L., Chatzipanagiotou, O. P., Ruzzenente, A., Aucejo, F., Marques, H. P., … Pawlik, T. M. (2024). Prognostic value of the advanced lung cancer inflammation index in intrahepatic cholangiocarcinoma. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 50(12), 108773.
- Distal Pancreatectomy with and without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy.
  Daniel, S. K., Hironaka, C. E., Ahmad, M. U., Delitto, D., Dua, M. M., Lee, B., … Poultsides, G. A. (2024). Distal Pancreatectomy with and without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy. Cancers, 16(20).
- Improving Recurrence Prediction in Intrahepatic Cholangiocarcinoma: The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes.
  Akabane, M., Kawashima, J., Woldesenbet, S., Macedo, A. B., Cauchy, F., Shen, F., … Pawlik, T. M. (2024). Improving Recurrence Prediction in Intrahepatic Cholangiocarcinoma: The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes. Annals of Surgical Oncology.
- Recurrence Timing and Risk Following Curative Resection of Colorectal Liver Metastases: Insights From a Hazard Function Analysis.
  Kawashima, J., Akabane, M., Endo, Y., Woldesenbet, S., Altaf, A., Ruzzenente, A., … Pawlik, T. M. (2024). Recurrence Timing and Risk Following Curative Resection of Colorectal Liver Metastases: Insights From a Hazard Function Analysis. Journal of Surgical Oncology.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

875 Blake Wilbur Drive

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

875 Blake Wilbur Drive

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Benign Pancreas Program Redwood City, CA

Redwood City, CA

Benign Pancreas Program

420 Broadway Street, Pavilion D 2nd Floor

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

Hypertension Center Stanford, CA

Stanford, CA

Hypertension Center

300 Pasteur Drive, 1st Floor Suite A11

Stanford , CA 94305

(650) 723-6961

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(21 Ratings)

Overall Rating

4.8/5

View Ratings by Category

4.8/5

Friendliness

4.8/5

Explanations

4.9/5

Listens

4.7/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(396 reviews)

Doctor Poultsides is professional yet easy to talk to.

Sep 2024

•

Verified SHC Patient

He was very knowledgeable about my cancer and treatment

Sep 2024

•

Verified SHC Patient

Nice man.

Sep 2024

•

Verified SHC Patient

Very grateful to Dr. Poultsides and his responsiveness and care.

Sep 2024

•

Verified SHC Patient

Lucky yo have him . He is very thorough and wants to check on reports and diagnosis before proceeding with any surgery

Sep 2024

•

Verified SHC Patient

Dr. Poultsides focused on issues and made quick decisions. He knew what he is talking about.

Aug 2024

•

Verified SHC Patient

Dr. George Poultsides was Kind and professional

Aug 2024

•

Verified SHC Patient

I can't say enough good things about him and his staff. I feel he is a top of the line, world class professional and I'm honored that he is working with me. I do believe that I'm receiving the very best care and treatment that is possible from him and his staff.

Jul 2024

•

Verified SHC Patient

I really like Dr Poultsides, he was super nice and explained everything in laymanâ€™s terms. Very pleasant experience considering I need to have surgery. I feel so much better about the procedure now.

Jul 2024

•

Verified SHC Patient

Efficiency

Jul 2024

•

Verified SHC Patient

He was polite and knowledgeable about my case. He explained things in terms that I could understand. He seemed confident that he would help me. Very professional. Thank you.

Jul 2024

•

Verified SHC Patient

excellent

Jul 2024

•

Verified SHC Patient

He made me feel comfortable and help me understand the process I will be going through.

Jun 2024

•

Verified SHC Patient

Dr. Poultsides is responsive, thorough, and overall an excellent doctor.

Jun 2024

•

Verified SHC Patient

Dr. Poultsides is very kind and patient to answer all the questions I had. I feel much relieved after the visit.

May 2024

•

Verified SHC Patient

He seems to be a very well spoken easy to understand doctor felt very comfortable talking with him

Apr 2024

•

Verified SHC Patient

Great doctor!

Apr 2024

•

Verified SHC Patient

Very nice to talk to doctor I am very pleased

Apr 2024

•

Verified SHC Patient

Listened and communicated an appropriate plan of action. Appreciated his detail and compassion for my concern. I look forward to meet his colleague and co surgeon

Apr 2024

•

Verified SHC Patient

I'm very satisfied with my visit thank you

Apr 2024

•

Verified SHC Patient

He was clear, thorough, candid. Very good visit.

Apr 2024

•

Verified SHC Patient

Dr. Poultsides has been trying to help me with my medical issues for some time now. I truly appreciate all that he is doing and all he has done for me. I understand that my problem is a very rare situation and that he's doing all he can to help me get through this. I would highly recommend both Dr. Poultsides and Dr. Sonu for their compassion and their continued search for a solution to my medical condition. Stanford is very fortunate to have them working on their team.

Mar 2024

•

Verified SHC Patient

He is a very busy doctor with very good recommendations and lots of patients, but he is positive and an expert in his field. He is also very thorough. I am glad he is my pancreatic physician.

Mar 2024

•

Verified SHC Patient

I really like him. He listens to your concerns. He is very engaging. Explains things in easy to understand verbiage.

Mar 2024

•

Verified SHC Patient

Very impressed with the video appointments.

Mar 2024

•

Verified SHC Patient

Dr. Poultsides seems very competent, knowledgeable and thoughtful.

Mar 2024

•

Verified SHC Patient

Dr. Poultsides is very caring and his concern shows through.

Mar 2024

•

Verified SHC Patient

Great doctor!

Mar 2024

•

Verified SHC Patient

Seems like a very nice person

Mar 2024

•

Verified SHC Patient

I trust him completely

Mar 2024

•

Verified SHC Patient

Dr. Poultsides is an exceptional surgery and doctor who saved my life. I will be grateful to George and Stanford forever.

Mar 2024

•

Verified SHC Patient

The doctor was very personable and instilled confidence.

Mar 2024

•

Verified SHC Patient

Very knowledgeable helpful kind

Mar 2024

•

Verified SHC Patient

Very professional. Very direct. Answered all my questions.

Mar 2024

•

Verified SHC Patient

We like Doctor Poultsides and trust him.

Mar 2024

•

Verified SHC Patient

Thank you, Dr. Poultsides and team.

Feb 2024

•

Verified SHC Patient

Highly recommended by Shane Tipton

Feb 2024

•

Verified SHC Patient

Thoughtful , thorough, concerned, and willing to seek answers to look for ways to serve and care for me.

Feb 2024

•

Verified SHC Patient

We have a mystery that remains unsolved. I have pain in my left side. It's been there since March 2021. Surgery in May 2022 did not alleviate the problem. Nobody seems to know why?

Feb 2024

•

Verified SHC Patient

Great doctor, answered all questions

Feb 2024

•

Verified SHC Patient

Seems extremely knowledgeable, as well good "bedside manner"

Feb 2024

•

Verified SHC Patient

Excellent doctor

Jan 2024

•

Verified SHC Patient

Knowledgable, helpful, positive, direct. I never felt rushed, but also didn't feel like my time was wasted - very professional.

Jan 2024

•

Verified SHC Patient

Mr Poultsides, was great. Very patient. Answered all my questions. Very kind and caring. I know I am good hands with this man. God bless him.

Jan 2024

•

Verified SHC Patient

Dr. Poultsides was so nice, professional and spoke to me in a way that I could uderstand as I didn't go to medical school. :-) I really liked him.

Jan 2024

•

Verified SHC Patient

He is a fantastic surgeon and a caring doctor

Jan 2024

•

Verified SHC Patient

Doctor George Poolside's is an excellent doctor. I'm so happy that he was the one to take care of me

Jan 2024

•

Verified SHC Patient

Dr Poultsides is friendly, to the point, and thorough with his conversations and recommendations. He is also aware of the upcoming endoscopy that will be done in Pleasanton by Dr Eldika. I am pleased that they know each other and can share medical info as needed, in the future.

Jan 2024

•

Verified SHC Patient

Excellent informative Dr

Jan 2024

•

Verified SHC Patient

Dr Poultsides saved my life Twice!! I am very thankful to him and his staff! His encouragement and positive attitude, both before and after my surgery was very helpful. Can't say enough about ALL the staff at Stanford!

Jan 2024

•

Verified SHC Patient

Great doctor , very informative

Jan 2024

•

Verified SHC Patient

Dr. P was very good and he answers all my questions.

Jan 2024

•

Verified SHC Patient

I felt he made his self very clear and how he felt and now itâ€™s up to me to make a decision. He also gave me a name of an oncologist that I could talk to if I wished, I thought he made himself very clear, and it was much easier on me than having to drive all the way up there again, and I thank him for being so professional when Iâ€™m going through as soon as right now, Iâ€™m very grateful for his professional opinion and I think Stanford for giving me the opportunity to do it this way

Jan 2024

•

Verified SHC Patient

Dr. Poutsides is very kind and professional. I am very grateful to be his patient!

Jan 2024

•

Verified SHC Patient

He is a good doctor as i had seen during our conversation.

Dec 2023

•

Verified SHC Patient

A tentÃ³ a su paciente

Dec 2023

•

Verified SHC Patient

I liked that he knew my health history and reviewed a scan with me , he supported not doing surgery , which my concern was a surgeon would simply agree to do surgery. Dr Poultsides will follow up with me in 3 months, which makes me and my family feel confident about my health.

Dec 2023

•

Verified SHC Patient

See previous answer. I can add that I have confidence in him due to his remarkable accomplishments. He also is frank and caring in his discourse.

Dec 2023

•

Verified SHC Patient

Dr. Poultsides was very attentive. and prepared to deal with my case. He seemed to have a plan on how to proceed with my case.

Dec 2023

•

Verified SHC Patient

I thought he was very thorough and answered all my questions

Dec 2023

•

Verified SHC Patient

Dr. Poultsides is very patient and encouraging. He listened to my concerns and provided suggestions.

Nov 2023

•

Verified SHC Patient

He is a very good doctor and he has done surgery on me 3 times and I will stick with him to do any surgeries I every need in the further. And Iâ€™ve been seeing him since 2013. He is the best. I always thank him every time I have an appointment with him for taking good care of me. And what I needed surgery for is to remove tumors I have a rare type of cancer called Liposarcoma. Again he is the best doctor.

Nov 2023

•

Verified SHC Patient

Excellent. Very professional but also very personable.

Nov 2023

•

Verified SHC Patient

Just tell him Thank You.

Nov 2023

•

Verified SHC Patient

THANKS FOR YOUR SKILLS. Also thanks for taking time to show me the kidney stones on the scans that were NOT noted in the scan report from Sept. 2023. They were very small BUT visible. I will address that with Primary Physician and MD Imagining. Evidently taking 4 capsules of 600 mg of Apple Cider Vinegar spread out through the day isn't a problem with or negated by taking the Famotidine 20mg tablet twice a day. Didn't remember Dr. Poultsides and I talking about that but did talk with Intern about just prior to Dr. Poultsides video visit.

Nov 2023

•

Verified SHC Patient

Very kind , but was hoping to move forward with the surgery instead of being recommended to another doctor

Nov 2023

•

Verified SHC Patient

Dr. Poultsides makes me feel that he's very interested in my situation. It is very reassuring to have him helping me. He and Dr. Sonu working as a team are keeping a close eye on my progress. Unfortunately, there doesn't seem to be a quick fix for my problem at the present time. The good news is that my mass hasn't grown since my last check in. Hopefully, something new will come up in the future to help me out. I appreciate all the help I am receiving from Dr. Poultsides and his team!

Nov 2023

•

Verified SHC Patient

My interactions with him have all been excellent.

Nov 2023

•

Verified SHC Patient

He is a good man, as well as an excellent medical professional. I like Jenny V who works with him, she is thorough and genuine. I am thankful to have Dr. Poultsides overseeing my medical needs!

Oct 2023

•

Verified SHC Patient

Thank you foe being such a great doctor

Oct 2023

•

Verified SHC Patient

Explained everything well

Oct 2023

•

Verified SHC Patient

Dr.poultsides provides excellent medical care and is extremely understanding and important for my recovery. He saved my life.

Oct 2023

•

Verified SHC Patient

Excellent customer service. Love my doctor.

Oct 2023

•

Verified SHC Patient

Great doctor to have!

Oct 2023

•

Verified SHC Patient

The, doctor was very complete and professional.

Oct 2023

•

Verified SHC Patient

Dr. Poultsides was very thorough to explain the findings and was able to answer all of my questions. It was very informative. Thank you for taking this survey.

Oct 2023

•

Verified SHC Patient

He is an excellent doctor and a wonderful person

Oct 2023

•

Verified SHC Patient

I think Dr. Poultsides is very professional knowledgeable, and provided me with a concrete path to deal with the cancer issue. I have. I look forward to working with him to resolve my cancer issue.

Oct 2023

•

Verified SHC Patient

Dr.Poultsides has a very pleasant and relaxed manner. He explained the details of my surgery very simply so I understood what was involved before, during , and after the procedure. I left the appointment feeling less anxious and confident that I am in excellent hands.

Oct 2023

•

Verified SHC Patient

I am confident that he is the right provider for me. Iâ€™ve heard his name SO many times since my diagnosis. Nothing but GREAT things. At our first meeting, I believe all of the wonderful things Iâ€™ve heard!

Oct 2023

•

Verified SHC Patient

He is a very caring man

Oct 2023

•

Verified SHC Patient

Dr. Poultsides is clearly extremely competent and knowledgeable (400 publications!). We had an excellent, informative exchange, aided by the preliminary interview with Alla Kulobenko, his resident. He allowed me to express all my concerns and answered my questions completely. He formulated a followup plan that makes complete sense to me. Despite an alarming condition, I am encouraged by having him on my health care team.

Oct 2023

•

Verified SHC Patient

Patient and friendly

Oct 2023

•

Verified SHC Patient

Dr does a good job.

Sep 2023

•

Verified SHC Patient

Dr Poulsides is a good doctor the way he explained about my health and the next thing to be done.

Sep 2023

•

Verified SHC Patient

He is doing good!

Sep 2023

•

Verified SHC Patient

Very professional, very direct, answered all my questions, inspired confidence that he could handle my surgery.

Sep 2023

•

Verified SHC Patient

He's AWESOME!!!

Aug 2023

•

Verified SHC Patient

Both Dr. Poultsides and the resident were very informed of my medical situation. They both had reviewed my record and scans prior to the visit. They both understood my perspective and respected my feelings about my current condition. They both get an A+

Aug 2023

•

Verified SHC Patient

First visit left a good impression.

Aug 2023

•

Verified SHC Patient

The doctor was very informative and was able to answer all of the questions that I asked.

Aug 2023

•

Verified SHC Patient

very clear

Jul 2023

•

Verified SHC Patient

Very helpful

Jul 2023

•

Verified SHC Patient

Dr. Poultsides is a good doctor. As I noticed when he talks and explains well the results of my labtest and ct scan and advised me what to do next. He knows his job.

Jul 2023

•

Verified SHC Patient

He answered all my questions clearly and patiently, wonderful visit

Jul 2023

•

Verified SHC Patient

He did a great job explaining everything.

Jun 2023

•

Verified SHC Patient

Excellent doctor.

Jun 2023

•

Verified SHC Patient

Very knowledgeable and excellent communicator. Felt more encouraged after 1 hour consult with Dr. Poultsides than I have in months.

Jun 2023

•

Verified SHC Patient

Great doctor

Jun 2023

•

Verified SHC Patient

He was very informative, patient, and caring.

Jun 2023

•

Verified SHC Patient

Dr George Poultsides is great . In a short span of time he cleared all my doubts about surgery.

Jun 2023

•

Verified SHC Patient

Excellent doctor!!!

Jun 2023

•

Verified SHC Patient

Dr Poultsides was very good - his Student Ana also.

Jun 2023

•

Verified SHC Patient

Professional. Direct and to the point. I liked him

Jun 2023

•

Verified SHC Patient

The doctor was concise and thorough. Despite not being familiar with medical jargon, Dr. Poultsides offered opportunities to ask for clarifications and questions and my wife and I did ask. He seemed to be a no nonsense and honest man not wasting a lot of words yet we felt comfortable asking questions. We also felt comfortable talking and answering questions that we asked by Dr. Chandler.

Jun 2023

•

Verified SHC Patient

Dr. Poultsides is a most effective professional surgeon, who inspires great confidence in his patients.

May 2023

•

Verified SHC Patient

Dr. Poultsides was a good listener and fully answered all of my questions.

May 2023

•

Verified SHC Patient

We are so very thankful that Dr G Poultsides accepted our case. Gave us a chance to battle pancreatic cancer. Having been diagnosed with pancreatic cancer January 2021 and still be here May 2023 is amazing. My husband was given a chance to fight and he continues to fight. Dr Poultsides and his nurse Abigail were always responsive via â€œMy Health Portalâ€ The quality of care from Stanford Medical Center and the ability to stay connected made this fight possible. Seeking medical service during the COVID pandemic was a challenge, a nightmare at times. Knowing we werenâ€™t alone brought so much comfort. Mahalo Dr Poultsides and all who were part of our care.

May 2023

•

Verified SHC Patient

Well Iâ€™m a new patient and weâ€™ve only spoken twice on a video call so itâ€™s hard to really get a feel for my Dr. but I put my trust in him whole heartedly.

May 2023

•

Verified SHC Patient

The visit was very satifactory.

May 2023

•

Verified SHC Patient

Very impressive.

May 2023

•

Verified SHC Patient

He is very calm very caring takes an interest in patients and listens to questions

May 2023

•

Verified SHC Patient

He was very informative and answered all my questions.

May 2023

•

Verified SHC Patient

Love that a complete and comprehensive visit occurred without having to travel 200 miles!

May 2023

•

Verified SHC Patient

Knowledgeable and recommended a great alternative to surgery.

May 2023

•

Verified SHC Patient

He is excellent

Apr 2023

•

Verified SHC Patient

Appreciated his frankness and honest opinion.

Apr 2023

•

Verified SHC Patient

Dr Poultsides was very pleasant to talk to he explain all the details about my how by my treatment is comming along ,itâ€™s always very comforting to know that Iâ€™m doing well wtith my treatment

Apr 2023

•

Verified SHC Patient

We are so impressed with Dr Poultsides. He is very caring and makes sure we understand everything that he has told us. He is an excellent Doctor and everything has gone very smoothly and according to plan.

Apr 2023

•

Verified SHC Patient

We picked Dr Poulsides because he respects our religious views on blood transfusions. We are Jehovahâ€™s Witnesses.

Apr 2023

•

Verified SHC Patient

He is very good

Mar 2023

•

Verified SHC Patient

Amazing doctor

Mar 2023

•

Verified SHC Patient

He was very informative. He suggested a plan of attack for my liver cancer.

Mar 2023

•

Verified SHC Patient

Thank you Dr. Poultsides for arranging this timely video visit and today's experience was great for me.

Mar 2023

•

Verified SHC Patient

He was extremely helpful.

Mar 2023

•

Verified SHC Patient

I appreciate the expertise of dr poultsides on my case.

Mar 2023

•

Verified SHC Patient

Very caring and extremely informative

Mar 2023

•

Verified SHC Patient

Dr is awesome I am so very grateful and very happy with Dr Poultsides Thank you so very muchðŸ¤—

Mar 2023

•

Verified SHC Patient

Great doctor.

Mar 2023

•

Verified SHC Patient

He's a wonderful human being who saved my life. I am cancer free because of this awesome physician

Mar 2023

•

Verified SHC Patient

I wish the rest of the world could experience the excellence of care continually exhibited by Dr. Poultsides.

Mar 2023

•

Verified SHC Patient

Great surgeon

Mar 2023

•

Verified SHC Patient

He is a good doctor and I enjoy having him as my doctor and as long as he is around I will never stop having him as my doctor. He has done 2 surgeries on me and this is going to be my 3rd surgery that he is going to be doing on my soon. I trust him to do my surgery. And I always tell family, friends and other people that I have talk to that he is a good surgeon.

Feb 2023

•

Verified SHC Patient

What a great surgeon and person. I am very grateful for his skills. Save my life twice already. Dr. Poultsides treats everyone with respect and dignity. He provides answers to all your questions and gives you hope.

Feb 2023

•

Verified SHC Patient

Informative and easy to understand

Feb 2023

•

Verified SHC Patient

Short to the point consult.

Feb 2023

•

Verified SHC Patient

Many Thanks spending time with me.

Feb 2023

•

Verified SHC Patient

He explained the procedure and showed me images that helped me understand. Very professional and knowledgeable.

Feb 2023

•

Verified SHC Patient

Dr.Poultsides is an excellent oncology surgeon. I feel very lucky to under his care and would be happy to recommend him to anybody who needs GI surgery

Jan 2023

•

Verified SHC Patient

Attentive, great bedside manner and through

Jan 2023

•

Verified SHC Patient

Simply the Best !!!!!

Jan 2023

•

Verified SHC Patient

Dr. Was very professional and informative. He truly has your best interests in mind

Jan 2023

•

Verified SHC Patient

Dr. Poultsides is a great professional and person. His liver resection surgery achieved wonderful results for me and was done to perfection. He removed all active disease and there is nothing of concern left in the liver. During this follow up visit, he answered my questions, showed me the images, talked me through what he was seeing, and instilled confidence in our next steps. He also recommended another doctor at Stanford, so it was a great visit. Dr. Poultsides was generous with his time, attention, and expertise, and I will forever be grateful to him and to Stanford for this lifesaving surgery.

Jan 2023

•

Verified SHC Patient

Great Doctor!

Jan 2023

•

Verified SHC Patient

Thank you

Jan 2023

•

Verified SHC Patient

Dr. George Poultsides is a wonderful person and surgeon - very caring as well as an expert in his field. I am grateful to have him as a part of my care team. And his staff of nurses are so responsive. Iâ€™ve received answers to my questions the same day. They are great.

Dec 2022

•

Verified SHC Patient

He was very knowledgeable and accommodating. He was very good at sharing information with me. I appreciate him.

Dec 2022

•

Verified SHC Patient

Wonderful doctor. So bless to have his as my surgent

Dec 2022

•

Verified SHC Patient

Dr. Poulsides is very nice, knowledgeable and professional. He takes the time to explain things in a way you understand. He is great!

Dec 2022

•

Verified SHC Patient

Was great, I love his patient to answer all my questions and concerns.

Dec 2022

•

Verified SHC Patient

He is very professional

Dec 2022

•

Verified SHC Patient

Very easy to talk to and informative with my questions.

Dec 2022

•

Verified SHC Patient

An excellent ,well versed about patient,s problems Dr Poultsides deserves all appreciations.

Nov 2022

•

Verified SHC Patient

He seems nice.

Nov 2022

•

Verified SHC Patient

Doctor George Poultsides is very nice and knowledgeable. He explained to me in great detail the scheme of my further treatment.

Nov 2022

•

Verified SHC Patient

Thank you for taking the time to answer my questions.

Nov 2022

•

Verified SHC Patient

Dr. Poultsides (his team)was an excellent doctor/team and The surgery was a success.

Nov 2022

•

Verified SHC Patient

Dr. Poultsides was very kind and concerned for my well being. He answered questions with patience.

Nov 2022

•

Verified SHC Patient

I really appreciate Dr. Poultsides attention and care. He is the best!

Nov 2022

•

Verified SHC Patient

He seemed very pleasant and knowledgeable and understood everything I told him.

Nov 2022

•

Verified SHC Patient

He is wonderful doctor

Nov 2022

•

Verified SHC Patient

He took his time and made sure that I understood everything that was said to me about what is going to happen.

Oct 2022

•

Verified SHC Patient

I think Dr. Poultsides is a great physician in his field and I am luck to have him treated my problem.

Oct 2022

•

Verified SHC Patient

I am very happy to meet you and your explanation helped me a lot. Thank you very much.

Oct 2022

•

Verified SHC Patient

He is knowledgeable, kind, thorough and highly skilled. I could not ask for a better doctor.

Oct 2022

•

Verified SHC Patient

Very friendly and informative

Oct 2022

•

Verified SHC Patient

Dr Poultsides is nice to talk to I enjoyed talking to him

Oct 2022

•

Verified SHC Patient

He was very nice and professional. Went over everything with me.

Sep 2022

•

Verified SHC Patient

Dr. Poultsides was very clear on the tests I had taken and is setting up another MRI.

Sep 2022

•

Verified SHC Patient

He is a great doctor. Trust his care decisions.

Sep 2022

•

Verified SHC Patient

He is the best

Sep 2022

•

Verified SHC Patient

He was great

Sep 2022

•

Verified SHC Patient

Dr Poultsides was very thoughtful and listened to all of our concerns. We are very confident that in his decisions.

Sep 2022

•

Verified SHC Patient

Heâ€™s great !!

Sep 2022

•

Verified SHC Patient

Very to the point and direct answers

Sep 2022

•

Verified SHC Patient

Always very thorough in explaining how to handle my health issues

Aug 2022

•

Verified SHC Patient

Very professional.

Aug 2022

•

Verified SHC Patient

He was very patient and answered all of the questions. He also explained clearly regarding all test done and what the next steps would be in my treatment

Aug 2022

•

Verified SHC Patient

Seems knowledgeable and good doctor

Aug 2022

•

Verified SHC Patient

Extremely knowledgeable and detail oriented. Very kind and thorough. The best kind of doctor one can find.

Jul 2022

•

Verified SHC Patient

he was attentive to my questions, and took care to explain everything thoroughly.

Jul 2022

•

Verified SHC Patient

He was very informative about the upcoming procedure and answered all my questions

Jul 2022

•

Verified SHC Patient

He was very polite. He explained me in detail what is good for me and what is the best option for me.

Jul 2022

•

Verified SHC Patient

I have appreciated Dr. Poultsides as my cancer surgeon. He has shown skill as a surgeon and compassion as a doctor during what has been a very tough time for me. I would highly recommend him to anyone requiring surgery to address malignant tumors.

Jul 2022

•

Verified SHC Patient

On a daily basis he extends peoples' lives. There is no more noble endeavor for a human being than the help save the lives of other human beings. I appreciate the intelligence, skill and determination it takes to do what he does.

Jul 2022

•

Verified SHC Patient

Dr. George Poultsides is an awesome doctor! I am most grateful for his outstanding care. â€”David Loftus

Jul 2022

•

Verified SHC Patient

See previous question--he needs to clone himself so he is not so busy as to run behind, but he is an excellent surgeon and doctor!!!

Jul 2022

•

Verified SHC Patient

George Poultsides is an excellent doctor.

Jul 2022

•

Verified SHC Patient

He is an excellent DR.

Jul 2022

•

Verified SHC Patient

His kindness, helpfulness, and professionalism. I appreciated the time he took to answer my questions. The wait was worth every minute. He certainly gave me more than 15 minutes of his valuable time It is a little confusing that one Dr. advises NO chemo and Dr. P advised chemo. As a patient I am trying to move along and belive that each new bit of information can change the diagnosis and the plan to take care of particular cancer. Again, thank you Dr. Poutsides, I am relying totally on you.

Jul 2022

•

Verified SHC Patient

I think he is very good at what he does.

Jul 2022

•

Verified SHC Patient

Very helpful consultation.

Jul 2022

•

Verified SHC Patient

Thanks!

Jul 2022

•

Verified SHC Patient

He is very nice and patient to explain every question I have.

Jul 2022

•

Verified SHC Patient

Dr Poultsides goes above and beyond to maintain contact with his patients. He does a good job with the video visits during this Covid time.

Jun 2022

•

Verified SHC Patient

Thank you, thank you, thank you for everything.

Jun 2022

•

Verified SHC Patient

I appreciate the time that Dr. Poultsides spent with me on the phone before the zoom meeting. I also appreciate that he is trying the least invasive procedures first.

Jun 2022

•

Verified SHC Patient

Outstanding caregiver, thorough in all explanations. I never felt hurried.

Jun 2022

•

Verified SHC Patient

I'm happy to have Dr.Poultsides as part of my Care team.I trust him and his judgement.

Jun 2022

•

Verified SHC Patient

He is the best!

Jun 2022

•

Verified SHC Patient

I appreciate his preparation of my case prior to our call. He seems like an excellent Dr. and Iâ€™m happy with the next steps he recommended.

Jun 2022

•

Verified SHC Patient

He is thorough and kind. I do want him to do surgery on me though because this tumor has me going to the bladder too often and also concerned.

May 2022

•

Verified SHC Patient

very good surgeon

May 2022

•

Verified SHC Patient

He is the very best!! I couldn't have had a better doctor or a better care team.

May 2022

•

Verified SHC Patient

Thanks!!!

May 2022

•

Verified SHC Patient

Very thorough with all my concerns.

May 2022

•

Verified SHC Patient

Dr. Poultsides is an excellent doctor and very affectionate.

Apr 2022

•

Verified SHC Patient

Excellent care and advice and very courteous

Apr 2022

•

Verified SHC Patient

Just say thank you a lot and appreciate .

Apr 2022

•

Verified SHC Patient

Dr Poultsides has been very professional and caring through my care, surgery and recovery. I never felt rushed with any visits. Everything was always explained to me in terms I could understand. He has a great bedside manner. I am grateful for Dr Poultsides and his team.

Apr 2022

•

Verified SHC Patient

Dr Poultsides was very good and Iâ€™m glad I have him as my son Dr

Apr 2022

•

Verified SHC Patient

Very knowledgeable and understand & listened to my concerns

Apr 2022

•

Verified SHC Patient

Excellent care from a very caring individual!

Apr 2022

•

Verified SHC Patient

Very considerate and positive. Instilled confidence in me for future treatment from Dr. Poulsides. Has great communication and trust with my oncologist .I am looking forward to our next meeting

Apr 2022

•

Verified SHC Patient

Great Doctor

Apr 2022

•

Verified SHC Patient

Very thorough visit and explanation was great. I felt confident moving forward with Dr.Poultsides.

Apr 2022

•

Verified SHC Patient

I think Dr. Poultsides is an excellent doctor and surgeon specialist on the pancreas. I trust his judgement and recommendations.

Mar 2022

•

Verified SHC Patient

Looking forward to his help in getting my currrent problems behind me.

Mar 2022

•

Verified SHC Patient

Dr Poultsides exuded confidence upon my initial visit.

Mar 2022

•

Verified SHC Patient

Wonderful doctor -- takes the time to review CT scans as well as show them -- answers questions and provides follow up plans --n 11 years plus with him and and appreciate his "efficiency" as well as his staff follow up!!

Mar 2022

•

Verified SHC Patient

Competent & caring.

Mar 2022

•

Verified SHC Patient

Dr. Poultsides is an excellent doctor who is knowledgable about what needed to be done and cares about how I am doing and spends time with me in addressing my concerns before and after my surgery. We should have more Dr. Poultsides in this world.

Mar 2022

•

Verified SHC Patient

A compassionate, excellent physician. Saved me from a wrong diagnosis and surgery through the second opinion process, then followed up with excellent communication and care. I could not be more pleased.

Feb 2022

•

Verified SHC Patient

Outstanding physician, answered all my questions. Thoughtful answers to my questions. Very trustworthy. Encouraged me. Obviously knowledgeable.

Feb 2022

•

Verified SHC Patient

Thank you so much for your time and expertise Dr Poultsides! We are very appreciative!

Feb 2022

•

Verified SHC Patient

The consultation was friendly, positive and thorough. We appreciate Dr. Sibley and her referral to Dr. Poultsides.

Feb 2022

•

Verified SHC Patient

Dr Poulsltsides is very knowledgeable to what I have problem now I know that he will treat me well in the coming weeks

Feb 2022

•

Verified SHC Patient

Dr. Poultsides and his team are excellent at providing patient care. I'm extremely thankful to him in helping me pull through a major illness. The Stanford and patient community are fortunate to have him. What I most appreciate about him is his overall dedication and commitment to his patients. Our questions have always been answered and follow-ups after hospital stay have effortlessly happened. We've never felt abandoned or ignored. We thank him and his team from our hearts.

Jan 2022

•

Verified SHC Patient

Very confidence-inspiring physician. Answers my questions and is supportive.

Jan 2022

•

Verified SHC Patient

Dr. Poultsides and his team gave me a chance, another chance at living. I've been dealing with this stage 4 leiomyosarcoma since November 2016 and I'm still here because of my Doctors. I'm told that his was the most intense and involved surgery yet. I feel like it was the easiest! I can't tell you how much better I feel now. We just went on a hike around the lake today....though it was only 1 1/2 miles, I haven't been able to do it without struggling. I am elated that I can walk to the back of our property, garden, come in and fix a meal and not have to struggle to do it. Dr. Poultsides answers all my questions in a way that is easy for me to understand and I love his honesty. He's never to busy to answer any question or concern that either I or my husband have had. I am very grateful to Dr. Poultsides, and to his team. Stanford is well represented in Dr. Poultsides.

Jan 2022

•

Verified SHC Patient

Dr. Poultsides is an excellent surgeon and doctor. He is also a kind and caring person. He is outstanding. If I had to give him a letter grade (I am a retired college professor), I would give him an A+. He is the best!!!

Jan 2022

•

Verified SHC Patient

Very caring and thorough.

Jan 2022

•

Verified SHC Patient

I love the guy! Awesome surgeon!

Jan 2022

•

Verified SHC Patient

He is knowledgeable and a great doctor

Jan 2022

•

Verified SHC Patient

Excellent, caring Dr. That wants the best care possible for me and my condition.

Jan 2022

•

Verified SHC Patient

This man saved my life, I will be forever grateful

Jan 2022

•

Verified SHC Patient

Excelent care

Dec 2021

•

Verified SHC Patient

explained everything that I was concerned about. Very thoughtful person

Dec 2021

•

Verified SHC Patient

THANK YOU Dr. Poultsides

Dec 2021

•

Verified SHC Patient

I found him to be thorough, factual and conveyed information that was readily understood .

Dec 2021

•

Verified SHC Patient

He is very professional, knowledgeable and polite. He gets right to the point, which I appreciate.

Dec 2021

•

Verified SHC Patient

Dr Poultsides is a very good surgeon

Nov 2021

•

Verified SHC Patient

Grateful to have Dr Poultsides as the primary surgeon on my husbandâ€™s upcoming Whipple surgery. His experience & confidence are reassuring.

Nov 2021

•

Verified SHC Patient

Very good Doc

Nov 2021

•

Verified SHC Patient

Very patient w/ me. Concerned about my well being.

Nov 2021

•

Verified SHC Patient

Excellent care from Dr. Poultsides and his team as always. Transfer of scans between SHC and PAMF remains a problem.

Oct 2021

•

Verified SHC Patient

Excellent Physician-Surgeon and wonderful, caring human being!

Oct 2021

•

Verified SHC Patient

Great surgeon. Personable and cares about you.

Oct 2021

•

Verified SHC Patient

Dr. George Poultsides was very thorough, professional and helpful. In my opinion heâ€™s an excellent doctor and I would highly recommend him!

Oct 2021

•

Verified SHC Patient

I feel very confident with Dr Poltsides. So blessed to have great care Thank you

Oct 2021

•

Verified SHC Patient

Wonderful doctor. Very happy to work with him.

Oct 2021

•

Verified SHC Patient

Dr. Poultsides is highly professional, and personable, at the same time, doctor,- I trust him.

Oct 2021

•

Verified SHC Patient

Recognized, respected and recommended by multiple healthcare professionals. I feel confident and comfortable with him and his team.

Oct 2021

•

Verified SHC Patient

SHORT N SWEET SUPPOSED TO BE THE BEST AT WHATHE DOES UST CANT HELP ME MY LOSS

Oct 2021

•

Verified SHC Patient

I thought you were very helpful and informative. I just wish you would have explained what the referral process would be like and how quickly I would be on chemo.

Oct 2021

•

Verified SHC Patient

Very knowledgeable, kind, informative and gained my trust from the beginning of our virtual meeting.

Oct 2021

•

Verified SHC Patient

Thank you for being direct and helpful.

Sep 2021

•

Verified SHC Patient

great

Sep 2021

•

Verified SHC Patient

Dr. George Poultsides clearly explained to me about a surgery that is required to cure my cancer. He also carefully listened to me and my husband and answered all our questions. Dr. Poultsides gave me a breath of fresh air. I am thankful to Dr. Poultsides for offering a surgery that can prolong my life, and I am looking forward to live longer.

Sep 2021

•

Verified SHC Patient

Thank you for your care, Dr. Poultsides!

Sep 2021

•

Verified SHC Patient

Thank you for your professional expertise and kindness. Your resident was great too.

Sep 2021

•

Verified SHC Patient

It was a very good video appointment & also he was excellent in explaining things to me. I feel safe having Dr. Poultsides operating on me

Sep 2021

•

Verified SHC Patient

He is an amazing doctor!!!!

Sep 2021

•

Verified SHC Patient

He is good

Sep 2021

•

Verified SHC Patient

To the point, straight forward

Aug 2021

•

Verified SHC Patient

I appreciate having him on my medical team and that he communicated everything clearly

Aug 2021

•

Verified SHC Patient

He is quite thorough with his assessment of the CT scan, and gave me information about when surgery may occer, when another CT scan would be scheduled, and the affirmation that chemo therapy would continue for 4 more rounds..

Jul 2021

•

Verified SHC Patient

He listened to me, addressed all my questions and concerns. He was clear and compassionate.

Jul 2021

•

Verified SHC Patient

This was my first interaction with physician and I found him very informative and decisive. I agreed with his future plans for my care and the time plan he recommended. However the follow up appointment does not match the schedule we agreed on. I will be incurring a large medical expense if I am not discharged from Nursing home/Rehab facility. This is weighing heavily on my mind. Thank you

Jul 2021

•

Verified SHC Patient

He has helped me a lot regardless of the distance. Dr. Poultsides is by far one of the best doctors I have interacted with. I appreciate everything you are doing to help me.

Jul 2021

•

Verified SHC Patient

For me , he is excelent doctor

Jul 2021

•

Verified SHC Patient

Very concise but friendly. Was helpful to talk to his associates before so they could gather additional background.

Jul 2021

•

Verified SHC Patient

Dr. Poultsides came across as highly experienced, caring and competent. He answered all of my questions and concerns.

Jul 2021

•

Verified SHC Patient

He is a good doctor and I am happy to have him as mine

Jul 2021

•

Verified SHC Patient

Thanks Dr .You do good job.

Jun 2021

•

Verified SHC Patient

Dr. Poultsides & his assistant, Taylor, were so nice & explained to me & my husband what his game plan was. Itâ€™s helped me calm down a bit. This cancer is new to me & I donâ€™t know what to ask. He told me weâ€™re having surgery, thereâ€™s no chemo after surgery. I feel better knowing what is going to happen. Had trouble sleeping lately. I feel Iâ€™m in good hands

Jun 2021

•

Verified SHC Patient

He is very attentive and concerned for his patients

Jun 2021

•

Verified SHC Patient

I like him!

Jun 2021

•

Verified SHC Patient

Wonderful doctor and person.

Jun 2021

•

Verified SHC Patient

Friendly clear answered all my questions

Jun 2021

•

Verified SHC Patient

He was very helpful in terms of scheduling my procedure and after the surgery he personally saw me and told me how did it go.

Jun 2021

•

Verified SHC Patient

Dr was very attentive

Jun 2021

•

Verified SHC Patient

I especially liked how Dr Poultsides face timed Dr Fang during our video meeting to discuss a plan. I understand everything was sudden and to have this sort of connection gave me comfort.

May 2021

•

Verified SHC Patient

I will be forever grateful to George Poultsides for saving my life and forever grateful that human beings such as he devote their lives to this.

May 2021

•

Verified SHC Patient

Liked him a lot and feel so good about him doing my surgery!

May 2021

•

Verified SHC Patient

He was very good to explain.

Apr 2021

•

Verified SHC Patient

No comments

Apr 2021

•

Verified SHC Patient

Dr. Poultsides' care for our son has been fantastic. He communicates well, answers all of our questions and keeps us informed. He has been a consummate professional and we are grateful for his and his team's care. Thank you!

Apr 2021

•

Verified SHC Patient

Heâ€™s wonderful. He saved my life.

Apr 2021

•

Verified SHC Patient

Heâ€™s such an amazing doctor

Apr 2021

•

Verified SHC Patient

I was very impressed with Dr. Poultsides. He explained things thoroughly and in lay terms. He was aware of my circumstances and seemed to answer some of my questions before I asked. He seemed to understand the concerns of the patient. He has an excellent PA also. As a team they were outstanding.

Apr 2021

•

Verified SHC Patient

Thank you for your attention and explanation on next appointment

Apr 2021

•

Verified SHC Patient

Good.

Mar 2021

•

Verified SHC Patient

Excellent careful "caring!" "listened" -

Nov 2020

•

Verified SHC Patient

Polite and friendly, very professional.

Aug 2020

•

Verified SHC Patient

Good experience.

Feb 2020

•

Verified SHC Patient

This was my 1st time at Stanford and was very pleased. Modesto's care is very bad.

Jan 2020

•

Verified SHC Patient

Dr. Poultsides excellent doctor.

Dec 2019

•

Verified SHC Patient

Very good. All the people very nice.

Dec 2019

•

Verified SHC Patient

I went to Stanford for a second opinion on my cancer treatment. I was given that I did it. It provided no new information.

Nov 2019

•

Verified SHC Patient

Dr. Poultsides is a wonderful & caring provider. We're blessed to have him as our care provider.

Oct 2019

•

Verified SHC Patient

The PA & nurses were very helpful in giving me details of what is happening & what to expect after chemotherapy.

Oct 2019

•

Verified SHC Patient

Very GOOD.

Oct 2019

•

Verified SHC Patient

I could every thing I got here in Fresno, but I thought my doctor/surgeon was the very best.

Aug 2019

•

Verified SHC Patient

Dr. Poultsides is terrific!

Aug 2019

•

Verified SHC Patient

I trust his knowledge and I could see his compassion. I wish he was able to help, but my situation is inoperable.

Jul 2019

•

Verified SHC Patient

Dr. Poultsides is not only super competent but a very good communicator. He is the best dressed physician at Stanford.

Jul 2019

•

Verified SHC Patient

Dr. Poultsides could not have been better with me. Really thorough and honest.

Jun 2019

•

Verified SHC Patient

Dr. Poultsides is outstanding I have have tremendous confidence in Dr. Poultsides.

Jun 2019

•

Verified SHC Patient

Very excellent.

May 2019

•

Verified SHC Patient

Superb professionalism.

Mar 2019

•

Verified SHC Patient

Dr. Poultsides was amazing and very caring. He always takes his time and demonstrates his dedication to the field of medicine.

Mar 2019

•

Verified SHC Patient

Dr. Poultsides is the BEST!

Nov 2018

•

Verified SHC Patient

Very good doctor.

Sep 2018

•

Verified SHC Patient

Dr. Poultsides is the most wonderful caring, dedicated physician.

Aug 2018

•

Verified SHC Patient

Dr. Poultsides is warm, caring, positive & very responsive to all my questions. He is an exceptional doctor! Kristan Wheeler was wonderful as well. Can't say enough good things about them!

Aug 2018

•

Verified SHC Patient

Comforting his knowledge of my situation and health.

Aug 2018

•

Verified SHC Patient

I truly trust Dr. Poultsides and will recommend him to others.

Aug 2018

•

Verified SHC Patient

Dr. Poultsides is beyond excellent doctor. He always take good care of me and I'm so lucky to have him.

Jul 2018

•

Verified SHC Patient

SUPREME!

Apr 2018

•

Verified SHC Patient

Well explained.

Apr 2018

•

Verified SHC Patient

Wish I could get a referral to an internal medicine dr. and pulmonary clinic in Stanford.

Apr 2018

•

Verified SHC Patient

Dr. Poultsides was very kind & professional - also continued to communicate by email.

Mar 2018

•

Verified SHC Patient

Dr. Poultsides was very professional and his staff really facilitated getting tests & studies scheduled extremely quickly.

Mar 2018

•

Verified SHC Patient

Dr. Poultsides is the most wonderful, professional physician ever.

Feb 2018

•

Verified SHC Patient

Top notch!

Jan 2018

•

Verified SHC Patient

Doctor Poultsides is the best doctor in the world. He brings my life back now and forever. My family love Doctor Poultsides so much.

Jan 2018

•

Verified SHC Patient

Dr. Poultsides is the absolute best!

Dec 2017

•

Verified SHC Patient

Dr. Poultsides is great. I would highly recommend him.

Dec 2017

•

Verified SHC Patient

I have complete confidence in Dr. Poultsides. He and his team provided a life-saving solution for my medical problem. Through surgery and follow up, I feel I have received world-class care.

Nov 2017

•

Verified SHC Patient

Doctor Poultsides is the BEST!

Oct 2017

•

Verified SHC Patient

Best care I have ever had at dr.'s office. Thank you for everything!

Oct 2017

•

Verified SHC Patient

I was able to see both surgeons while there and get a scan. Surgery was very well explained to me.

Sep 2017

•

Verified SHC Patient

All providers were top notch.

Aug 2017

•

Verified SHC Patient

Dr. Poultsides is "Da Bomb." Superb. Excellent. Great.

Aug 2017

•

Verified SHC Patient

Cancer is a serious scary thing, but some of us try to keep the scary at a distance with light humor. George is just a little stiff around the collar.

Jul 2017

•

Verified SHC Patient

Dr. Poultsides is an excellent doctor.

Jul 2017

•

Verified SHC Patient

Superb doctor & staff.

Jun 2017

•

Verified SHC Patient

We are pleased to be able to have the quality of the personnel to attend to our needs.

Apr 2017

•

Verified SHC Patient

Great service - I am a terrible patient when I do not feel good - he helped me a lot.

Apr 2017

•

Verified SHC Patient

Dr. Poultsides was extremely helpful.

Apr 2017

•

Verified SHC Patient

For me the best doctor in their specialty.

Apr 2017

•

Verified SHC Patient

Not on any medicine. We LOVE Dr. Poultsides. he is always available for issues & questions. Saved my husbands life. We cannot thank them enough!

Mar 2017

•

Verified SHC Patient

My care team is the very best.... always!

Mar 2017

•

Verified SHC Patient

Had some complications but the surg. and his dream team figured it all out! I did suffer a little but the made it as comfortable as the could without breaking the rules.

Mar 2017

•

Verified SHC Patient

He was amazing as was the whole team.

Nov 2016

•

Verified SHC Patient

Dr. Poultsides is wonderful.

Nov 2016

•

Verified SHC Patient

Dr. Poultsides & his team are exceptional. This includes his PA & RN. Knowledgeable & caring.

Aug 2016

•

Verified SHC Patient

Good.

Aug 2016

•

Verified SHC Patient

Very good experiences here your the best.

Jul 2016

•

Verified SHC Patient

Dr. P.'s people always tops.

Jun 2016

•

Verified SHC Patient

He never seemed rushed!

Jun 2016

•

Verified SHC Patient

Dr. Poultsides & care provider staff was great.

May 2016

•

Verified SHC Patient

Very professional

Apr 2016

•

Verified SHC Patient

You people are the best and I always go away knowing I have been well treated.

Apr 2016

•

Verified SHC Patient

Excellent care provider, I hope that you always continue having staff as well as very good qualities.

Apr 2016

•

Verified SHC Patient

Dr. Poultsides exhibited sincere interest in my wife's well being from his very first phone call to us. I have been amazed and impressed with how personally involved he has been.

Apr 2016

•

Verified SHC Patient

Excellent communication. Dr. answered all my questions. Very satisfied with my dr.

Mar 2016

•

Verified SHC Patient

Dr. Poultsides is very compassionate and patient. I felt he explained everything to me with great compassion and concern. He was very optimistic when discussing my prognosis which put me at ease.

Mar 2016

•

Verified SHC Patient

It was clear and specific the problem was explained to me very well and was very friendly, they are very specific in any problem to me I liked it and it was a good experience.

Mar 2016

•

Verified SHC Patient

My first visit seemed to go better and I felt much more reassured by the resident/PA and doctor as to the information I received regarding surgery options, my condition in general. Better listening and more detailed discussion. The first visit.

Mar 2016

•

Verified SHC Patient

Cannot say enough. Dr. Poultsides was GOD sent! Awesome.

Mar 2016

•

Verified SHC Patient

Dr. Poultsides was excellent, friendly doctor. He concerned all my problems and explained everything to me.

Mar 2016

•

Verified SHC Patient

I am so very appreciative for Stanford!!! Love my doctor

Jan 2016

•

Verified SHC Patient

Dr. George Poultsides is a very brilliant surgeon. I have great confidence on his expertise being a surgeon. He is very concern on the safety of his patient, definitely I will recommend him to others. His PA, Dr. Wheeler is very friendly too... thanks a lot for your great services.

Jan 2016

•

Verified SHC Patient

Dr. Poultsides is kind, sensitive & are of the BEST physicians I have ever met.

Dec 2015

•

Verified SHC Patient

Dr. Poultsides and Dr. Ganjoo very good at their jobs and take time to help this patient at each step in the process.

Dec 2015

•

Verified SHC Patient

Dr. Poultsides has a wonderful bedside manner -

Nov 2015

•

Verified SHC Patient

Dr. Poultsides, aside from being an excellent physician, is the most caring, thoughtful person!!

Sep 2015

•

Verified SHC Patient

Dr Poultsides is wonderful. He quickly took ownership of my problem and very possibly saved my life. I love him!

Sep 2015

•

Verified SHC Patient

My experience with the entire hospital was a life changing. Keep it up.

Aug 2015

•

Verified SHC Patient

Dr. Poultsides was an excellent doctor!! Very caring!!

Aug 2015

•

Verified SHC Patient

Dr. Poultsides is a gem. She should teach all other doctors how to interact with patients.

Jul 2015

•

Verified SHC Patient

Excellent doctor, would highly recommend.

Jul 2015

•

Verified SHC Patient

Dr. Poultsides work as a surgeon is exceptional.

Jun 2015

•

Verified SHC Patient

The best.

Jun 2015

•

Verified SHC Patient

Very good experience - Explained drugs very well -

Jun 2015

•

Verified SHC Patient

Dr. Poultsides & NP Kristen Wheeler both did exceptional work!

May 2015

•

Verified SHC Patient

Everything was explained.

Apr 2015

•

Verified SHC Patient

Dr. Poultsides is the BEST! "Very good" is not enough for him. You should add a "beyond excellent" category so that I can mark that!! Truly an amazing doctor and person.

Mar 2015

•

Verified SHC Patient

He is a great doctor!

Jan 2015

•

Verified SHC Patient

I wish you worked as a team. The surgeon knew the other doctors & you were in one location.

Jan 2015

•

Verified SHC Patient

I had a good experience.

Jan 2015

•

Verified SHC Patient

The very best of the best.

Dec 2014

•

Verified SHC Patient

Dr. Poultsides & his team were absolutely wonderful!

Dec 2014

•

Verified SHC Patient

Very grateful for all the care and attention from my doctors.

Nov 2014

•

Verified SHC Patient

Brilliant doctor.

Oct 2014

•

Verified SHC Patient

I was very impressed w/Dr. Poultsides and his nurse, Sara. I would have had my surgery there, if my insurance company would have allowed it.

Oct 2014

•

Verified SHC Patient

He's a very busy person, recognized as the best gastroenterologist/cancer man - but maybe is overwhelmed.

Sep 2014

•

Verified SHC Patient

Dr. Poultsides has gone above & beyond. He makes himself very available to his patients & that is truly fantastic. I know from first hand experience that not all doctors do this.

Sep 2014

•

Verified SHC Patient

Excellent second opinion. The process was flawless.

Sep 2014

•

Verified SHC Patient

Drs. Fisher and Poultsides and their PA's are both excellent and caring drs.

Aug 2014

•

Verified SHC Patient

Dr. Poultsides is the kindest doc. I've met.

Aug 2014

•

Verified SHC Patient

Dr. Poultsides is the best, listens to concerns & is a very caring dr. - A++++ - Thank you.

Jun 2014

•

Verified SHC Patient

Great doctor!

Mar 2014

•

Verified SHC Patient

Dr. Poultsides was very caring & listened & answered all my concerns. Thank you so much, you are the best.

Jan 2014

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

George A. Poultsides, MD, MS

Hepatobiliary surgeon, Pancreatic surgeon, Liver surgeon, Sarcoma specialist, Gastrointestinal specialist, Minimally invasive surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Benign Pancreas Program Redwood City, CA

Benign Pancreas Program

Hypertension Center Stanford, CA

Hypertension Center

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(396 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

George A. Poultsides, MD, MS

Hepatobiliary surgeon, Pancreatic surgeon, Liver surgeon, Sarcoma specialist, Gastrointestinal specialist, Minimally invasive surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Benign Pancreas Program Redwood City, CA

Benign Pancreas Program

Hypertension Center Stanford, CA

Hypertension Center

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(396 reviews)

Referring Physicians

PHYSICIAN HELPLINE